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Abstract  XV 
Abstract 
 
Mussels, marine organisms, attach to underwater surfaces by making a byssus, which is an extra-
corporeal bundle of tiny tendons attached distally to a foreign surface and proximally by insertion 
of the root into the byssal retractor muscles. The interaction exterior of byssus and marine surface 
is an adhesive plaque that contains different proportion of five mytilus edulis adhesive proteins 
(mefp-1 to 5). Relatively high contains of Lys, L-3,4-dihydroxyphenylalanine (DOPA), trans-4-
hydroxyproline, and trans-2,3-cis-3,4-dihydroxyproline formulates MAPs as an adhesive protein. 
Derivation of synthetic bio-adhesives from MAPs have been limited due to fairly unsuccessful 
synthesize adhesive polypeptides and poor yield in extraction from biological source. 
In this study, syntheses of mussel adhesive protein analogues have been performed. Several 
oligomers and polymers were synthesized with the comibation of bicyclic dipeptide building 
blocks, DOPA, Lys and Tyr. Use of bicyclic dipeptide building block has advantage over use of 
Hyp and Ser as former is expensive and latter needs side chain protection. Molecular structure, 
mass and size of these polymers were characterized using various techniques like NMR, MALDI, 
and GPC. The adhesive properties of these polymers were tested using diffusion ordered 
spectroscopy (DOSY) NMR experiment and AFM spectroscopy. Results obtained using AFM 
shows adhesion of poly-Lys-Bic-Tyr to graphite surface. These results open up a wide area in 
which finely tuned adhesive synthetic bio-polymers can be synthesized. 
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Zusammenfassung XVII 
Zusammenfassung 
 
Muscheln, marine Organismen, heften sich unter Wasser an Oberflächen durch einen Byssus an. 
Diese extrakorporalen Fibrillen aus winzigen Sehnen heften sich in der Ferne an fremde 
Oberflächen, deren Wurzeln mit der Insertion in den byssalen Retraktor der Muscheln enden. Die 
Wechselwirkung außerhalb des Byssus und an marinen Oberflächen kommt durch eine marine 
Plaque zustande, die aus „Muschel-adhäsiven Proteinen“ (MAPs) bestehen. Es wurden fünf 
unterschiedliche MAPs entdeckt, von denen mytilus edulis adhäsiv Protein- 1 (mefp-1) im größten 
Umfang untersucht wurde. Mefp-1 besteht aus sich wiederholenden Decapeptiden, von denen 
jedes Decapeptid aus zwei Lys, ein bis zwei L-3,4-Dihydroxyphenylalanin-Resten (DOPA), ein 
bis zwei Resten trans-4-Hydroxyprolin und ein Rest trans-2,3-cis-3,4-Dihydroxyprolin bestehen. 
Diese spezielle Umgebung aus Lys-, DOPA- und Hyp-Resten macht mefp-1 zu einem adhäsiven 
Protein, das wissenschaftliche Aufmerksamkeit auf sich gezogen hat als eine Vorlage für 
künstlich erzeugbare Bioadhäsiva. Versuche zur Synthese von adhäsiven Polypeptiden sind bisher 
ohne Erfolg. Ein limitierender Faktor ist die geringe Ausbeute bei der Extraktion dieser Proteine 
aus natürlichen Quellen. 
In dieser Arbeit wurden verschiedene synthetische Oligomere und Polymere hergestellt, die aus 
Amionosäuren-Analoga und Dipeptid-Blöcken bestehen. Die molekularen Strukturen, Massen 
und Ausmaße dieser Polymere wurden durch verschieden Techniken, wie NMR, MALDI und 
GPC charakterisiert. Die adhäsiven Eigenschaften der Polymere wurden durch DOSY-NMR-
Experimente und AFM-Spektroskopy getestet. Die Ergebnisse der AFM-Aufnahmen zeigen 
adhäsive Eigenschaften von poly-Lys-Bic-Tyr an Graphit-Oberflächen. Diese Ergebnisse öffnen 
ein weites Feld mit denen abgestimmte künstliche Biopolymere mit adhäsiven Eigenschaften 
synthetisiert werden können. 
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1   Preamble 1 
1. Preamble 
Emil Fischer introduced the concept of peptides and polypeptides and presented protocols for 
their synthesis in the early 1900s. Although others scientists contributed in those days, most 
notably Theodor Curtius, the co-worker of Fischer and his colleagues stands out. The chemistry 
developed by Fischer and others during those early days led to the production of molecules 
containing as many as 18 amino acids [1, 2]. Nonetheless, the syntheses performed were difficult 
and limited to simple amino acids, and the progress was slow for many years. Then the discovery 
of an easily removable carbobenzoxy protecting group in 1932 by Bergmann and Zervus provided 
new impetus by opening the way to the use of polyfunctional amino acids [3]. Later, synthesis of 
an active peptide harmone, by du Vigneaud (1953), was a sensation in the peptide synthesis as he 
used solution-phase segment condensation method. The attempts to syntheses peptides further 
stretched by new technique called solution phase stepwise addition method developed by 
Bodanszky and Williams (1967). Around the same time, Bruce Merrifield made a land-marking 
achievement by introducing solid-phase peptide synthesis [4], for which he was awarded Nobel 
Prize in chemistry in 1984. Invention of solid-phase peptide synthesis (SPPS) together with the 
enormous improvements in liquid chromatographic techniques have changed peptide chemistry 
from being a specialist area in which a few research groups were active, into a field where 
virtually any scientist whose research leads to the need for the synthetic peptides can utilize these 
synthetic techniques. 
In this thesis, synthesis and characterization of peptides derived from mussel adhesive proteins 
will be presented. These peptides are designed by mimicking the adhesive property of the mussel 
adhesive proteins. 
Marine organisms such as mussels and barnacles attach themselves to almost any kind of 
underwater solid surfaces using specialized adhesive mechanism that utilizes mixture of several 
proteins. These proteins belong to a family of protein and are named as mussel adhesive proteins 
(MAPs). So far, five adhesive proteins from the blue mussel have been isolated, namely, mytilus 
edulis foot protein-1 (mefp-1) to mefp-5 [5-8]. J. H. Waite and co-workers characterized peptides 
from tryptic digests being the first of these families of protein [9, 10]. Mefp-1 protein contains high 
Lys and hydroxylated amino acids such as DOPA, is formed by 897 residues and has a molecular 
weight in the range of 115-130 kD[11, 12]. Mefp-1 is mainly formed by two building blocks (or 
domains) consisting 71 decapeptides composed of the residues Ala-Lys-Pro-Ser-Tyr-DiHyp-Hyp-
Thr-Tyr-Lys and 12 hexapeptides containing Ala-Lys-Pro-Thr-Tyr-Lys with mainly random coil 
and partially helical conformation [13]. 
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The efforts to develop biomedical adhesives from mefp proteins have been hampered largely due 
to difficulties associated with the isolation of proteins from biological sources. Therefore, 
synthetic polymers are a potential source to mimic the adhesive characteristics of MAPs. 
Investigations on the synthesis of adhesive peptides and adhesive polymers, with incorporation of 
functional components of the MAPs, were performed by several groups [7, 14-17]. 
This work is continuation of earlier attempts and efforts that were focused on the design and 
synthesis of simplified adhesive peptides and polymers that mimic adhesiveness of the MAPs. 
The approach used in this thesis involves the use of dipeptide building blocks. Dipeptide building 
blocks are polar, rigid and stabilized by extended helical conformation found in the mefp-1. In the 
course, we seek to develop new polar adhesive oligopeptides and have a comprehensive 
understanding of the role of hydroxylated amino acids when adhering to marine wet surfaces. 
Synthetic adhesive peptides also will also prove important in clarifying the principle of molecular 
recognition of adhesive peptides. 
To begin with, chapter 2 starts with the introduction to the natural amino acids extending it further 
to non-protein amino acids. Introduction to the structural elements commonly found in proteins is 
then briefly given. 
Mussels make a byssal adhesive plaque to adhere to the wet surface. In chapter 3 an in-depth 
discussion on mussel adhesive peptides is featured. This includes all the five known mussel 
adhesive proteins (mefp-1 to 5), their occurrence, conformational studies and biological 
importance. This chapter also informs about the importance of amino acid like DOPA in MAPs. 
The second part of this chapter discusses previous attempts to synthesize poly amino acids, which 
would be analogues to the MAPs′. 
Chapter 4 comprises the synthesis of adhesive peptides that were designed and developed during 
this study. The synthesis of adhesive peptides was achieved in solution as well as in solid using 
Boc and Fmoc strategies. The bicyclic di-peptide building block, co-polymeric and polymeric 
amino acids were synthesized in an attempt to design synthetic adhesive biopolymers. 
Information on the molecular structure of these peptides was gained using 2D Nuclear Magnetic 
Resonance Spectroscopy, whereas molecular weight was determined by MALDI-TOF, gel 
permission chromatography (GPC) and gel electrophoresis. The details of these characterizations 
are mentioned in chapter 5. In order to test adhesive property of synthesized oligomers and co-
polymers, diffusion ordered spectroscopy (DOSY) and atomic force microscopy (AFM) was used. 
Chapter 5 has details of these studies with concluding evidences of adhesiveness of synthesized 
co-poymers. 
Chapter 6 gives summary of the research work performed in this thesis. 
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The detailed experimental procedures, analytical characterization of all the synthetic molecules 
performed during this study are listed in chapter 7. 
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2. Introduction 
Amino acids can be broadly divided based on the hydrophobic and hydrophilic character of its 
side chain. The hydrophobic amino acids include those with aliphatic side chains, such as, Ala, 
Val, Ile, Leu and Met, and those with aromatic side chains, such as Phy, Tyr and Trp. The 
hydrophilic amino acids include (i) neutral and polar side chains, such as, Ser, Thr, Asn and Gln; 
(ii) with acidic side chains such as Asp and Gln, and (iii) with basic side chains such as His, Lys 
and Arg. Ala with its small aliphatic side chain and Gly can be found in hydrophilic regions of 
peptides and proteins where as long alkyl chains of Lys and Arg give those residues an overall 
hydrophobic character with just the terminal charged group being hydrophilic. The two amino 
acids Cys and Pro have special properties. Cys contains a thiol to form a disulfide linkage by 
which peptide chains are covalently linked together to stabilize secondary or tertiary structure or 
to hold two different peptide chains together. Free thiols are also present in some proteins, where 
they often serve as ligands for metal chelation, as nucleophiles in proteolytic enzymes, such as 
papain or as carboxyl activators in acyl transferases. The second amino acid, Pro has specific 
conformational effects on the peptide or protein backbone both because of its cyclic structure and 
because of the alkylation of the amino group. It plays an important role in stabilizing or 
influencing the secondary structure of proteins [18]. All amino acids, except Gly, are chiral with an 
asymmetric center at α-carbon with the L absolute configuration at this center. The L does not 
refer to the direction of optical rotation but, rather to having the same stereo-chemical 
arrangement as L(-)-glyceraldehyde. In the more unambiguous Cahn-Ingold-Prelog convention, L-
amino acids have the S absolute conformation (except Cys, for which this configuration is defined 
as R). Additionally, Thr and Ile have a second asymmetric center at the β-carbon. Thr has the R 
absolute configuration at the β-carbon, and it is 2-(S)-amino-3-(R) hydroxybutonic acid. Ile has 
the S absolute configuration at the β-carbon; it is 2-(S)-methylpentanoic acid, because of the two 
asymmetric centers in the molecules, for stereo isomers exist for each of these amino acids. The 
D-amino acid has the opposite configuration at both asymmetric centers; D-Ile is the 2-(R)-3-(R) 
isomer. 
2.1. Peptides and Proteins 
A peptide is any group of compounds consisting of two or more amino acids linked by chemical 
bond. A peptide can be a short segment of a larger protein, often, a completely functional 
molecule by itself. Use of a fragment of a parent protein (as a peptide) is frequently useful as one 
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has to deal with relatively small molecule. Additional advantages could be ease in handling, less 
chances of biodegradation and proteolysis, uncomplicated and established synthetic methods to 
prepare in a laboratory. Peptides found in the human body can take the function of hormones 
(e.g., antidiuretic hormone), can form proteins, or may have functions in the digestive process 
(and therefore may be found throughout the body - in the digestive tract, blood, cells and tissues). 
Proteins, naturally occurring polypeptide chains, are formed by combinations of twenty naturally 
occurring amino acids. The choice of the amino acid and its position in the protein chain are 
determined by the corresponding DNA template. In a laboratory, proteins can be either over-
expressed in relatively simple cells (e.g., E.coli, yeast cells) by adding a gene of interest in the cell 
or can be extracted from respective tissues of living organism (e.g., collagen, soy). Proteins have 
evolved in nature to perform specific functions. Known functions of proteins encompass vast 
array of tasks such as enzymatic activity, building up large assemblies like muscle fibers or virus 
particles, regulating cell functions and signal transduction. These functional properties of proteins 
depend upon their three-dimensional structure. Understanding functional properties of a protein 
can be very important to reveal its biological significance, novel drug design as well as to prepare 
synthetic biomaterials. Together with structural data, functional aspects of a protein can be very 
useful, particularly, to design a tailor-made synthetic molecule with enhanced bioactivity. 
Therefore, mimicked synthetic biomolecule often functions better than its parent molecule. Such 
approach is routinely practiced today and synthetic analogues of many important biomolecules are 
available for study as well as for therapeutic purpose. 
The polyamide peptide backbone is also an important contributor to overall protein and peptide 
structures, a double-bond character is found in the carbon-nitrogen peptide bond due to the 
resonance structure shown in Figure 2 -1. 
 
 
 
Figure 2 -1: Resonance forms of an amide bond depicting zwitter-ionic form (on the right hand side 
structure). 
 
The amide bond is flat with the carbonyl carbon, oxygen, nitrogen, and amide hydrogen all lying 
in the same plane. No free rotation occurs about the carbon-nitrogen bond because of its partial 
double bond character. The torsional angle of that bond,ω , is defined by the peptide backbone 
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atoms Cα-CO-NH-Cα. Because of the partial double bond character, there are two rotational 
isomers for the peptide bond, namely, trans with ω  180≈ o  and cis with ω  0≈ o  as shown in 
Figure 2 -2. 
 
 
 
Figure 2 -2: The cis-trans isomerisation across peptide bond. Thick arrow indicates propagation of the 
peptide chain from and to connecting resides. In most of the cases a trans conformation is favored as it 
posses lowest free energy unless otherwise additional stability due to cis conformation. 
 
The lower energy isomer is the trans peptide bond, which is commonly found for all peptide 
bonds not involving Pro. In the case of amide bond involving Pro, the energy of the trans X-Pro 
bond is somewhat elevated, and both the difference in energy between cis and trans isomers and 
the barrier to rotation is lowered. Pro containing peptides thus will often exhibit cis-trans 
isomerization along trans X-Pro bond. It is found that the cis content of X-Pro peptides generally 
increase when X is a bulky and hydrophobic amino acid [19]. 
The resonance forms of the amide bond give it one other characteristic that is extremely important 
in peptide and protein structure. The amide bond is quite polar and has a significant dipole 
moment, which makes the amide carbonyl oxygen a particularly good hydrogen-bond acceptor 
and the amide NH a particularly good hydrogen-bond donor. Hydrogen bonds involving the 
peptide backbone are an important stabilizing factor in protein secondary structures. Peptide 
bonds of regular secondary structures, such as helices and β-sheets are internally solvated by the 
hydrogen bonds hat stabilize those structures. The peptide bonds of the random coil or irregular 
structures, also participate in an extensive network of hydrogen bonds involving internal polar 
side chains, bound water molecules and backbone interactions. 
2.2. Nonprotein Amino Acids 
Many naturally occurring amino acids exist that are not commonly found in proteins. Some of 
them, like γ-aminobutyric acid, have important functions as neurotransmitters. Others like 
ornithine appear as intermediates in metabolic pathways and dihydroxyphenylalanine is a 
precursor to amino acid derivative products. These unusual amino acids can confer unusual 
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biological activities on peptides that contain them. Such peptides have been the basis either of 
biochemical tool molecules or of antibiotics, immunomodulators or antineoplastic agents that 
have therapeutic utility [20]. 
Nonprotein organic amino acids can be roughly classified into a few basic structural types. Some 
nonprotein organic amino acids are simply the enantiomeric D-amino acid analogue of a protein 
L-amino acid, e.g., D-Ala and D-Glu, which are important constituents of the proteoglycan 
bacterial cell wall. Other has a normal α-amino acid structure but with a novel side chain. The 
side chain can be a simple alkyl group such as in norvaline. Some non-protein organic amino 
acids deviate from the normal α-carbon, such as the aminoisobutyric acid of the ionophoretic 
antibiotic peptide alamethicine [21, 22]. Also, in large number of non-protein amino acids, the 
amino group is not on the α-carbon but at some other position in the molecule [20]. Sometimes 
several of these features are combined in one amino acid such as in statine [3-(S)hydroxyl-4-(S)-
amino-6-methylheptanoic acid, Sta] which is the critical residue in the fungal orotease inhibitor 
pepstatin [23]. 
2.3. Strategies for Peptide Synthesis 
As stated earlier (cf. Chapter 1), peptide chemistry and synthesis have gone through dramatic 
changes since Crutius and Emil Fischer have synthesized the first simple peptide derivatives [1, 2]. 
The solid phase peptide synthesis technique, developed by Merrifield in 1963 [4], substantially 
facilitates the practical peptide synthesis procedure. In this approach, the anchoring of the C-
terminal amino acid to the insoluble support allows the use of an excess of amino acids and 
coupling reagents, which enables almost quantitative yields for the coupling steps of small 
peptides. Furthermore, after reaction, coupling and by-products can be removed by simple 
filtration. 
The synthesis of peptides longer than two amino acids requires the tactical utility of orthogonal 
temporary and permanent protecting groups [24]. Amongst several approaches developed so far, 
the Boc-strategy [25-28] and subsequently developed Fmoc/tBu-strategy [27-30] are most prominent 
today. The Fmoc/t-Bu-strategy has proved to be especially practical in combination with SPPS 
and has been represented in Figure 2 -3. 
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Figure 2 -3: Peptide synthesis according to the Fmoc/tBu-strategy on a solid support. 
 
Solution phase peptide synthesis is also one of the effective synthetic methods for the preparation 
of small peptides and oligomers. Introduction of Nα-protected amino acids in solution phase 
synthesis normally involves in situ carboxyl activation of the incoming amino acid. The 
mechanism of peptide bond formation involves the attack of a nucleophilic α-amino group upon 
the activated carboxyl function of a protected amino acid or peptide segment. 
Several other coupling methods such as the azide process [1], acid chlorides [31], acid fluorides [32] 
or nitrophenyl- and pentaflurophenyl active esters [25, 33], were developed in the course of time 
though the use of in situ activated amino acids became very popular. Suitable condensing agent 
such as DCC, BOP and HBTU can be employed to mediate coupling via in situ activation [34]. In 
situ activation reagents are widely accepted as they are easy to use, give fast reactions, even 
between sterically hindered amino acids and their use is generally free from side reactions. 
Most are based on phophonium or iminium salts, under basic condition they convert protected 
amino acids to a verity of activated species. Most commonly employed BOP, PyBOP, HBTU and 
TBTU, generate OBt esters, and these have wide application in coupling reactions. 
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In comparison to other coupling reagents such as DCC, BOP couplings are essentially 
recemization free and exhibits superior kinetics [35, 36]. However, the use of BOP reagent in 
peptide synthesis is avoided since it leads to the formation of hexamethylphosphoric triamide, a 
respiratory toxin and possible carcinogen [37]. Chemical structure of some of these coupling 
reagents is given in Figure 2 -4. 
 
 
 
Figure 2 -4: Coupling reagents commonly used in peptide synthesis. (A) DCC; (B) PyBOP and (C) 
TBTU/HBTU. 
 
Replacement of phosphorus atom in BOP by carbon atom yields, o-benzotriazolyl-N, N, N′, N′-
tetramethyluronium hexafluorophosphate salt (HBTU), like the BOP reagent. HBTU was found to 
be an excellent coupling reagent for peptide synthesis in solution and solid phase. The amount of 
racemization of the synthesis peptides was very low and the reaction time was fast [38]. BOP can 
be substituted by PyBOP, which is an expensive reagent. If the reagent used excess then 
carboxylic acid component as this can lead to capping of the amino terminus through guanidine 
formation [39]. 
Coupling reagent which generate more reactive active ester then OBt are also accomplished. 
Under basic condition HCTU generate corresponding 6-ClOBt ester are more reactive than their 
OBt counterpart owing to the lower pKa of HOCt compared to HOBt (pKa 3.35 for Cl-HOBt and 
4.60 for HOBt). HCTU was found to give superior results to PyBOP and TBTU in the synthesis 
of difficult peptides [40] and in hindered coupling [41]. 
Koenig and Geiger have led to the recommendation of 1-hydroxybenzotriazole (HOBt) as a most 
efficacious in situ additive for coupling in peptide synthesis. The active species in solution is 
presumably the 1-hydroxybenzotriazole ester, which is aminolyzed at a rate about 103-fold faster 
than N-hydroxysuccinimide and similar active esters because of a concerted bifunctional catalytic 
mechanism [42, 43]. These coupling additives are shown in Figure 2 -5. 
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Figure 2 -5: Chemical representations of the coupling additives such as (A) HOBt, (B) HOAt and (C) 
DIPEA. 
 
Upon addition of benzatrazoles HOBt and/or Cl-HOBt to the carbodimide base, coupling reagents 
leads to the formation of benzatrazol active esters. These esters are less reactive then the o-
acylisourea lowering racemization of protected amino acids and avoiding the formation of other 
derivatives [44]. Cl-HOBt performs at least as well as HOBt [45, 46], but since it is more acidic and it 
is better leaving group and its active ester are more reactive than OBt ester another advantage in 
Cl-HOBt is that the chlorine atom stabilise the structure, making Cl-HOBt less hazards coupling 
reagent. HOBt and Cl-HOBt are also added to the aminium salt mediated coupling reactions with 
the purpose of favouring the active ester formation, thus HOBt and Cl-HOBt are used as an 
additive together with HBTU to suppress recimization. 
2.4. Structural Elements of Proteins and Peptides 
Protein (henceforth also peptide) structures are organized in several hierarchical levels of 
increasing structural complexity. The most basic level is the primary structure or amino acid 
sequence. Secondary structure is formed by the folding up of short segments of the protein chain 
into regular structures such as α-helices, β-sheets and turns. Tertiary structure describes how the 
secondary structural elements of a single protein chain interact with each other to fold into the 
native protein structure. Quaternary structure involves the interaction of individual protein 
subunits to form a multimeric complex [47]. 
In the design of peptides, the primary structure or sequence of a protein is readily obtainable by 
chemical sequence analysis of the isolated purified protein or by translation of the corresponding 
DNA coding sequence. Computer programs are available to analyze and compare protein primary 
structure [20]. 
Amino acid chains can fold into several types of regular structures that are stabilized by intra-
chain or inter-chain hydrogen bonds in the amide backbone. Helixes and turns are formed from 
continuous regions of protein sequence and are stabilized by inter-chain hydrogen bonds. The 
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parts of a protein sequence that do not appear in helices, sheets or turns are said to be in random 
coil. 
The conformation of the peptide backbone can be described by three torsional angles: φ , which is 
the angle defined by C(O)-N-Cα-C(O); ψ , which is defined by N-Cα-C(O)-N; and the amide 
torsional angle ω , these angles are shown graphically in Figure 2 -6. 
 
 
 
Figure 2 -6: Demonstration of the peptide backbone torsion angles, φ , ψ  and ω . Only certain 
combinations of the angle φ  and ψ  are allowed, while the amide torsional angle ω  remains planar. Thus 
information of the torsion angle can be very helpful for the structure calculation and/or prediction. 
 
The convention in protein chemistry is that these angles are defined with respect to the peptide 
backbone. The angle φ is 180° when the two carbonyl carbons are trans to each other and the 
angle ψ is 180° when the two amide nitrogen are trans to each other as in Figure 2 -7. The angle 
ψ, therefore, is +180° compared to the usual chemical definition. A fully extended peptide chain, 
however, would have backbone torsional angles close to 180°, just like a fully extended carbon 
chain. 
 
 
 
Figure 2 -7: Newman projections for the torsion angles φ  = 180° (A) and ψ  = 180° (B) in a typical 
extended polypeptide chain.  
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2.4.1. Helices 
One of the common types of secondary structure in protein is the helix in which amino acid 
residues are wrapped around a central axis in a regular pattern. Trans and planar peptide bonds as 
well as helices can be uniquely defined by their φ  and ψ  angles. Several types of helices are 
found in protein structures, the α-helix being the most common. These helices and their 
characteristic torsional angles are listed in Table 2 -1. 
 
Table 2 -1: Possible helical structures and their φ  and ψ  combinations. 
 
Type of Helix φ  ψ  
α-helix (right-handed) -57° -47° 
α-helix (left-handed) 57° 47° 
310 helix -60° -30° 
Collagen helix 
-51° 
-76° 
-45° 
153° 
127° 
148° 
Polyproline -78° 149° 
 
Helices are also characterized by the number of residues per turn and the hydrogen bonding 
pattern, specifically the number of atoms in the cyclic structure formed by the hydrogen bond. 
There are two most relevant helices for protein and peptides, which is defined by the screw sense 
of the helix. Looking down the helical axis from amino terminus to carboxyl terminus in a 
clockwise sense in a right handed helix, helical structures are stabilized by intra-chain hydrogen 
bonds in a helix, the carbonyl bonds and amide NH bonds lie parallel to the helix’s axis with the 
carbonyls pointing downward, in the direction of the carboxyl terminal of the helix and the NHs 
pointing upward in the direction of the amino terminus. 
In an α-helix, the carbonyl of any residue i is hydrogen-bonded to the amide NH of the i+4 
residue; that is the residue four amino acids farther down along the peptide chain. In a 310 helix, 
the carbonyl of ith residue is hydrogen bonded to the NH of i+3 residues (see Figure 2 -8). 
The helix forms a polyamide cylinder. The uniform arrangement of carbonyl and NH groups 
impacts a strong dipole moment to the helix, with the positive end at the amino terminus and the 
negative end at the carboxyl terminus. The side chains of residues are arranged radially outwards 
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A                B                   C                        D
 
 
Figure 2 -8: Ribbon (A) and space fill model of helices (B, C and D). B represents a right handed α-helix 
with a top view. C and D represent a 310 and π type of helices. Both panel C and D also shows top view of 
the corresponding helices (Figure reproduced from [48]). 
 
from the helix, looking down the helix axis. Because all the backbone amide groups are involved 
in intra-chain hydrogen bonds, the interactions of helices with other peptide chains or small 
molecules occurs predominantly through side-chain interactions (hydrophobic interactions, salt 
bridges and hydrogen-bonding interactions and side chain interactions) and the interactions with 
helix dipole itself. Because of the arrangement of inter-chain hydrogen bonds, the amide bonds of 
the helix can be thought of as being internally solvated, resulting in the helix being more readily 
accommodated in a nonpolar environment, such as a lipid bilayer. The membrane-spanning 
regions of transmembrane proteins are generally with the axis of the helix perpendicular to the 
plane of the membrane [49, 50]. 
2.4.2. β-Strands and Sheets 
Linus Pauling and Corey derived a model for the conformation of fibrous proteins known as beta-
keratins [51]. In this conformation the polypeptide does not form a coil, but zigzags in a more 
extended conformation than the α-helix. A section of polypeptide with residues in the β-
conformation is referred to as a β-strand and these strands can associate by main chain hydrogen 
bonding interactions to form a β sheet. 
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The conformation of each peptide chain is generally extended and inter-chain hydrogen bonds 
occur between the carbonyl oxygen and the amide NH of every other residue in the backbone. 
Two possible arrangements of adjacent strands occur parallel, in which each peptide strand runs in 
the same direction and antiparallel in which the peptide stands run in opposite directions. Both 
type of sheets can be found in protein structures, these two arrangements are shown in Figure 2 -9. 
 
 
 
Figure 2 -9: Ball and stick representation of anti-parallel (A) and parallel (B) sheets. Black: Carbon, Blue: 
Nitrogen, Red: Oxygen and White: Proton (Figure adopted from [52]). 
 
The β-structure can be thought of as forming a surface or sheet, although there is a slight twist to 
it because the peptide backbone is not fully extended. In contrast to the α-helical residues, amino 
acid residues in the β-conformation have negative φ  angles and the ψ  angles are positive. The 
torsional angles for β-structure are given in Table 2 -2. 
 
Table 2 -2: Possible β-sheet structures and the allowed φ  and ψ  combinations. 
Type of β-sheet φ  ψ  
Parallel β-sheet -119° 113° 
Antiparallel β-sheet -139° 135° 
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The side chains extend roughly above and below the plane of the sheet, with every other side 
chain on one surface, because the inter-chain hydrogen bonds between two adjacent chains 
involve only every other residue and there is a possibility of larger structures forming that involve 
many strands. Another structural motif is that twist of the β-structure also allows sheets to fold 
into cylindrical structures is called as β-barrels. 
2.4.3. Turns 
Turns are the third type of classical secondary structures. Approximately one-third of all residues 
in globular proteins are contained in turns that serve to reverse the direction of the polypeptide 
chain. 
Turns are classified by the number of residues that are involved in the regular structure; β-turns 
contain four amino acid residues, while γ-turns contain three residues. Each structure is stabilized 
by a hydrogen bond extending across the turn, in effect holding the two ends together.  
The first residue of a turn is usually designated as i. In a β-turn, the hydrogen bond is between the 
carbonyl of the i residue and the NH of the i+3 residue, giving the equivalent of a 10-membered 
ring. There may be an additional hydrogen bond between the NH of the i residue and the i+3 
residue, as if they were an incipient antiparallel β-structure (see Figure 2 -10).  
 
 
 
Figure 2 -10: A ball and stick representation of a β-I (A), β-II turn (B), β-I’ turn (C), and β-II’ turn (D). 
Intermolecular hydrogen bond is denoted by bond dashed lines. In panel A and B, COi+1 and 
intermolecular hydrogen bond are below the plane whereas in latter two cases they are above the plane. 
Each residue is numbered starting from αi. Atoms colours used are, carbon: big sized white; nitrogen: blue; 
hydrogen: small sized white; and oxygen: red. 
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In a γ-turn, the hydrogen bond is between the carbonyl of the i residue and the NH of the i+2 
residue, giving the equivalent of a seven-membered ring. Several type of β-turns are possible, the 
planer amide bond β and γ turns are uniquely defined by the torsional angles of the internal 
residues i+1 and in the case of β-turns, i+2. Type III is simply a single turn of a 310 helix. 
The peptide backbone in a turn forms a rough plane that contains the intra-molecular hydrogen 
bond. In a β-turn, the amide bond between the i+1 and i+2 residues lies perpendicular to this 
plane since it is not part of the hydrogen bonding structure of the turn. 
In protein, β-turns are most often found on the protein surface, where the i+1-i+2 peptide bond 
can be solvated by bulk solvent. When such a turn is located in the (generally hydrophobic) 
interior of a protein, it is often solvated by a bound water molecule [53]. Beside the amide bond, 
the side chains of the i+1 and i+2 residues, which form the corners of the turn, are also 
particularly exposed. In case of small peptides such as vasopressin or somatostatin, where a turn 
has been postulated based on the cyclic nature of the peptide chain, the corner residues are 
implicated as important elements in the expression of the biological activity of the peptide [54, 55]. 
Side chains will adopt either a pseudo-axial or pseudo-equatorial arrangement around the cyclic 
hydrogen-bonded turn structure. One diagnostic criterion for the importance of a turn involves 
changing the chirality of a corner residue to allow the side chain to be in the more stable 
equatorial configuration without otherwise alternating the peptide backbone structure. 
Replacement of this residue with a D-amino acid should allow for equatorial placement of the side 
chain while the peptide backbone remains unchanged, lowering the overall free energy of that 
structure and making it more stable. Replacing the i+1 residue with a Gly with no side chain 
should have a similar effect. 
Since a turns have several unsatisfied backbone hydrogen bond donors and acceptors, they are 
polar, and are usually found near the surface of the protein. Pro is very common in turns, as it 
always has the correct φ  angle. Gly is also very common in turns because its R group presents 
little steric hindrance. 
2.4.4. Structural Motifs 
In biological macromolecules, structural patterns are often repeated across different molecules. 
The introduction of the term as super-secondary structures or motifs was necessary when it 
became clear that certain arrangements of two or three consecutive secondary structures (α-
helices or β-strands), are present in many different protein structures, even with completely 
different sequences. 
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Classic units of structural motifs include the α-α unit where two α-helices are joined by a hairpin 
bend changing the chain direction by 180°. Another common structural motif is β-β unit with two 
anti-parallel β-strands connected by a hairpin. The β-α-β motif is formed by two parallel β 
strands, separated by an α-helix, anti-parallel to them, with two hairpins separating the three 
secondary structures.  
Other motifs of super-secondary structures those are commonly found are α-β-β  and β-β-
α units [56]. Detection of these common motifs in a new molecule can provide useful clues to the 
functional properties of such a molecule [47]. 
In addition to these structural patters, it has been also found that a protein can have repeats of a 
particular sequence, particularly, if the sequence is vital for the associated function. The Gly-Pro-
Hyp tri-peptide repeat of collagen is well known whereas elastin contains as many 15 repeating 
hexapeptides and 11 pentapeptides in a run [57]. Silk fibroin has 50 repeats of a sequence that is 
59-residues long. Recently the Pro-rich submaxillry protein of saliva was found to contain four 
repeats of a heptapeptide [58]. 
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3. Mussel Adhesive Proteins 
The tenacious holdfasts of barnacles and mussels have been long known for their hard adhesive 
bonds with the underwater marine surfaces. These holdfasts are protein based adhesives exhibit 
striking materials properties and are formed by extensive cross-linking of protein precursors [59-61]. 
This cross-linking approach to biomaterial synthesis is shared by glues from mussels, limpets, and 
kelp, cements from barnacles, oysters, and polychaete worms, coral skeletons, and skate egg shell 
cases [60, 61]. There is lack of a detailed picture of the bonding schemes employed for material 
construction in all these cases although large numbers of researchers from various areas of 
sciences are involved. These attempts have revealed some basic features of the organs and the 
adhesives. For example, mussel adhesive plaques, post-translational inclusion of 3,4-
dihydroxyphenylalanine (DOPA) into the protein is indispensable for subsequent cross-linking 
and proper adhesion [59-61]. Other interesting properties of the mussel glues include a transition-
metal-ion content (e.g., copper, iron, and zinc) [62, 63] up to 100000 times that found in open ocean 
waters [64]. 
Biomedical and commercial use of the adhesive properties of these substances have been sought 
by many groups [65] such as in experimental epikeroplasty and for cellular attachment [66, 67], and 
in the attachment of osteoblasts and epiphyseal cartilage cells to substrata [68]. The strong adhesive 
properties have recently inspired a proposed use for these proteins as mucoadhesives for drug 
delivery [69], and these substances may offer a strong alternative to substances such as 
chitosans [70]. 
However, the small yields obtained in the extraction from biological sources and difficulties in the 
laboratory expression made these proteins luxurious for studies. To overcome this situation many 
groups have been involved in mimicking the adhesive properties of MAPs into relatively simple 
and easy to produce synthetic polymers. As has mentioned before, our attempt here is to 
synthesize peptides and co-polymers of amino acids that are abundant in MAPs, and have been 
known to contribute adhesive properties. Further insights into synthetic schemes and strategies, 
however, can only be gained by fully understanding the principles of adhesion used by mussels. 
This chapter is devoted to this introduction. 
3.1. Byssus Adhesive Plaque 
Mussels attach to marine underwater surfaces by making a byssus, connective tissue peculiar to 
mussels. The byssus is an extra-corporeal bundle (thread) of tiny tendons attached distally to a 
3   Mussel Adhesive Proteins 19 
foreign surface and proximally by insertion of the root into the byssal retractor muscles [71]. It is 
deposited outside the boundaries of living tissue and contains no cells for maintenance or repair. 
Byssus functions in providing mussels with secure attachment to rocks and pilings. Byssus 
mediates contact between very soft living tissue and a very stiff inert material such as rock or ship 
hull. 
 
 
 
Figure 3 -1: A photograph showing mussels adhering to the glass surface (Reproduced from [72]). 
 
Every individual mussel byssus thread represents a unit of attachment with the distal end bonded 
to rock and proximal end inserted into living mussel tissue (see Figure 3 -1). Each thread 
measures between 2 and 4 cm in length and 50 µm in diameter (in Mytilus edulis and M. 
galloprovincialis). These threads were dubbed ‘collagenous’ on the basis of fiber X-ray 
diffraction [73, 74], hydroxyproline content [75], amino acid composition [76-78] and shrinkage 
temperatures [79]. The collective evidence presents a strong case, some of the extraordinary 
properties of byssus are hard to reconcile with typical collagens. These include the high melting 
temperature, lack of banding patterns and resistance to denaturants, acids and 
proteases [79, 80].According to several lines of evidence, byssal threads are not uniformly 
collagenous throughout, i.e., the diffractive and mechanical properties typical of fibrous collagen 
are best reflected at the stiff distal end of the fibrous collagen are best reflected at the stiff distal 
end of the thread, whilst the more extensible or elastic proximal end seems to be disordered [81, 82]. 
This has lead to the suggestion that protein gradients including a collagen gradient occur along the 
length of each byssal thread [81, 83]. 
Byssal threads are assembled by the mussel foot from granular precursors in a rapid process 
resembling polymer injection-molding [84]. When a new thread needs to be made, fiber-containing 
granules are released from large holocrine glands and conducted through ciliated ducts into the 
ventral groove of the foot, which serves as the mold. There they coalesce into a thread that is 
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shaped, and possibly oriented, by peristalsis in the groove. Before being disengaged from the 
groove, the thread is sized by a protective coating [84]. 
Scanning electron microscopy and biomechanical studies have established that it is much more 
than a tether but represents a mechanically graded fiber that is significantly stiffer at the distal end 
where it joins to the attachment plaque than at the proximal end where it joins to living tissue (see 
Figure 3 -2). The stiffness in tension at the distal end is 500 MPa in M. galloprovincialis, whereas 
at the proximal end it is only 50 MPa [71]. This ten fold reduction in the distal to proximal 
direction does not adequately compensate for the remaining mismatches with the rock (25 GPa) or 
the byssal retractor muscles (0.2 MPa). These can be addressed by additional adaptations vested 
in the plaque and stem structures [85]. 
 
 
 
Figure 3 -2: Schematic mussel on the half-shell with one byssal thread showing the incremental steps in 
stiffness, Ei, from the retractor muscles to the rock. Note the 10-fold decrease in stiffness between the 
distal and proximal portions of the thread (Reproduced from [86]). 
 
The disparity between the mechanically graded mussel byssal thread and Anaphe cocoon silk 
(spider dragline) may reflect differences in the processing of the two tissues. In the latter case the 
stiffness is even but still high (10 GPa). Silk is spun from a pair of ampullate glands containing 
polymer liquid crystals (LC) [87] whereas byssal threads are reaction-injection molded in the 
mussel foot from mixture of polymer LCs exuded from at least a dozen different pores [84]. The 
process of generating a solid structure from the molded LCs might be driven by covalent cross-
linking and intermolecular metal ligand bridges. 
High degree of cross-linking in byssal threads made it insoluble in any extraction method. 
Fortunately, pepsin digestion does not deter the native triple helical structure of the collagen 
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domain allowing PreCOL- D, P and NG* collagenous remnants to be compared from each thread 
segment [88]. These investigations concluded that the distribution of the preCOL-D and -P 
domains along the thread axis in the byssal threads [85]. PreCOL-D decreases from distal to 
proximal, whereas preCOL-P, which starts beyond midlength, increases from midlength to 
proximal. 
In addition to ProCOL-P and -D, Ptmp-1 is also found in byssal proteins which is distributed as 
gradient and increases towards the proximal end of the thread [89]. Ptmp-1 is a protein with two 
von Willebrand type-A domain repeats. In contrast, Gly-, Tyr- and Asn -rich protein dtmp-1 is 
concentrated towards the distal end. Both of these proteins are present at concentrations of < 10% 
those of the preCOLs and appear to serve as a matrix between the preCOL fibers. 
A thin protective protein coating, dubbed mefp-1 (mytilus edulis foot protein -1), protects the 
threads from abrasion by sand as well as degradation by bacteria and other microorganisms. The 
presence of mefp-1 to mefp-5 is also located at the end of each thread, in an adhesive plaque, 
allowing plaque to anchor to wet solid surfaces [6]. 
3.2. Mytilus Edulis Adhesive Proteins 
3.2.1. Mytilus Edulis Adhesive Proteins -1 (mefp-1) 
Mytilus edulis adhesive protein-1 has a molecular weight of 115 kDa based on mass 
spectroscopy [11] and of 130 kDa on the basis of gel chromatography [12]. Mefp-1 protein is mainly 
built from two building blocks 71 deca-peptides composed of the residues Ala1-Lys2-Pro3-Ser4-
Tyr5-Pro6-Pro7-Thr8-Tyr9-Lys10 and 12 hexa-peptides containing Ala1-Lys2-Pro3-Thr4-Tyr5-Lys6 
as shown in Figure 3 -3. 
The deca-pepetide part contains three post-translation modifications. First being at the 6th residue 
in which a Pro converts to dihydroxyproline, second at the 7th position where a Pro gets modified 
into a hydroxyproline. The third modification which more important, as we will see in the 
following sections, leading to a conversion of Tyr to 3,4-dihydroxyphenylalanine or DOPA. Tyr 
at the 5th position in the hexa-peptide also gets modified into DOPA. These hydroxylated amino 
acids constitute the strikingly high percentage of mefp-1 protein. 
                                                 
* PreCOL is a block copolymer that contains a central collagen domain, which occupies roughly half of the preCOL. 
Its other domains are the N- and C-terminal His-rich domains (HIS), the flanking domains, and an acidic motif. The 
collagen domains are highly homologous in the three known variants, preCOL-P, -D, and -NG in which the 
postscripts P, D and NG denote proximal distal and non-graded respectively. 
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Figure 3 -3: The location of the deca- and hexapeptide on the backbone of mefp-1 based on DNA 
analysis (Reproduced from [11]). 
 
Like the deca and hexa peptide the N-terminus non-repetitive domain is hydrophobic and rich in 
Lys residues. Between different populations of mussels, the composition of the decapeptide itself 
remains roughly the same. The presence and location of the Tyr and/or DOPA and Lys in this 
sequence is completely invariant. 
The origin of hydroxyproline and DOPA in mefp-1 is difficult to explain with the exception of 
post translational enzymatic hydroxylation. In the pioneering study, Henkens and co-workers 
characterized the enzyme modifications of 20 repeats of the original peptide sequence (Ala-Lys-
Pro-Ser-Tyr-Pro-Pro-Thr-Tyr-Lys) using mushroom tyrosinase. It has been long known that 
mushroom tyrosinase can introduce site-directed modifications. It catalyzes both the 
hydroxylation of monophenols such as Tyr, including protein tyrosyl groups and oxidative 
dehydrogenation of o-diphenols [90]. In the presence of high concentrations of ascorbate the 
reaction can be limited to hydroxylation as the o-quinone is reduced back to the o-diphenols by 
ascorbate. Mushroom tyrosinase oxidizes Tyr-26 in the β-chain of insulin at the rate 13 times 
faster than Tyr-16 which is thought to be buried [91]. Henkens and co-worker suggest that there are 
two tyrosyl reactivities in the 20-mer analogue of the polyphenolic protein. These vary in their 
rate of hydroxylation by a factor of about 20. The sequence of the hydroxylated peptide derived 
from the 20-mer by trypsinization indicated that Tyr-9 is almost completely converted to DOPA 
by tyrosinase, while Tyr-5 is only marginally modified in the peptides. Perhaps Tyr-9 is the more 
accessible of the two in the folded structure. This pattern of hydroxylation is similar to that of the 
natural (wild-type) protein, expect that the levels of Tyr-5 to DOPA conversion at 3h in the 20-
mer are somewhat lower that those in polyphenolic protein. 
Although hydroxyproline is erroneously assumed to be unique to collagenous proteins, in the 
polyphenolic protein most or all of the hydroxyproline remains associated with the Gly-deficient 
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collagenase-resistant fragment. The collagenase labile moiety may contain a collagen-like domain 
such as that in torpedo acetylcholinesterase [92] and alvrolar glycoprotein [93]. Waite detected 
DOPA in another protein (periostracin) also from Mytilus, but there are no other known reports 
of its natural occurrence in that protein. The role of the DOPA in protein is still a matter of 
speculation [94]. Recent studies are worth mentioning in light of their relevance to adhesion: 
a) o-diphenols (including DOPA) and o-quinones can irreversibly displace water from a 
surface [95]. 
b) o-diphenols are readily oxidized to o-quinones which undergo nucleophilic addition reaction 
with primary amines such as lysine via Michael addition [96]. 
c) Bis and tris complex of DOPA with multivalent metal ions present in the marine environment. 
i.e., copper, Iron, manganese and zinc [72, 97]. 
In order to make intimate contact with a surface, the polyphenolic protein needs first to displace 
water molecules from that surface whether it relies on DOPA residues to accomplish this remains 
to be shown. For case (b), some kind of protein cross-linking in the adhesive plaque is suggested 
by the insolubility of material in all but hydrolytic solvents [79].The formation of DOPA quinine is 
known to be catalyzed by a DOPA oxidase in the foot and byssal secretion of the mussel [98-100], 
DOPA-Lys cross-links have yet to be isolated, Ketamura and coworker [101] observed that, the 
proton of Tyr may be effective at pH 11.2. The NOESY spectrum obtained by NMR spectroscopy 
showed that a Lys residue lay close to a Tyr residue, within at least 5Å. Although these residues 
can be adjacent to each other, it is clear that their side chains are close. This means that a Lys 
residue and a Tyr residue can react not only between molecules but also within the molecule to 
form the o-quinone linkage after the modification of tyrosinase. Formation of covalent cross-links 
in the polyphenolic protein could serve to improve the cohesive performance of the substance. 
With regards to third point, the adhesive properties of DOPA have long been speculated as to 
direct interactions between the catechol side chains of DOPA and the surface to which they are 
adsorbed. It is known that the catechol has strong binding affinity to several metal ions 
particularly Fe (III). The protein has the capacity to bind between 50 to 75 tightly complexed 
ferric ions depending on whether it adopts a tris- or bis-(catecholato) coordination mode. Mefp-1 
is applied to the byssus as a lacquer-like coating; the addition of ferric iron may render it an “iron-
clad” finish and contribute to the notorious intractability of this material. In the presence of ferric 
iron, mefp-1 forms an extremely complicated macromolecular coordination of ferric ion. 
Notwithstanding the current study that mefp-1 behaves very similarly to low molecular weight 
catecholates like the siderophores, the protein can solubilize ferric iron even when resent in 
polynuclear hydrolytic species inaccessible to simple complex agents. 
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In previous studies, the interaction of ferreascidin, a 10 kDa DOPA glycoprotein from the blood 
cells of the ascidian pyura stolonifera, with ferric ion revealed that the protein adopts a bis 
(catecholato) coordination mode with possibly one Tyr ligand [102]. Subsequently, it was shown 
that ferreascidin binds iron (III) as novel bi-and trinuclear cluster [103]. 
S. W. J. Taylor found that peptides derived from mefp-1 bind to Fe (III) in bis- and tris-
(catecholate) coordination [104]. Using spectrophotometric titrations, electron paramagnetic 
resonance (EPR) and resonance Raman spectroscopy, Waite and co-workers [105] studied the bis 
and tris complex of DOPA with multivalent metal ions present in the marine environment may 
also contribute to cross-linking (see section 3.3). 
DOPA probably owes its existence to a protein-specific 3-tyrosylhydroxylase. An examination of 
sequences reflected an enzyme preference for Tyr in the sequence Hyp-Hyp-Thr-Tyr or Pro-Pro-
Thr-Tyr, depending on the priority of hydroxylations [5]. Tyr is present almost entirely as DOPA 
in such sequences. Conversion to DOPA is lowered to 50% in the sequences Lys-Pro-Thr-Tyr and 
Lys-Pro/Hyp-Ser-Tyr. Hydroxyproline is detected as two trans isomers in sequences atypical of 
collagen. This distinguishes the polyphenolic protein along with elastin [57] and 
geographotoxins [106, 107] as the only known animal protein with hydroxyproline in non-
collagenous sequences. The putative 4-prolylhydroxylase demonstrates specificity for the 
sequences Pro-Ser / Thr-Tyr and Pro-Ser / Thr-DOPA depending on the order of hydroxylation. 
Additional specificity is indicated by the fact that unhydroxylated Pro is never detected in the 
second position of the sequence Hyp-Hyp-Thr-DOPA. 
From long decades several groups are trying to solve the conformation of the mefp-1 protein using 
different analytical data. Protein residues contain (Ala, Lys and DOPA) with strong α-helix 
potential and others (Thr, Tyr and Ser) with β-sheet propensities. The high frequency of imino 
acids, however, is theoretically capable of breaking either of the above conformation or imposing 
a poly(L-Pro) type-II helix [9]. The non-collagenous hydroxyproline rich glycoproteins from the 
cell walls of algae [108, 109], plants [110] and in some bacterial capsules [111] probably do have some 
poly(L-Pro) type-II helical structure [112]. 
Using model peptide obtained by E. coli expression system, which has the similar structure to that 
of the native adhesive protein from a marine mussel Kitamura and co-workers [101] studied the 
Circular Dichromism (CD) spectrum, which indicated that about 80% of this peptide existed in a 
random coil structure. The change in the CD spectrum with pH indicated that some structural or 
conformational changes occurred under these conditions due to electrostatic repulsion among the 
ions, or the shielding effect due to the ions of inorganic salts. CD studies in various solvents and 
at various temperatures of the glue protein and non-hydroxylated analog, which consists of 20 
repeats of the peptide sequence Ala-Lys-Pro-Ser-Tyr-Pro-Pro-Thr-Tyr-Lys were obtained in the 
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far-UV wavelength range under a variety of condition. The spectra of the glue protein in a pH 7.0 
and 0.6 M guanidine hydrochloride found to be nearly the same as the spectra of non-
hydroxylated 20-mer. Since there was no noticable change in the different solutions, the effect of 
temperature was examined. The spectrum was found to change systematically with the mean 
residue ellipticity becoming more negative in the 215-230 nm region and less negative in the 200-
215 nm region as the temperature was increased. 
The spectral analysis was performed by least-squares fits to model data taken from Chen et. 
al., [113] and Bolotina [114], the result of the analysis of the protein in buffer containing NaCl and 
KCl at 25°C suggest that the protein is 65-75% random coil structure as well as buffer containing 
6.0 M guanidine hydrochloride at 25°C did not appear to alter the structure significantly as 
reflected in the estimates of 71 % and 79 % for the random structure. 
The non-hydroxylated 20-mer exhibited CD spectra nearly identical to those of the natural glue 
protein in all buffer. Consequently using 20-mer as a model and evaluated its amino acid 
sequence by the Chou and Fasman rules of analysis in order to correlate the predicted structure to 
the estimated structure obtained from the analysis of the CD spectra. For the decapeptide (Ala-
Lys-Pro-Ser-Tyr-Pro-Pro-Thr-Tyr-Lys) the analysis suggest that there is little probability of 
formation of any β or α structures while the four-amino sequences (Lys-Pro-Ser-Tyr) and (Pro-
Pro-Thr-Tyr) are sequences with a good probability for forming β turns. Chou and Fasman [115] 
analysis which predicts little α and β structure is supported by the analysis of the CD spectra, the 
presence of only 18.6 % β turn structure is detectable on the basis of the CD spectrum, the similar 
spectra obtained for the hydroxylated and the non-hydroxylated forms suggest that the degree of 
hydroxylation does little to influence secondary structure of the protein in solution [116]. 
Gert Frens and co-worker studied the conformational of mefp-1 protein under the physiological 
conditions [117] using dynamic light scattering instrument. They experimentally obtained a 
hydrodynamic radius of mefp-1 as 10.5 ± 1.1 nm which can be explained by two different models. 
Mefp-1 on larger length scales resembles a random coil but that its decapeptide segments may 
have a helical appearance. 
Such helical appearance of the decapeptide resulting from the Pro content would make its contour 
length shorter than the 3.6 nm according to the virtual chain model (9.4 times the distance 
between two α-atoms of a peptide chain was 0.38 nm). The approximate numbers of decapeptides 
contain was 90 and the segment length per decapeptide was 2.7 nm. 
The condition chosen in these experiments differ significantly from each other, which makes it 
difficult to draw final conclusion on the native conformation of mefp-1. 
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3.2.2. Possible Applications of mefp-1 
The mussel adhesive protein tends to bind to practically any surface it encounters; the researchers 
believe that the new compound can similarly attach to other surfaces used for medical devices, 
including stainless steel and plastic. Several attempts are being made to make biomedical and 
commercial use of the adhesive properties of these substances. The adhesive properties of certain 
types of biopolymer can be used to increase the residence time of orally or nasally administered 
drug, understanding of the molecular process underpinning such ‘mucoadhesive’ phenomena will 
help in the optimal design of delivery system. Jochen Schnurrer [69] observed that MAP impresses 
with an excellent mucoadhesive bonding strength compared with the hitherto golden standard of 
poly(acrylic acid) derivatives, such as polycarbophil. It may even be speculated that the 
mucoadhesion of MAP or MAP like polypeptides may still be improved by better purification or 
preparation methods. But it is also appears that non-oxidative conditions for manufacturing and 
storage of MAP-based drug delivery systems will be necessary to fully exploit its 
mucoadhesiveness, which may be a certain disadvantage compared with other mucoadhesive 
polymers. Also the mucoadhesion interaction of mefp-1 protein has been studied by S. E. 
Harding [118] despite this impressive demonstration mefp-1 would be of limited practical use since 
protein-based mucoadhesives would be rapidly eaten away by the enzymes of the digestive tract, 
sedimenting at 7000 s also represents too strong an interaction with little opportunity for control. 
However, this provides the stepping stone for consideration of the use of polycationic 
polysaccharides that are not attacked by the digestive system and can be readily manipulated to 
control the extent of complexation. 
MAP has seen recent interest in the biomedical community as a tissue adhesive. The protein has 
also been used in experimental epikeroplasty in laboratory animals, The preliminary study 
indicates a potential adjunctive role for MAP in epikeratoplasty, On the basis of clinical 
examinations and histopathologic studies J. B. Robin and co-workers [66] observed that there is no 
untoward effects of the adhesive on the donor lenticules or host keratotomics corneal tissue. This 
study marked the first in vivo use of this material in adhering ophthalmic tissue planes and as an 
adhesive agent to increase cellular attachment to substrate. 
So far, this compound has not undergone animal or human testing, nevertheless, if all goes well in 
future studies the compound could be used in medical devices in coming years. The compound 
could be used as bone glue as well as tooth coating to prevent dental plaque, which is caused by 
bacterial infection. Also it could be used in the shipping industry as an environmentally friendly 
alternative to toxic antifouling coatings currently used on boats to protect against mussels, 
barnacles and related organism. 
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3.2.3. Mytilus Edulis Adhesive Protein-2 (mefp-2) 
Mefp-2 is a second major DOPA protein of the blue mussel and it appears to be a structural 
component exclusively of the plaque, contributing up to 25% of plaque protein [6]. It is Cys rich, 
tendemly repetitive 45 kD protein. It is multi-domain protein, with short, acidic, DOPA 
containing N-and C-terminal regions and a large central domain constrained by quasi-periodic 
internal disulphide bridges to compact conformation resistant to proteolytic degradation [119]. The 
peptide motifs of mefp-2 are quite unlike those of any other known structure are premature, 
because in tendemly repetitive proteins, the correct order of short peptide motifs over an entire 
protein cannot be deduced by standard peptide mapping techniques, and it is debatable whether all 
members of the heterogeneous mefp-2 family share identical subsets of motifs, Nevertheless the 
sequence of mefp-2 contains Pro and/or Gly rich segments that alternate with sequences 
containing none of these β-turn associated residues, and it is therefore consistent with 
conformational models, such as the β-meander postulated for certain Gly and Tyr rich 
Schistosoma eggshell protein [119]. 
The composition of mefp-2, incorporating Cys and DOPA, implies some role involving the 
stabilization of the plaque matrix by covalent disulphide and quinine derived cross-links. Mefp-2 
can from oligomeric aggregates that might be stabilized by rearrangement of disulphide bonds to 
form inter-molecular cross-links. If mefp-2 indeed constitutes 25% of plaque protein, then it 
would incorporate 90% of the plaque Cys residues and thus would be virtually its own sole 
potential disulphide cross-link partner. The DOPA residues might then serve to cross-link the 
resulting disulphide-linked mefp-2 homopolymer to other protein component of the plaque [6]. 
Consideration of the amino acids composition of mefp-1 and 2 and of the terminal adhesive 
plaques of byssal threads suggests that mefp-2 makes up about 25% of plaque protein, whereas 
mefp-1 content is about 5%. Mefp-2 has minimal sequence homology with known structural 
proteins and may have a properly folded structure in the plaque matrix. 
3.2.4. Mytilus Edulis Adhesive Protein-3 (mefp-3) 
Mytilus edulis adhesive protein-3 (mefp-3) is a small (6 kDa), non-repetitive protein. Mefp-3 
resembles to other byssal precursor proteins in basicity and DOPA content. Specific variants of 
the mefp-3 family may be preferentially deposited onto glass, stainless steel and polyethylene. 
Mass spectrometry with time-of-flight suggests that mefp-3 is the only detectable protein family 
near the plaque-substrate interface [120]. It is also Arg rich and many of these residues are modified 
to 4-hydroxy-L-arginine. At least 10 electophoretic variants of mefp-3 can be detected in 
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individual mussels. Only one of these has been completely sequence, is known as variant F [120]. 
4-Hydroxyarginine has been previously detected only as a free amino acid in the seeds of vetch, 
lentils and in tissues of sea anemones and sea cucumbers, but never as a part of the primary 
structure of proteins neither its function nor the reason for its incomplete conversion from Arg in 
mefp-3 are known at this time. 
DOPA suggests some interaction between hydroxyarginine and DOPA, hydrogen bonding that 
blocks enzyme access to the peptide bond (see Figure 3 -4). Four HO-Arg-DOPA pairs exist in 
mefp-3. Like DOPA, Arg and presumably its hydroxylated derivative is also an asset for the 
molecular interactions indispensable for adhesion [121]. 
 
 
 
Figure 3 -4: The intermolecular H-bond between DOPA and hydroxyarginine suggesting that this 
conformation might protect the underlying peptide bond from trypsin attack. 
 
DOPA engages in H-bonding, metal complexation, π-π and π-cation interactions. Hydroxyl-Arg is 
capable of forming six H bonds as well as π-π and coulombic interaction, such functionality is 
well adapted for organometallic complex [105, 122] on metal and mineral surfaces; π-π and π-cation 
interaction are strongly suggested on aromatic surfaces [123]. Arg can be a hydrogen donor in as 
many as 5 hydrogen bonds in which the acceptors are usually backbone carbonyl groups [124]. It is 
also involved in planar parallel stacking with aromatics that does not impede the hydrogen 
bonding capacity of Arg [125], for these reasons perhaps Arg rich proteins bind polyphenols avidly 
and are rather readily insolubilized by them [126]. 
Seven additional sequences of mefp-3 are predicted from cDNA clones [127]. In contrast to other 
mussel adhesive proteins such as mefp-1 and 2, which have large number of highly conserved, 
tendemly repeated peptide motifs, the function of mefp-3 in byssal adhesion is unknown [121]. 
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3.2.5. Mytilus Edulis Adhesive Protein-4 (mefp-4) 
The mefp-4 protein belongs to this family of proteins with a mass of 70-80 kDa. All have a 
common N terminus and contain elevated levels of G, R, and H. It has been assumed that mefp-4 
is located in the bulk adhesive of the plaque. Occurrence of the DOPA in this protein is 5 
mole% [120]. 
3.2.6. Mytilus Edulis Adhesive Protein-5 (mefp-5) 
Mytilus edulis adhesive protein-5 (mefp-5) is an adhesive protein derived from the foot of the 
common mussel, Mytilus edulis, and deposited into the byssal attachment pads [7]. Purification and 
primary structure of mefp-5 was determined by peptide mapping and cDNA sequencing. The 
protein is 74 residues long and has a mass of about 9500 Da. Mefp-5 composition shows a strong 
bias for non-aromatic amino acids, Lys and Gly represent 65 mol% of the composition. More than 
a third of all the residues in the protein are post translationally modified by hydroxylation or 
phosphorylation. The conversion of Tyr to DOPA and serine to o-phosphoserine accounts for the 
hydroxylation and phosporylation [7]. 
At over one in every four amino acid, contains the highest level of DOPA have been found in 
mefp-5. DOPA and the abundance of basic residue are reminiscent of other characterized byssal 
precursors particularly mefp-3, but detection of a significant number of phosphoserine residues 
distinguishes it. Seven or eight Ser residues in mefp-5 are phosphorylated. The precise location of 
the non-phosphorylated Ser is unknown [128]. Mefp-5 joins a growing number of phosphorylated 
extracellular proteins with a structural role. These include salivary statherins, osteopontins, dentin 
phosphoryns, epidermal precursor profilaggrin and certain protein from mollusk shells. In most of 
these, the phosphoserines are presumed to have been shown to bind calcium and a mineral 
surface [129, 130]. This closely matches similar sequences in statherin, β-casein and osteopontin that 
are mineral and calcium ion-binding. 
Recent studies with synthetic DOPA-containing random copolymers have revealed that high 
concentrations of DOPA are critical for wet adhesion. Perhaps the high mol % of DOPA in the 
precursors, mefp-3 and 5 is an adaptation to their interfacial role. DOPA is not the only 
functionality exploited for adhesion. Phosphoserine would be an ideal modification for adhesion 
to that substrate, to which DOPA-rich proteins shows only moderate binding [131, 132]. 
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3.3. Role of DOPA in Mussel Adhesive Proteins  
One of the defining characteristics of MAPs is the presence of L-3,4-dihydroxyphenylalanine 
(DOPA), an amino acid that is formed upon posttranslational modification of Tyr [133]. Recent 
studies suggest that DOPA is primarily responsible for the exceptional adhesives characteristics of 
MAPs [132, 134]. DOPA group has a double role in marine adhesion, it is important for both the 
cohesive and adhesive properties of the mussel’s adhesive. The adhesive properties of DOPA 
have long been speculated as being due primarily to direct interactions between the catechol side 
chains of DOPA and the surfaces to which they are adsorbed. As mentioned earlier, the high 
content of transition metal content in the mussel adhesives is also surprising [97]. UV/Vis 
absorption spectroscopic studies with the DOPA containing peptide models Ac-Ala-DOPA-Thr-
Pro-CONH2 (AdopaTP) and Ac-Asn-DOPA-Arg-Gly-CONH2 (NdopaRG) [135] showed strong 
binding of the DOPA catechol-like side chain to FeIII, but no interaction with CuII, ZnII, or any 
other divalent transition-metal ion [72]. 
Catecholato iron (III) complex are widely distributed in biological systems in which at least three 
functional categories of these compounds are distinguishable. The first and best characterized 
examples are the siderophores, low molecular weight catecholamides, which are secreted by 
bacteria to selectively sequester iron [136]. The second consists of enzymes with ferric ion-
containing active sites that bind low molecular weight catecholes either as substrates, e.g., 
catechol dioxygenases [137] or as products e.g., tyrosine 3-monooxygenases, [138] or as inhibitors 
with useful spectroscopic properties, e.g., soybean lipoxygenases [139]. A third emerging area is the 
coordination chemistry of high molecular weight proteins and peptides with catecholic functional 
groups present in the primary structure as peptidyl (3,4-dihydroxyphenyl)-L-Ala (DOPA). 
Examples of peptidyl-DOPA come from both artificial systems such as radiation- or radical-
damaged proteins [140, 141] or mutant recombinant ribonucleotide reductase [142] and natural 
systems in which DOPA is formed as a post-translational modification of Tyr. 
Certain marine invertebrates produce DOPA containing proteins which are believed to fulfill a 
range of functions including adhesion, sclerotization, wound repair, etc. Perhaps many of these 
functions result from properties attributable to the tendency of DOPA residues to oxidize and 
cross-link in a process known a squinone tenning [61]. Presence of high concentration of metal ions 
in the proximity of these proteins both intracellular (such as in ascidian blood cells) and 
extracellular (as in mussel byssus) implicates them as non-covalent cross-linking agents. This is 
particularly true of iron (III), which forms catechol complexes of exceptionally high stability. 
Iron (III) binding to the DOPA-containing mefp-1 has been studied by J. H. Waite and co-worker 
using spectrophotometric titration, electron paramagnetic resonance (EPR) and resonance Raman 
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spectroscopy [105]. According to those studies, at pH 7.0, purple (λmax = 548 nm) and pink (λmax = 
500 nm) forms of the iron-protein complex existed. The pink form was favored at high DOPA:Fe 
ratios and the purple was at low DOPA:Fe ratios. Resonance Raman spectroscopy of these two 
forms demonstrated that the chromophores were ferric catecholate complexes. EPR spectra of 
both forms of the protein measured at the same iron concentration reveal a resonance (g ≈ 4.3) of 
approximately four times the intensity in the spectrum of the pink, complex competed with that of 
the purple form. On the basis of the evidence, a model for the purple form of the ferric mefp-1 
involving bis (catecholato) coordination of ferric ions with most of the iron (III) complexed as 
EPR-silent µ-oxo- or µ-hydroxo-bridged binuclear clusters was suggested. In the pink form the 
ferric iron is EPR-active, mononuclear and present in high-spin tris (catecholato) complex. This 
bis and tris-complex of DOPA with multivalent metal ions present in the marine environment also 
thought to contribute to cross linking of MAPs. 
Jannifer M and J J. Wilker investigated role of metals in cross-linking in marine mussel adhesives 
and from penetration tests using metal ions [97]. There were no significant differences seen 
between the chloride and nitrite salt of any metal ion and the force values presented for these ions 
were found to be averages from both salts. A striking observation was that the protein extract 
containing Fe3+ yielded the highest resistance to penetration. The majority of metal ions tested did 
not bring about any curing beyond that of the water control. The level of hardening induced by 
Ca2+, Cu2+, H2O2 and tert-butyl hydroperoxide (BHP) were slightly greater than that of the water 
control but not nearly high as that found for Fe3+. 
Additionally, with the help of EPR and IR spectroscopic methods, J. J. Wilker provided evidence 
for metal-DOPA interactions in mussel adhesive plaques [72]. An adhesive film was produced by 
iron curing of extracted protein. In the presence of air, iron oxidized both extracted protein and 
peptide models to yield product that contain organic radicals. The coordination environment of 
iron in these studies were gained from EPR spectroscopy in which the FeIII of plaques did not 
resemble bis[Fe(DOPA)2], bonding. The adhesive film prepared by reaction of iron and protein 
displayed a UV spectrum similar to that of the tris[Fe(AdopaTP)3] model. Only the 
tris[Fe(AdopaTP)3] complex underwent oxidation to yield a radical upon exposure to air. FeIII 
brings about curing of adhesive extracts more than other ions [97]. Thus, iron remains as a key 
reagent in protein cross-linking within adhesive cross-linking and synthesis. Therefore, it was 
proposed that the iron center in mussel plaques cross-links three DOPA residues as shown in 
Figure 3 -5. 
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Figure 3 -5: Proposed mussel adhesive metal-protein cross-link (Adopted from [72]). 
 
Ooka and Garrell characterized the adsorption of peptide models* of mefp-1 to colloidal gold 
using surface enhances Raman spectroscopy (SERS) [134]. According to their studies, the peptide 
adsorb primarily through deprotonated catecholate oxygen atoms of the DOPA residue and also 
interact with the surface through one or both of the primary amine group. The orientation of the 
DOPA residue on the gold surface in which the plane of the aromatic ring is perpendicular or 
tilted on the surface (not flat) and is coordinated to the metal through the catechol oxygen atoms 
(see Figure 3 -6). 
 
 
 
Figure 3 -6: The proposed orientation of the deprotonated DOPA side chain on gold (front and side views). 
Adopted from [134]. 
                                                 
* such as Pro-Pro-Thr-DOPA-Ala which is modified sequence of second half of decapeptide of mefp-1. 
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Comparison of the SER spectra of the peptides with that of mefp-1 revealed that the peptides are 
valid methods for mussel protein adsorption on colloidal gold. Like the peptides, mefp-1 
coordination to the gold surface through the catechol oxygen atoms of the DOPA plays a 
significant role in mefp-1 adsorption and overall adhesion. 
It is known that catecholes have strong binding affinities to Fe (III), Cu (III) and Ag (III), and 
these results suggest that mefp-1 may exploit the DOPA residue to bind the metal surface other 
than gold. 
MAPs are initially secreted as fluids that undergo an in situ hardening reaction and DOPA 
residues are also believed to participate in the intermolecular cross-linking reactions that lead to 
the formation of a solid adhesive plaque [143]. The cross-linking reaction are not fully understood, 
evidence suggests that oxidation of DOPA to DOPA-quinone or DOPA-semiquinone by catachol 
oxidase enzyme (or also by nonenzymatic means) can lead to cross-linking either with other 
DOPA residues by a radical mechanism or with an side chain amino group of Lys by Michael 
addition mechanism. Although all attempts to detect this product to date have been unsuccessful, 
the importance of the Michael addition in quinine chemistry has generated strong support for Lys 
cross-linking in MAPs [143, 144]. 
 
 
 
Figure 3 -7: Proposed cross-linking reaction pathways for peptidyl DOPA and DOPA o-quinone residues. 
(adopted from [132]). 
 
With the help of low molecular weight DOPA model compound and mass spectroscopy, Deming 
and co-worker [132] recently confirmed that the catechol functionality is primarily responsible for 
moisture-resistant adhesion and that the oxidized o-quinone functionality is primarily responsible 
for cross-linking. 
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Yamamoto and co-workers [145] suggested a role of lysyl oxidase (LO) induced cross-linking of 
the collagenous substances responsible for the underwater adhesion of the mussel species. Using 
LO-mediated insolubilization reactions of the Lys-containing polypeptides, which have an 
elastine like composition enriched in Ala and Lys residues and the synthetic marine adhesive 
proteins. The insolubilization occurs in the following order (i) oxidation of the ε-amino groups of 
the Lys residues in the polypeptide side chains and (ii) cross-linking formation between the 
polypeptides. The former is the enzymatic and the latter is a chemical process. Together the result 
from the NBS-induced insolubilization experiments, the letter process is mainly affected by the 
dissociation state of the ε-amino group in the Lys residues. The collagen and elastin (tropoelastin, 
the soluble precursor of elastin) were that only two kinds of physiological substrates known, 
mainly in vertebrate [146]. The mussel byssus is composed of adhesive proteins and three kinds of 
collagen like proteins [147]. The LO activity exited in the mussel foot and that the mussel adhesive 
proteins were in fact insolubilized via the LO-catalyzed oxidation of the Lys residues. This 
indicated that LO is a possible candidate involved in the cross-linking of the collagenous 
substances responsible for the under water adhesion of the mussel species. 
3.4. Availability of Mytilus Edulis Adhesive Proteins - 1 to 5 
Adhesive proteins, mefp-1 to 5 are difficult to produce biochemically as well as it is very difficult 
to extract them from the biological source (i.e., marine mussels) because of poor yields. This 
situation makes synthetic approaches unique and demanding for accessing more quantities of 
these proteins. As it has been shown, certain residues like DOPA play a very important role in the 
adhesive properties of MAPs thus making it a plausible constituent of the synthetically prepared 
adhesive polymer.  
Synthetic methodologies offer tailored possibilities for synthesizing adhesive proteins and one 
could make stable, easy to produce and probably amplified characteristic. Peptidomimetics of 
protein of interests offer conformationally restrained structures that can be more effective. Also, 
addition of hydrophobic residues and/or replacement of amide bonds results in better transport 
properties through cellular membranes. In addition to that isosteres, retro-inverso peptides, cyclic 
peptides and non-peptidomimetics all reduce the rate of degradation by peptidases and other 
enzymes. 
Before getting into details of synthetic strategies used in this thesis, it is better to review some 
common building blocks as well as some earlier attempts of making these polymers. A general 
introduction to the polymer chemistry is also given in latter sections. 
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3.5. Dipeptide Building Blocks  
As shown in chapter 2, β-turn is one of the important folds commonly found in peptides and 
proteins. Peptide analogues having a β-turn are commonly used for synthesizing longer chain of 
amino acids. A β-turn dipeptide building block could be effectively used for this purpose. One 
such common dipeptide building block is azabicycloalkane. 
The general method for the synthesizing thiazabicycloalkane amino acid involves condensation of 
ω-formyl α-amino acid analog with a Cys derivative to provide a thiazolidine intermediate that 
can be treated directly under conditions to effect intramolecular N-acylation and furnish the 
bicyclic lactam (see Scheme 3 -1). Bicyclic dipeptide isosterrs like beta turn dipeptide [148, 149] 
contains the torsions iφ  and i 1+ψ  and the side chain orientation of a dipeptide unit. The central 
amide bond is fixed to the trans orientation and βI/βΙΙ equilibrium. 
 
 
 
Scheme 3 -1: Commonly used strategy for the synthesis of thiazabicycloalkane amino acid analogues and 
the major product of this reaction. Further description of R, R1, R2, R3, m and n is given in Table 3 -1. 
 
Table 3 -1: Various combination of R, R1, R2, R3, m and n and their respective product from scheme 3-1. 
 
Sr. No. m n R R1 R2 R3 R4 Major Product 
1. 1 1 Bn H Boc H Me (2S, 5R, 7R)-1 
2. 1 1 Bn H Cbz Me Me (2S, 5R, 7S)-1 
3. 1 1 Bn H Cbz Me Me (2R, 5S, 7S)-1 
4. 2 1 CH2 CH2 Cbz H Me (2S, 5R, 8R)-2 
5. 2 1 (CH2)2 TMS Pht Et Et (2R, 5S, 8S)-2 
6. 2 1 CH2 CH2 Cbz Me Me (2R, 5S, 8S)-2 
7. 2 1 Me Me Pht H H (2R, 5S, 8S)-2 
8. 2 1 CH2 CH2 Cbz Me Me (2S, 5R, 8S)-2 
9. 3 1 H H Pht Me Me (2R, 5RS, 9S)-3 
10. 3 2 H H Pht Me Me (2S, 6S, 10S)-4 
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Yields of bicyclic products can be controlled by employing enantio pure amino acid substrates in 
the condensation/lactam cyclization sequence. In the case of 5,5- and 6,5-bicyclic systems, the 
major diastereomer that is ordinarily formed possesses the ring-junction hydrogen and the Cys 
derived carboxylate, on the same side of the thiazolidine ring. 
The ω-formyl α-amino acids were protected to avoid intramolecular cyclization in those cases 
that could lead to the formation of dehydroprolines and dehydropiperidines. Although pthalimides 
were initially used for amino protection, N-(Cbz)oxazolidinones have been used more recently to 
protect both the amine and acid group, thereby preventing intramolecular cyclization and 
simultaneously active the α-carboxylate for intramolecular lactam formation [150-152]. The 
hydroxyl methyl group that resulted from ring opening of the N-(Cbz)oxazolidinone was 
subsequently removed under mildly alkaline conditions. 
3.5.1. 7-thiaindolizidiene Amino Acid and Bicyclic Thiaindolizidiene 
Nagai and co-workers had introduced the 7-thiaindolizidiene amino acid, 5 [148]. 
 
 
 
Figure 3 -8: 7-thiaindolizidiene amino acid. 
 
It is a bicyclic dipeptide thiazolidine derivative with fixed conformation simulating that of the two 
central amino acid residues in type II β -turn had been synthesized 5 starting from L-Glu and L-
Cys which showed super-imposable conformation of type II β-turn on that of D-Ala-L-Pro 
residues [148]. The thiazo[4.3.0]-alkane amino acid was stable under physiological condition and 
was introduced into various peptides and biologically active molecules [151, 153, 154]. 
R. L. Johnson and co-workers [150] studied the two compounds, 6 and 7, containing bicyclic 
thiazolidine lactam constraints capable of mimicking a type-II β-turn and which are able to 
modulate dopamine receptors. Both peptidomimetics, 6 and 7, found to be more effective than 
Pro-Leu-Gly-NH2 (PLG) in enhancing the binding of the dopamine receptor agonist 2-amino-6,7-
dihydroxy-1,2,3,4-tetrahydronapthalene (ADTN) to dopamine receptors. 
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Figure 3 -9: Bicyclic thiazolidine lactams 6 and 7 as possible peptidomemetics of PLG. 
 
Both of these bicyclic systems restrict two, 2ψ  and 3φ , of the four torsion angles that define a β-
turn. Molecular modeling studies were carried out on the N-acetyl-N'-methylamide 5,5- and 6,5- 
bicyclic thiazolidine lactam model compound (see Figure 3 -10) using the random incremental 
pulse search (RIPS) program of Ferguson and Raber [155, 156]. 
 
 
 
Figure 3 -10: N-acetyl-N'-methylamide. 5,5 and 6,5-bicyclic thiazolidine lactam model compounds as 
shown A and B respectively. 
 
The lowest energy conformer of 5,5-bicyclic model was found to possess 2ψ  and 3φ  torsion 
angles of 109.3° and 77.4°, respectively. The 2ψ  and 3φ  values that were obtained for the lowest 
energy conformer of the 6,5-bicyclic model on the other hand, were 132.0° and 69.1°. It showed 
that both 5,5- and 6,5- bicyclic thiazolidine lactam ring systems restrict the 2ψ  and 3φ  torsion 
angles to values which were quite close to those of an ideal type-II β-turn ( 2 120ψ = ° , 
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3 80φ = ° ) [157] The most significant difference between the 5,5- and 6,5-bicyclic thiazolidine 
lactam was found to lay in their different 2ψ  torsion angles (109° versus 132°). 
Compound 6 possesses 5,5-bicyclic system showed greater effectiveness than the peptidomimetic 
containing the 6,5-bicyclic systems compound 7. The major difference between the 5,5- and 6,5-
bicyclic thiazolidine lactam systems was the magnitude of the 2ψ  torsion angle, this may be a 
leading factor behind the difference in activity observed for 6 and 7. 
The use of thiazolizidinone amino acid 2 in conjunction with studies of different biologically 
active peptides had lead to several potent conformationally-constrained surrogates [148, 158, 159]. 
Similar antibacterial activity and CD spectra indicated that (2R, 5S, 8S)-2 mimics the type II β-
turn in gramicidin S, replacing D-Phe at the i+1 and Pro at the i+2 position [149, 158, 160, 161], in 
which thiaindolizidinone amino acid 2 had been incorporated into peptide analogs, lacking 
biological activity might have been resulted from mimicking an inactive conformation and from 
structural features that interfere with receptor recognition. NMR and computational studies of an 
inactive cyclic hexapeptide mimetic of tendamistat showed that (2R, 5S, 8S)-2 adopted a 
conformation in which the constrained dipeptide occupied i and i + 1 position rather than i + 1 
and i + 2 position of a type II β-turn [153]. On the other hand (2R, 5S, 8S)-2 was recently shown to 
adopt the desired type II β-turn, and to stabilize a bioactive geometry in a cyclic hexapeptide 
inhibitor of the interaction between integrin α4β1 and the vascular cell adhesion molecule-1 [162]. 
3.5.2. Epimerization of Thiazabicycloalkane Amino Acids 
Epimerization had been encountered during the synthesis and further transformation of 1-
azaoxobicyclo [X.Y.0] alkane amino acids [150, 163]. 
 
 
 
Scheme 3 -2: Conversion of (2S, 5R, 7R)-8 to (2S, 5R, 7R)-9 and (2S, 5R,7R)-9  
 
Treatment of (2S, 5R, 7R)-N-(Boc)aminothiapyrrolizidinone methyl ester 8 with NH3 in methanol 
gave a 9:1 mixture of (2S, 5R, 7R)- and (2S, 5R, 7S)-N- (Boc)amino thiapyrrolizidinone 
carboxamides 9 (see scheme 3-2). 
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Scheme 3 -3: Synthetic scheme for preparation of thiazabicyclo[5.4.0]alkane phthalimido ester. 
 
Whereas, during the preparation of thiazabicyclo [5.4.0] alkane phthalimido ester 10, treatment of 
pure ester 10 of either (2S, 6S, 10S)-, (2R, 6S, 10S)- or (2R, 6R, 10S)- configuration with p-
toluenesulfonic acid in benzene at reflux for 2-4 hr furnished a 10:30:<1:15 ratio of  
(2S, 6S, 10S)-, (2R, 6S, 10S)-, (2R, 6R, 10S)- and (2S, 6R, 10S)- diastereomers 10 as shown in 
scheme 3-3. The mechanism for epimerization of 10 may involve enolization of an imino ester 
intermediate or equilibration of iminium ion intermediates under the acidic condition [164]. Very 
few synthesis methods of thiazolidines based on cyclization mode are known [165]. 
One of the main reasons is that chiral amino thiols are not so easily available compared to chiral 
amino alcohols. The most easily available chiral aminothiol is Cys. This primary aminothiols 
forms stable NH-thazolidine through imine cyclization. This stability strongly contrasts with the 
stability of NH-oxazolidines that mainly exists in solution in an equilibrium with open imine 
form [166]. 
3.5.3. Iminium Ion Cyclization 
Iminium ion cyclization is probably one of the most powerful methods to form nitrogen-
containing heterocycles since it offers several advantages over the other possible cyclization 
method. Iminium ions are quite often prochiral species and thus offer the possibility of the 
construction of new stereogenic centers during the cyclization process. This is the important 
feature concerning the preparation of chiral heterocycles [165]. 
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Condensation of D-glucorono-3,6-lactone and L-Cys methyl ester was carried out in water and 
pyridine (9:1) gives polyhydroxylated bicyclic thiazolidine lactam (see Figure 3 -11) probably via 
an acyliminium as shown in scheme 3-4. 
 
 
 
Scheme 3 -4: Synthesis of polyhydroxylated bicyclic thazolidine lactam [9a (R) H-5-oxo-(6S, 7S, 8S, 9R)-
tetrahydroxy-octahydro-thiazolo-[3,2-a] azepin-3R-carboxilic acid-methyl ester]. Reagents used were (a) 
L-Cys methyl ester, H2O:Py (9:1), RT. 
 
The experimental studies showed that seven membered ring of 11 is found exclusively in the chair 
conformation [167]. O-6 occupies an equatorial position and O-7, O-8, and O-9 are found in axial 
positions. 9-OH forms a hydrogen bond with the carbonyl oxygen of the ester group and hold the 
exocyclic torsion (N-C3-CO-O) in a preferred conformation. This hydrogen bond is maintained in 
solution since all derivatives of 11 exhibits a large three bond 3J9,9OH coupling constant and a 
distinct shielding of the 9-OH. Whereas, condensation of D-glucorono-3,6-lactone and L-Cys 
methyl ester in water or pyridine to give thiazolidine (see Figure 3 -11) which were unable to 
form the aminolysis of the lactone. 
 
 
 
Figure 3 -11: Chemical representation of Thiazolidines (A) and N-acyliminium ion (B). 
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Introduction of amino group at α-hydroxyl group can be done in a two to three step 
transformation without the protection of secondary hydroxyls to get the polyhydroxylated bicyclic 
dipeptide building block (Bic) as shown in scheme 3-5. 
 
 
 
Scheme 3 -5: Conversion of 11 to 12. Reagents used were (i) Tf2O, Py, CH2Cl2 (89%); (ii) NaN3, DMF 
(82%) (iii) Pd/C, MeOH (90%). 
 
This bicyclic template orientated the amino – or carboxyl terminal peptide chains and additionally 
acted as a scaffold which presents extra functionalities. The seven-membered ring contained a cis 
amide bond and therefore populated a well-defined chair conformation [168]. 
Five stereo centers of the polyol dipeptide shown in scheme 3-5 (Compound 12) were introduced 
by starting materials, the controlled by the reaction conditions [168]. The energy-minimized 
structural model of trimer 13 folded into a left handed helix with backbone torsions corresponding 
to that of the polyproline II (PPII) helix [169]. 
 
 
 
Figure 3 -12: Trimer of Boc-protected polyhydroxylated dipeptide. 
 
3   Mussel Adhesive Proteins 42 
One pair of φ  and ψ  torsions was found constrained within the annelated ring system to the 
values of -80° and 160°. The amino terminal φ  torsion is less severely restricted to values around 
-90° and the carboxyl terminal ψ  torsion of the bicyclic dipeptide unit is tethered by the hydrogen 
bond to 140°. Values which deviate from the idealized PPII torsions (-78°, 146°) uncoil the 
extended helix slightly towards the β-sheet conformation [169]. 
3.6. Polymerization of Amino Acids 
Polymers are a class of colossal molecules consisting of discrete building blocks linked together 
to form long chains. Simple building blocks are called monomers, while building blocks that are 
more complicated are some times referred to as repeat unit. When only one type of monomer is 
present, the polymer is referred to as a homopolymer. Polyethylene- the material commonly used 
in plastic bags- is a homopolymer formed by polymerization of ethylene. A copolymer is formed 
when two of more monomers that are different are linked together. The process, by which the 
monomers are assembled into polymers, either chemically or biologically, is referred to as 
polymerization. Polymers can be either linear or branched. 
Biopolymers are diverse and versatile class of materials that have potential applications in 
virtually all sectors of the economy. For example, they can be used as adhesives, absorbents, 
lubricants, soil conditioners, cosmetics, drug delivery vehicles, textiles, high-strength structural 
materials, and even computational switching devices. Currently many biopolymers are still in the 
developmental stage, but important applications are beginning to emerge in the areas of 
packaging, food production, and medicine. Some biopolymers can directly replace synthetically 
derived materials in traditional applications, whereas others possess unique properties that could 
open up a range of new commercial opportunities. 
In general, biopolymers fall into two principal categories,  
a) Polymers that are produced by biological systems such as microorganisms, plants and animals. 
b) Polymers that are synthesized chemically but are derived from biological stating materials such 
as amino acids, sugars, natural fats or oils. 
There are various types of naturally occurring biopolymers defined on the basis of the chemical 
structure of their monomeric units and indicates the functions hat these polymers serve in lining 
organisms. For example, DNA, which carries the essential genetic information of living systems, 
is a linear copolymer composed of four monomer nucleotides. The nucleotides are linked together 
along a pair of helical sugar-phosphate backbones. 
Proteins also referred to as polypeptides are complex copolymers composed of up to 20 different 
amino acids building blocks. Proteins can contain a few hundred amino acid units or thousands of 
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units. Each protein has a specific chemical composition and three-dimensional shape. The amino 
acid building blocks are linked by amide bonds in specific sequence determined by the DNA code 
of the corresponding gene. 
In recent years, researchers have been able to synthesize various polypeptides that are similar to 
natural proteins found in, for example, in biominerals such as shell or bones. Synthetic 
polypeptides are usually created from amino acids precursors. 
Poly amino acids are an important class of synthetic polymers produced by chemical 
polymerization of the same amino acid building blocks found in naturally occurring proteins [170]. 
Poly amino acid chains are sometimes referred to as polypeptides. Approximately 20 amino acids 
can be found in proteins and from these basic building blocks a variety of homopolymers and 
complex copolymers have been synthesized. Because of the great chemical diversity of amino 
acid monomers-anionic, cationic, hydrophobic, polar, non-polar, thermally stable-polyamino acids 
can be envisioned for virtually all types of polymer application (“Anionic” monomers are 
negatively charged; “Cationic” monomers are positively charged). 
Polymer chains consisting of Glu, Asp, Leu, and Val are the polypeptides most frequently used 
for biomedical purposes. Lys and Met are also important amino acid building blocks in 
polypeptide polymers. Glu and Asp are hydrophilic, whereas Leu and Val are hydrophobic. When 
these hydrophilic and hydrophobic building blocks are combined, copolymers with vastly 
different rates of biodegradation can be created. This allows the copolymers to be used as delivery 
systems for a verity of different drugs. Homopolymers and copolymers of these simple amino 
acids are nonimmunogenic, i.e., they do not produce an immune response when injected into 
animals. Polyamino acid microspheres-spheres ranging in size from 50 nm to 20 microns are 
currently being developed for oral drug administration [171]. 
In an effort to duplicate the adhesive characteristics of MAPs in synthetic polymers, several 
groups have investigated the synthesis of adhesive polymers by incorporation of DOPA into 
synthetic polymer backbones, side chains or end groups ([132]). 
3.7. Synthetic Polymers 
In an effect to duplicate the adhesive characteristics of MAPs in synthetic polymers, several 
groups have investigated the synthesis of adhesive polymers by incorporation of functional amino 
acids like Lys, Tyr and DOPA into synthetic polymer backbone [154, 172-175]. 
Yamamoto and co-workers synthesised DOPA homopolymer as well as specific sequence 
copolymers of DOPA with L-Lys and L-Glu using solution polymerisation of the p-nitrophenyl 
ester of the corresponding di-, tri-, and tetrapeptides [172-174, 176] and synthesis of random co-
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polypeptides that contains as many as 18 different amino acids, including DOPA [177, 178]. Studies 
on the cross-linking and adhesive properties of these polymers were limited and adhesive 
properties of these polymers were limited. Initial adhesive studies were performed using iron and 
Al2O3 adhered with no oxidising agents [175]. More detailed studies focused on L-Lys/L-Tyr 
random copolymer and complex random copolymers using tyrosinase enzymes as the oxidising 
agent [154, 179]. Yamamoto and co-workers observed that the absorption spectra of Boc-L-DOPA 
quinine exhibited an absorption at 340 nm and a shoulder at around 270 nm and after the addition 
of Boc-L-Lys into same solution new band are develop at 360-365 nm due to the cross reaction 
was gradual. The addition of tyrosinase and α-chymotrypsin to the poly(Lys-Tyr) solution caused 
a rapid 275 nm spectroscopic change in seawater and turbidity formed after 4 min. After 
hydrolysis same sample showed absorption band at 360-365 nm, which was similar to cross-
linked compound. A possible insolubilizing mechanism was thought that using oxidase enzymes 
tyrosinase was found to catalyze a successive reaction form phenol to catechol and finally to o-
quinone in both fresh water and sea water. The oxidation reaction was found to be much faster 
towards Tyr than towards Tyr copolymer. α-chymotrypsin thought to exist in the integument and 
to act as a kind of activator of prephenol oxidase, randomly digests the Tyr copolymer at aromatic 
residues and accelerates oxidation by tyrosinase, followed by rapid precipitation due to 
intermolecular cross linking. 
Deming and co-workers [131] prepared sequentially random water soluble co-polypeptides contains 
L-DOPA and L-Tyr using ring opening polymerization of α-amino acid N-carboxyanhydrides 
(NCAs) as shown in scheme 3-6. 
NCAs are readily prepared from amino acids by phosgenation and can be polymerized into high 
molecular weight polypeptides via successive ring-opening addition reactions that liberate carbon 
dioxide [180]. 
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Scheme 3 -6: Synthesis of adhesive co-polypeptides using NCA monomers. Reagents used were (i) 
NaOtBu, THF, (ii) HBr, HOAc. 
 
Aqueous solution of these copolymers, when mixed with a suitable oxidizing agent (e.g., O2, 
mushroom tyrosinase, Fe3+, H2O2 or IO4-), formed cross-linked networks that were found to form 
moisture resistant adhesive bonds to a verity of substrates, e.g., aluminum steel, glass and 
plastics [131]. The plastic adherents formed the weakest adhesive bonds of all adherent studies. It is 
likely the relatively nonpolar surfaces displayed by the plastics provided a poor substrates 
displayed by the plastics provided a poor substrate for chemisorption of the polar functionalities 
of the polymer. The polar surface of glass provided a better substrate, nearly equivalent to the 
metals. Steel adherents gave adhesive bond strength that was comparable to those formed on 
aluminium. The major difference from aluminium was that adventitious iron oxide present on the 
steel surface was able to act as an efficient polymer oxidant. Consequently, no additional oxidant 
was necessary to obtain fast oxidation on steel adherents. In particular, it was found to be 
unnecessary to scrupulously clean the steel surface since a thin coating of iron oxide promoted 
rapid curing of the adhesive also by the variation of the oxidizing agent and pH. The kinetics of 
gel formation and gel strength were followed by viscosity measurement. Periodate, hydrogen 
peroxide and base (pH = 12) formed gels fastest, as compared to the tyrosinase and aerobic 
oxidation. Hydrogen peroxide and base also gave the highest cross-link densities, as estimated by 
solution viscosities. It appears that either basic aqueous solution or H2O2 would be the most 
efficient oxidants for the synthetic adhesive polymer. 
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The conformational assignment for Poly-Tyr has been widely studied using variety of physical 
methods including ultra-violet absorption (UV), optical rotatory dispersion (ORD), circular 
dichroism (CD), infra-red absorption (IR), nuclear magnetic resonance (NMR), ultra-
centrifugation, calorimetric measurement, light scattering and potentiometer titration. In solvent 
such as aqueous sodium chloride (below pH 11.5), methanol, dimethylformamide, trimethyl 
phosphate[(CH3O)3PO], quinoline, water/ethanol mixed solvent, dimethyl sulphoxide (Me2SO)/ 
dichloroacetic acid (DCA) mixed solvents, Me2SO/D2O mixed solvents and Me2SO/ (CH3O)3PO 
mixed solvents poly-Tyr assumes an α-helical conformation. In strongly basic aqueous solution or 
Me2SO poly Tyr is a random coil. If the pH is lowered very slowly a transition from coil to 
antiparallel β-conformation is observed in water and in the prevailing aqueous region. 
In the conformational study of Poly(L-Lys), Grourke and co-workers [181] observed that at 25°C 
un-ionized poly(L-Lys) above pH 10 is known to exist in a right-handed α-helix and ionized poly 
(L-Lys) is a random coil structure. During the conformational study of Poly (DOPA) and 
sequential polypeptides containing DOPA and Lys, Yamamoto and co-workers [176] observed that, 
in water or methanol-trimethyl phosphate, in the ratio 1:1 (v/v), mixed solvents unionized poly(L-
DOPA) below pH 10.4 assume a right handed helical structure and ionized poly(L-DOPA) shows 
a random coil structure in dimethyl sulphoxide or water/ trimethyl phosphate mixed solvent above 
pH 11. 
In case of five sequential polypeptides, containing L-Lys and L-DOPA, when Lys content is 
greater than 67 mol%, sequential polypeptides composed of Lys and DOPA shows a helical 
conformation in alkaline solution at room temperature or in alcohol rich solutions and it show β-
structure above 60°C. sequential poly (L-lysyl-L-DOPA), with 50 mol% Lys content takes a β-
structure, These results is similar as compare to previous result finding by Seipke et al. [182, 183]. 
Pierre et al. [184] and Trudelle [185]. When the DOPA content is greater than 67 mol%, sequential 
polypeptides assume the α-helical conformation below pH 7 at 25°C based on the CD peak 
position at 274-285 nm, the IR frequencies for the amide bond, the NMR α-CH chemical 
shifts [172] and copolymer study to conform the helical structure [186]. The conformation of poly(L-
lysyl-L-Phe) [182, 183] poly (L-tyrosyl-L-Lys) [184] and poly(L-lysyl-L-DOPA) were assigned a β-
structure. The only difference between the three aromatic amino acids is that Phe has no hydroxyl 
group; Tyr has one hydroxyl group at the 3- and 4-position in the benzene ring. 
 
 
4   Adhesive Peptides and Copolymers: Synthesis 47 
4. Adhesive Peptides and Copolymers: Synthesis 
As seen in last chapter, synthetic adhesive peptides are important and methods to synthesize them 
in a laboratory are needed to be established. Laboratory synthesis of adhesive peptides will help to 
exploit adhesive characteristics as well as in understanding of their biological importance. This 
chapter gives details on the preparation of synthetic peptides with adhesive properties using 
solution as well as solid phase peptide synthetic strategies. The polymer synthesis was carried out 
by means of dipeptide building blocks those were described in earlier chapter. 
4.1. Synthesis of Dipeptide Building Blocks 
In recent years, peptide chemistry has gained enormous popularity and relevance, particularly 
with the emergence of unnatural analogues as components of molecules with therapeutic 
potential. The need to replace natural amino acids in peptides with non-protiogenic counterparts 
in order to obtain drug-like target molecules has stimulated a great deal of innovation on several 
fronts. 
Several unnatural building blocks have been prepared and are in use [164, 187, 188]. These building 
blocks are used to exhibit favourable properties in peptide coupling protocols. Unnatural fused bi-
cyclopeptide building blocks are also in use with different ring size [164], e.g., 5,6 fused 1-aza-2-
oxobicycloalkane amino acid. 
The heteroatom analogues in which carbon is replace by sulphur, oxygen or nitrogen, at different 
synthetically attainable sites are also used [149, 164]. The presence of functional group as pendant 
substituents on the basic ring systems or its heteroatom congeners also provides opportunities for 
diversification. The structure of dipeptide motif is shown in Figure 4 -1, with specific substituents 
on either ring with amide appendages at each end could be the ultimate objective as a drug-like 
molecule. Synthetic strategies for such motifs must therefore be versatile to allow the inclusion of 
substituents. The particular interest has been the replacement of dipeptide motif, formed by 
natural amino acids in peptides, with substrate with a constrained or rigidified counter part that 
simulates β-turn and exhibit type I and type II β-turn [189-200]. 
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Figure 4 -1: General skeleton of a 1-azaoxobicycloalkane where as X, Y and Z can be either carbon or 
any heteroatom. 
 
These properties have been established in a dipeptide building block that is polar and rigid in 
structure [169]. 
In order to synthesize simplified adhesive peptides and peptide oligomers, polyhydroxylated 
dipeptide building blocks were used in this work. In fact, these building blocks do not constitute 
Hyp and Pro, amino acids that are present in mussel adhesive peptides mefp-1. The advantage of 
using polyhydroxylated dipeptide building blocks is to avoid expensive Hyp and Ser that would 
need additional side chain protection during peptide synthesis. Additionally, the polyhydroxylated 
dipeptide building block could stabilise the extended conformations in the deca-peptide repeating 
units to maximise the numbers of intermolecular contacts as in fibrous peptides. 
4.1.1. Boc-and Fmoc-protected dipeptide building blocks 
Boc- and Fmoc- protected dipeptide building blocks are derived in 5 steps from D-glucorono-3,6-
lactone and L-cysteine methyl ester, which are shown in Scheme 4 -1, Scheme 4 -2, and Scheme 4 
-3. Conversion of triflate to azide with retention of configuration was a key step for the 
preparation of both Boc- and Fmoc- protected dipeptide building blocks (8 and 9). 
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Scheme 4 -1: Synthesis of azide methyl ester 3. Reagents used were (i) L-cysteine methyl ester, 
H2O:Py (9:1), RT, 4 days, 90%. (ii) Trifilic anhydride, DCM, 89%. (iii) NaN3, DMF, 82%. 
 
Synthesis of azide precursor 3 has been executed earlier [169]. Simple one step condensation of D-
glucorono-3,6-lactone and L-cysteine methyl ester yields bicyclic thiazoliden lactone 1 (Scheme 4 
-1, step 1). The probable mechanism of this reaction possibly involves formation of an acylnimum 
ion shown in Figure 4 -2 [165]. 
 
N
O
OH
OH
OH
OH
SH
CO2Me
Cl
+
 
 
Figure 4 -2: N-acylnimum ion which is assumed to be formed during condensation of D-glucorono-3,6-
lactone and L-cysteine methyl ester. 
 
Selective activation of α-hydroxyl groups without protection of side chain (other hydroxyl groups) 
with triflate occurred using triflic anhydride at 0○C, yielding 2 (Scheme 4 -1, step 2). Thus under 
inversion of configuration at C6 position at 50°C in DMF the triflate ester 2 was converted to 
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azide 3 (Scheme 4 -1, step 3). Later, compound 3 was used for the synthesis of both Boc and 
Fmoc-dipeptide building blocks (Scheme 4 -2). 
 
S
N
O
HO
OHHO
O
N3 OMe
S
N
O
HO
OHHO
O
Boc-HN OMe
S
N
O
HO
OHHO
O
NH2 OMe
S
N
O
HO
OHHO
O
Fmoc-HN OMe
3
4
5
6
i
ii
iii
iv
v
 
 
Scheme 4 -2: Synthesis of Boc and Fmoc protected methyl ester (5 and 6). Reagents used were (i) Pd/C, 
MeOH, RT, 94%. (ii) (Boc)2O, Pd/C, MeOH, RT, 96%. (iii) Fmoc Succ., Pd/C, MeOH, CH3CN, 38%, 
(iv) (Boc)2O, Na2CO3, MeOH, RT, 90%. (v) Fmoc Succ., NaHCO3, MeOH, CH3CN, RT, 68%. 
 
The azide compound 3 was reduced with hydrogen using 10% Pd/C in MeOH to yield about 94% 
of free amine ester 4 (Scheme 4 -1, step 1). This reaction was also performed previously with the 
use of H2S for the conversion of azide ester 3 into amine ester 4 [169]. Use of rotten egg smelling 
H2S as a reducing agent, was the major drawback of this reaction. Alternatively, reduction of 3 
was performed using 10% Pd/C with hydrogen. The yield obtained in both cases was 
quantitatively similar (94 % for 3 to 4 using 10% Pd/C with hydrogen and 95% using H2S). 
Compound 4 was simultaneously protected by Boc- and Fmoc- group using (Boc)2O and Fmoc-
succinimide (Scheme 4 -2, step 4 and 5). This step yielded, respectively, about 96% and 68% of 
Boc and Fmoc protected polyhydroxylated dipeptide building blocks 5 and 6, respectively. 
Conversion of azide 3 to Boc and Fmoc protected polyhydroxylated dipeptide building blocks 5 
and 6 was also performed using one-pot synthesis. This was achieved by using (Boc)2O, Pd/C, 
MeOH and Fmoc-succinimide, Pd/C, MeOH under hydrogen, respectively. Yields obtained for 
the one step conversion of 3 into Boc protected acid 5 was 96%, while that for two step 
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conversion of 3 to 5 (via 4) was 94%. One pot conversion of 3 to Fmoc protected acid 6 yielded 
38 %, whereas two step conversions of 3 to 6 (via 4) yielded 68%. 
Conversion of Boc and Fmoc protected dipeptide methyl ester to Boc and Fmoc protected acid 
yielded compounds 8 and 9 (Scheme 4 -3) which are further useful for the solution as well as 
solid phase peptide synthesis. 
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Scheme 4 -3: Synthesis of Boc- and Fmoc-protected dipeptides (8 and 9). Reagents used were (i) KOH, 
H2O, HCl, quant. (ii) (Boc)2O, Na2CO3, H2O, Dioxan, 85%. (iii) Fmoc-Cl, NaHCO3, H2O, CH3CN, 40 %. 
 
In this reaction, the methyl ester of free amine 4 was quantitatively deprotected to 7 using 2 eq. of 
KOH and water. The reaction was stopped after 35 min by addition of 1eq. of 1N HCl into the 
reaction mixture. Choice of 35 min was based on the observation that the compound 4 was not 
stable under basic conditions. Reaction product was seen to undergo decomposition when it was 
stirred more than 35 min. Compound 7, the amine ester, was protected by Boc and Fmoc group 
using (Boc)2O and Fmoc-Cl to yield, respectively, 85% and 40% of Boc and Fmoc protected 
polyhydroxylated dipeptide building blocks 8 and 9. 
Conversion of 6 to 9 is also feasible and was performed under acidic conditions using acetic acid 
and 5 M hydrochloric acid as a catalyst. This reaction yielded about 97%. Thus direct conversion 
of 6 to 9 yields more product than the conversion of 7 to 9. 
Compounds 8 and 9 were used as starting compounds for further peptide synthesis that was 
carried out using solution as well as solid phase peptide synthesis protocols. Additionally, it was 
observed that the Fmoc protected polyhydroxylated dipeptide 9 was stable under acidic 
conditions. This fact was quite helpful, particularly, for solid phase synthesis. 
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4.1.2. Saponification Reaction 
Saponification was optimized to understand the conversion of methyl ester to the acid. This 
information would prove important for the preparation of suitable and easy dipeptide building 
block. Various bases were tested for the optimization of this transformation. A general protocol of 
saponification is represented in Scheme 4 -4. 
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Scheme 4 -4: Saponification reaction performed to convert methyl ester to the acid. Reagents and 
substituents used were a) X1 = -OH, -N3, -NH2, -Boc-NH. b) Bases = KOH, NaOH, LiOH. 
 
The optimization of saponification reaction was achieved by monitoring the reaction using 
nuclear magnetic spectroscopy (NMR). One dimensional 1H NMR gives a clean spectrum of 
product if the saponification reaction works. For optimization of saponification reaction, three 
different bases have been used, namely, KOH, NaOH, and LiOH. The choice of three different 
bases was driven by the fact that their basic strength is in the increasing order from KOH to 
LiOH. The cause for the difference in the basic strength depends on the electronegativity of the 
metal ion and thus is greatest for Li. 
The reaction was performed by stirring the reaction mixture at room temperature for 30 min with 
H2O as a solvent. It was observed that 30 min duration is optimum as decomposition of reaction 
products were seen when the reaction was allowed to proceed for more than 30 min (in this case 
40 min). Therefore, the reaction mixture was quenched by 1eq. of 1N HCl after 30 min while 
using all bases. 
Saponification reaction for compound 1 (Scheme 4 -1) (for X1 = -OH) worked well using all three 
bases. However, the reaction product, i.e., formed acid, was difficult dissolve in organic solvents. 
This has limited our attempts to convert methyl ester to acid (for X1 = OH) and thus was left out 
from further synthetic steps. 
Saponification reaction for compound 3 (Scheme 4 -2, for X1 = -N3), did not work in all three 
bases. The probable cause of this failure could be the fact that the 6-H proton is more acidic. This 
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acidic proton might lead to the opening of the ring at C6 position, thus leading to decomposition 
of the reaction mixture. 
On the other hand, saponification reaction for compound 4, (Scheme 4 -2, for X1 = -NH2) worked 
excellent, as seen in the clean one dimensional 1H NMR spectrum of this compound. This reaction 
was performed in all the three bases and in each case formed product was the salt of amine and 
acid. This salt is stable for about 40 minutes under strong basic conditions. After 40 minutes, 
additional peaks were seen in the NMR spectrum arising from the decomposed product. The 
reaction product was also easy to purify as was purified by simple washing with 10% MEOH in 
CHCl3. After the protection of amine through Boc-and Foc- group, the salt of amine and acid, 
yielded Boc- and Fmoc- protected dipeptide building blocks. 
Tremmel and Geyer performed saponification reaction on the compound 5 (Scheme 4 -2, for X1 = 
-NH-Boc) using only LiOH as a base [169]. The method of analysis of reaction product used by 
then was NMR and TLC. Additionally, this reaction was performed using previously mentioned 
other bases (i.e., NaOH and KOH). In our observation, results obtained using KOH and NaOH 
were similar with the furnished method which was performed using LiOH.  
 
Table 4 -1: Yields obtained in saponification reaction 
 
Sr. No. Product Yield 
1 
S
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O
HO
OHHO
O
OH OH
 
86% 
2 
S
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OHHO
O
N3 OH
 
87% 
3 
S
N
O
HO
OHHO
O
Boc-HN OH
86% 
 
It is important to mention that the reaction products obtained for compound 5 were not very pure, 
particularly as was observed with compound 4. The obtained Boc- protected acid 5 was found to 
have impurities as seen by additional NMR signals. However, when the saponification reaction 
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was performed on compound 4, followed by the protection of amine by Boc- group, resulted 
compound 5 was pure as seen by NMR. 
This set of saponification reactions helped us in deducing that the reaction performance was best 
for compound 4. The conversion of methyl ester to acid with amine at X1 position was, clean and 
suitable for the preparation of Boc-and Fmoc-protected dipeptide building blocks. 
4.2.  Synthesis of Peptides in Solution 
Solution phase peptide synthesis is one of the effective synthetic methods for the preparation of 
adhesive peptides. For the preparation of fibrous peptides, dipeptide building blocks were coupled 
with Tyr, Lys and DOPA using coupling regent HBTU, additive HOBt and DIPEA as base. The 
latter mentioned amino acids are essential amino acids in mefp-1 protein (see section 3.2.1). Using 
Boc-stratergy, different tetrapeptides were which details are given in following sections. 
4.2.1. Synthesis of Tetrapeptide 
Four different tetrapeptides were synthesized using Boc-strategy. Compound 11 was the main 
building block for the preparation of two tetrapeptide molecules. Synthetic scheme for the 
compound 11 is shown in Scheme 4 -5. 
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Scheme 4 -5: Synthesis of Bic-Tyr tripeptide 12. Reagents used were (i) L-Tyr methyl ester, HOBt, HBTU, 
DIPEA, DMF, RT, 6h, 92%. (ii) HCl/Et2O, RT, 1h, quant. (iii) KOH, H2O, RT, quant. 
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The Boc protected polyhydroxylated dipeptide building block was coupled with L-Tyr methyl 
ester using the coupling reagent HBTU and additive HOBt between pH 8-9 (pH was maintained 
with base DIPEA), which yielded Boc-protected tetrapeptide compound 10. Boc- group was 
quantitatively cleaved to 11 using HCl/Et2O at room temperature. Compound 11 further used for 
the preparation of compound 18 tetrapeptides DOPA-Bic-Tyr and compound 16, Lys-Bic-Tyr. 
Quantitative cleavage of methyl ester of compound 11 was carried out using 2 eq of KOH and 
water at room temperature, the reaction mixture was stopped after 40 minute by addition of 1 eq 
1N HCl into the reaction mixture yields compound 12, it shown in scheme 4-5. Compound 12 
further used for polymerization reaction. 
4.2.2. Synthesis of Tetrapeptide (Lys-Bic-Tyr) 
Synthesis of Lys-Bic-Tyr tetrapeptide was performed using compound 11 (Scheme 4 -5). 
Coupling of compound 11 with Boc-Lys(z) was carried out using the coupling reagent HOBt and 
additive HBTU between pH 8-9. pH of the reaction mixture was maintained using DIPEA. The 
reaction mixture was stirred for 6 h which then yields Boc-protected tetrapeptide 13. 
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Scheme 4 -6: Synthesis of tetrapeptide 16. Reagents used were (i) Boc-Lys(z), HOBt, HBTU, DIPEA, RT, 
6h, 80%, (ii) 1N KOH, MeOH, RT, 7h,1N HCl, quant. (iii) HCl/Et2O, RT, 40 min, quant. (iv) Pd/C, MeOH, 
RT, H2 atm. quant. 
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Quantitative cleavage of methyl ester of compound 13 was carried out using 2 eq of KOH and 
water at room temperature, the reaction mixture was stopped after 40 minute by addition of 1 eq 
1N HCl into the reaction mixture yielded compound 14 shown in Scheme 4 -6. 
Compound 15 was obtained through quantitatively cleavage of Boc- group using HCl/Et2O at 
room temperature, which was further used for polymerization reaction. The cleavage of Boc- 
group is normally achieved in 40 minutes. It was observed here that this time duration was ample 
enough to start cleavage of Z group. Further, it was observed that six hours duration was enough 
to cleave Boc- as well as Z group in one-pot. Deportation of Z group was carried out by hydrogen 
using 10% Pd/C in MeOH yielded compound 16. 
4.2.3. Synthesis of Tetrapeptide (DOPA-Bic-Tyr) 
Unprotected catecholic oxygen of Boc-DOPA was used for the coupling reaction in solution 
phase. All the coupling reactions of the DOPA are done between pH 7 and 8. Stirring of the 
reaction mixture was stopped after the completion of the reaction, and the product was purified 
immediately using column chromatography. 
Compound 11 was coupled with Boc-DOPA using the coupling reagent HOBt and additive 
HBTU between pH 8 and 9. pH of the reaction mixture were maintained using the base DIPEA to 
achieve Boc- protected tetrapeptide 17 is shown in Scheme 4 -7. 
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Scheme 4 -7: Synthesis of (DOPA-Bic-Tyr) tetrapeptide 18. Reagents used were (i) Boc-DOPA, HOBt, 
HBTU, DIPEA, DMF, RT, 6h, 79%; (ii) HCl/Et2O, RT, 1h, quant. 
4   Adhesive Peptides and Copolymers: Synthesis 57 
Compound 18 was prepared through quantitative deportation of compound 17 using HCl/Et2O at 
room temperature. 
4.2.4. Synthesis of Tetrapeptide (Boc-Bic-DOPA-Tyr-OMe) 
Synthesis of Bic-DOPA-Tyr-OMe tetrapeptide was performed using compound 20. It is main 
building block for the preparation of two tetrapeptides Bic-DOPA-Tyr-OMe and Lys-DOPA-Tyr-
OMe and is shown in Scheme 4 -8 and Scheme 4 -9, respectively. 
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Scheme 4 -8: Synthesis of (Boc-Bic-DOPA-Tyr-OMe) tetrapeptide 21. Reagents used were (i) Boc-
DOPA, HOBt, HBTU, DIPEA, RT, 6h, 93%. (ii) HCl/Et2O, RT, 1h, quant. (iii) Boc-Bic, HOBt, HBTU, DIPEA, 
DMF, RT, 6h, 80%. 
 
Boc-protected dipeptide 19 was obtained by coupling of L-Tyr methyl ester and Boc-DOPA using 
additive HOBt and coupling reagent HBTU between pH 8-9. pH of the reaction mixture was 
maintained using DIPEA. Boc- group was quantitatively cleaved using HCl/Et2O. Further, 
compound 20 was coupled with Boc-Bic using HOBt and HBTU between pH 8 to 9 to get 
compound 21. 
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4.2.5. Synthesis of Tetrapeptide (Lys-DOPA-Tyr) 
Synthesis of (Lys-DOPA-Tyr) tetrapeptide was performed using compound 20 and is shown in 
Scheme 4 -9. 
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Scheme 4 -9: Synthesis of (Lys-DOPA-Tyr-OMe) tetrapeptide 23. Reagents used were (i) Boc-Lys(Z), 
HOBt, HBTU, DIPEA, DMF, RT, 6h, 80%. (ii) HCl/Et2O, RT, 40 min, quant. (iii) Pd/C, MeOH, H2 atm, 3h, 
quant. 
 
Dipeptide compound 20 was coupled with Boc-Lys (Z) using the coupling reagent HOBt and 
additive HBTU between pH 8-9. The pH of reaction mixture was maintained using DIPEA, yields 
compound 21. Boc group was quantitative cleavaged using HCl/Et2O at room temperature to yield 
compound 22. Further, cleavage of Z group was done with hydrogen using 10% Pd/C in MeOH, 
to produce compound 23. 
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4.2.6. Synthesis of Dipeptide (Lys(2-Cl-Z)-Tyr) 
Synthesis of Lys(2-Cl-Z)-Tyr dipeptide was performed using coupling of Boc-Lys(2-Cl-Z) and L-
Tyr methyl ester and shown in Scheme 4 -10. 
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Scheme 4 -10: Synthesis of Lys (2-Cl-Z)-Tyr 27. Reagents used were (i) Boc-Lys(2-Cl-Z), HOBt, HBTU, 
DIPEA, DMF, 6h, 92%. (ii) 1N KOH, MeOH, RT, quant. (iii) HCl/Et2O, RT, quant. 
 
Coupling of L-Tyr methyl ester with Boc-Lys (2-Cl-Z) was carried out using additive HOBt and 
coupling reagent HBTU between pH 8-9. DIEPA base was used to maintain pH of the reaction 
mixture to yield compound 25. Methyl ester of compound 25 was quantitatively converted into 
free acid using 2 eq of KOH and MeOH at room temperature, the reaction mixture was stopped 
after 7 h by addition of 1 eq HCl into the reaction mixture to get compound 26. Additionally, Boc- 
group was quantitatively cleaved using HCl/Et2O to receive compound 27. It further used for 
polymerization reaction that is described in latter sections. 
4.3.  Oligomerization reactions 
In an effect to duplicate the adhesive characteristics of MAPs in synthetic polymers, several 
groups have investigated the synthesis of adhesive polymers by incorporation of Lys, Tyr and 
DOPA into the synthetic polymer backbone [17, 154, 177, 178, 184, 201]. 
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As stated prior, major objective of this thesis work was to produce synthetic polymers made up of 
essential amino acids found in mefp-1. 
In this work, oligomerization of L-Tyr, L-DOPA, L-Lys, and dipeptide building blocks was 
accomplished without protection of side groups (phenolic –OH) in the first three cases and 
without protection of secondary hydroxyl group in the latter case. Oligomerization reactions were 
carried out using poly-DCC or DCC and HOBt. Oligomerization of dipeptide building blocks as 
well as copolymerization of dipeptide molecules with Lys and Tyr worked effectively. Sequence 
of oligopeptides was characterized using MALDI-TOF mass spectrometer. Several analytical 
techniques, such as NMR, GPC and AFM were used to characterize these oligomers as well as to 
study the interaction of the molecules on different surfaces. 
But before getting into performed work a short introduction on poly amino acid is presented in the 
following section. 
4.3.1. Poly Amino Acids: Synthetic Methods, Isolation and Purification 
Poly amino acids are an important class of synthetic polymers produced by chemical 
polymerization of the same amino acid building blocks found in naturally occurring protein [170]. 
Poly amino acid chains are sometimes referred to as polypeptides. Because of the great chemical 
diversity of amino acid monomers, anionic, cationic, hydrophobic, polar, nonpolar, thermally 
stable poly amino acids can be envisioned for virtually all types of polymer applications. 
When hydrophilic and hydrophobic building blocks are combined, copolymers with vastly 
different rates of biodegradation can be created. This allows the copolymers to be used as delivery 
systems for a variety of different drugs. The fact that the homopolymers and copolymers of these 
simple amino acids are nonimmunogenic (i.e., they do not produce immune response when 
injected into animals) makes them particularly attractive for medical application. 
Various methods have been used for the synthesis of poly-amino acids. Some of them cause 
racemization, while others give rise to products with low molecular weights. Certain methods are 
promising and may permit not only the preparation of optically active poly amino acids of a high 
molecular weight but, also polypeptides with a known repeating sequence of amino acids. 
Several reactions leading to the stepwise synthesis of low molecular peptides [202, 203], based on the 
activation of either the amino or carboxyl group of reactants have been used, with slight 
modification, for the synthesis of poly amino acids. In such synthesis “monomers” composed of 
suitable amino acid or peptide derivatives, with two functional groups, were chosen, and the 
polymerization proceeded by a classic polycondensation reaction. In order facilitate the 
polycondensation, the terminal α-amino or the α-carboxyl group of the monomer is generally 
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activated chemically. Methods of activation used in the stepwise syntheses of peptides are 
discussed in a most lucid manner in the review article of Grassmann and Wunsch [203]. Some of 
the activation methods are as follows: 
(i) A number of different derivatives of α-amino acids and peptides have been used as monomers 
for the preparation of poly-α-amino acids. The most suitable and commonly used are the N-
carboxy-α-amino acid anhydrides (NCAs) as shown in Figure 4 -3. These NCAs readily undergo 
polymerization, with carbon dioxide evolution, to yield the corresponding poly-α-amino acids. 
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Figure 4 -3: Chemical representation of N-Carboxy-α-amino acid anhydrides. 
 
(ii) The polymerization of peptide esters seems of particular interest since it permits the synthesis 
of copolymers in which the amino acid sequence reoccurs regularly. 
Esters of α-amino acids and peptides generally undergo condensation reaction more readily than 
the free amino acids and peptides [204, 205] and normally polymerization works up to 10 to 35 
residues. 
(iii) Thiol ester of α-amino acids also used for the activation of carboxyl groups. Polymerization 
of thiol ester of amino acids in water at alkaline pH or in acetone yields copolymers with the 
defined sequence of amino acid. The product obtained was up to 2700 as determined by 
dinitrophenylation of the terminal α-amino end group [206].  
(iv) Preparation of poly amino acids can also be obtiained by the polycondensation of amino acids 
and peptides chlorides in bulk or solution as shown in Scheme 4 -11 [207-209]. 
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Scheme 4 -11: Poly amino acids from hydrochlorides of α-amino acids. Reagents used are (i) PCl5, 
CH3COCl, and (ii) HCl. 
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This method has been used for synthesis of polymers of Ala, Leu, Phe, Val, β-Ala, α-amino 
butyric acid, Trp and Pro are reported. In these cases, the average degree of polymerization ‘n’ 
obtained was 10 to 20 which was determine by end group analysis. 
(v) The formation of poly-α-amino acids from α-amino acids and peptide chlorides as well as 
peptide azides, containing a free α-amino group; clearly indicate that amino acid and peptide 
derivatives with an activated carboxyl group and a free amino group may undergoes 
polycondensation like any other bifuncational monomer (see Scheme 4 -12). 
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Scheme 4 -12: Poly amino acids from peptide azide. Reagents used were (i) NaNO2 (ii) OH. 
 
(vi) N-carbothiophenyl of many amino acids and peptide polymerization in benzene, which was 
accelerated by small quantities of pyridine or dioxan, gave N-carbothiophenyl-α-amino acids as 
demonstrated in Scheme 4 -13. The average molecular weight obtained in solution was in the 
range of 10,000 to 130,000 as measured osmometrically. 
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Scheme 4 -13: Polymerization from N-carbothiophenyl-α-amino acids and peptides. Reagents used were 
(i) Benzene:Pyridine. 
 
(vii) Several other methods are reported for the insitu preparation of active ester using the 
coupling reagent EDC [210], DCC [34], α-N-carboxyanhydride [211], N-hydroxysulfosuccinimide 
ester [212] and N-hydroxysuccinimide [213, 214] have been well established. 
(viii) Isolation and purification: In polymerization, mixtures leading to the formation of poly 
amino acids from the corresponding monomer(s), following low molecular weight compounds 
may appears: (a) diketopiperazines; (b) hydantoi-N-3-acetic acid derivatives; (c) low molecular 
weight peptides; (d) amino acids; and (e) unreacted monomer. Since these are, as a rule, more 
soluble in common organic solvents than the high molecular weight polypeptides, they are left in 
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solution on precipitating the polymer from the polymerization mixture. Further purification may 
be attained by extraction with suitable solvents or by dialysis. 
Poly amino acid which has been prepared by the polymerization of the corresponding amino acid, 
is dissolved in a suitable solvent (e.g., dimethylformamide, acetic acid, formic acid, chloroform, 
or methylene chloride) and precipitated by pouring the solution into a non-solvent (e.g., water, 
acetone, alcohol, ether, or petroleum ether). Water soluble poly amino acids may be freed from 
low molecular weight impurities by dialysis and isolated by precipitation or freeze-drying. To 
obtain high molecular weight polypeptides in a fluffy, readily soluble form, it is advisable to 
lyophilize solutions of the finally purified polymers in water, dioxane, acetic acid or 
trifluoroacetic acid. 
4.3.2. Oligomerization of Dipeptide Building Blocks 
The poor receptor subtype selectivity, poor bio-stability and unfavourable absorption properties 
that often accompany therapeutically relevant peptides has generated a considerable amount of 
interest in the design of high affinity and selective peptidomimetics [215-219]. This is usually 
accomplished by the systematic replacement of backbone amide bonds or the incorporation of 
constrained elements. In a successfully designed peptidomimetic, the essential amino acid side 
chains of the corresponding peptide are displayed on an alternative scaffold such that the spatial 
orientation of the side chains corresponds to the display in the bioactive conformation of the 
peptide [189]. Several building blocks are synthesized which are an alternative to natural 
substrate [164, 187, 188]. These building blocks are used to exhibit favorable properties in peptide 
coupling protocols. Unnatural fused bi-cyclopeptide building blocks are also in use with different 
ring size [164]. The polyhydroxylated dipeptide building blocks with has polar and rigid structure 
which can stabilises extended helical conformation, as found in mefp-1, was accomplished [169]. 
This dipeptide features an alternative to Hyp and Ser in which former is an expensive compound 
and latter needs protection of side chains during coupling reaction. 
In the current work, oligomerization of polyhydroxylated dipeptide building blocks that was 
carried out without protection of secondary hydroxyl group is described. It was accomplished 
with the use of coupling reagent like poly-DCC and/or DCC and additive HOBt (see Scheme 4 -
15). Copolymerization of dipeptide building blocks with Tyr and Lys were worked out effectively 
and are described in the subsequent sections. As stated previously, Tyr, DOPA and Lys are 
functional amino acids in mefp-1 protein. 
4   Adhesive Peptides and Copolymers: Synthesis 64 
For optimization of oligomerization reaction several coupling reagents, bases and several reaction 
conditions were used. MALDI-TOF MS gave information about number of oligomers obtained 
after oligomerization. 
N-(3-dimethylaminopropyl)-N'-ethylcarbodiimidhydrochloride (EDC) was synthesized for the 
oligomerization of amino acids L-Ala and L-Gly in presence of carboxylic acid activating agent 
such as N-hydroxysuccinimide [210]. Using similar conditions oligomerization of dipeptide 
molecule of two different bases DIPEA and Et3N was carried out (see Scheme 4 -14). 
Oligomerization worked up to n = 2. Oligomerization reaction did not work using SOCl2 with 
base DIPEA. PyBOP was also used for oligomerization reaction using two different reaction 
conditions at RT and at 70°C with base DIPEA. It yielded oligomers up to n = 2. 
 
 
 
Scheme 4 -14: Oligopeptide formation of α-amino acids using EDC in two steps via formation of o-
acylurea. 
 
HBTU was used with two bases DIPEA and Et3N with additive HOBt at different reaction 
conditions from room temperature to 100°C resulting upto n = 3 oligomers. Oligomerization using 
the coupling reagent DCC with bases DIPEA and Et3N was not effectively but after the addition 
of HOBt, the reaction worked. Reaction mixture was stirred for 48 h with 2 eq DCC using Et3N 
base and 5 eq HOBt as a additive. It gave different molecular weight oligomers in the array of n = 
1 to n = 8. The same reaction also worked using poly-DCC instead of DCC. Results obtained in 
both cases are similar. Both coupling reagents yielded oligomers ranging from n = 1 to n = 8. 
Oligomerization reaction using 2 eq DCC or poly-DCC and 2 eq HOBt with base Et3N and 
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solvent DFM was not very effective. In that case, oligomerization worked up to n = 1 and n = 2. 
Use of 5 eq HOBt instead of 2 eq HOBt helped to enhance effectiveness. The detail reaction 
conditions and reagents used for oligomerization reaction are mention in table Table 4 -2. 
 
Table 4 -2: Reaction conditions and reagents which are used for oligomerization reaction 
 
Coupling Reagents Additives/Base/Solvent Reaction conditions Number of Oligomers 
EDC DMF RT, 70°C n = 2 
EDC DIPEA/DMF RT, 70°C n = 2 
EDC 
NHS/Et3N/DMF or 
DMSO 
RT, 70°C n = 2 
HBTU 
HOBt/DIEA or 
Et3N/DMF 
RT, 0°C, 50°C, 100°C n = 1, 2, 3 and 4 
DCC NMP/DMF RT n = 3. 
DCC DIEA/DMF RT, n = 2 
PyBOP DIEA/DMF RT, 70°C n = 2 
SOCl2 DIEA/DMF RT -- 
DCC 
HOBt/DIEA or 
Et3N/DMF 
RT n = 1, 2 
poly-DCC or DCC HOBt/Et3N/DMF RT n = 1, 2,…., 7, 8 
 
Both coupling reagents poly-DCC and DCC were worked for oligomerization reaction, MALDI 
shows series of oligomers ranging from numbers 1 to 8. After Oligomerization, 1D Proton NMR 
shows two new peaks at 5.89 ppm and 4.33 ppm. Further, 2D COSY NMR experiement study of 
oligopeptide confirmed that the proton signal at 5.89 ppm belongs to 9a-H and proton signal at 
4.33 ppm was belongs to 9-H. This NMR study also helped to validate that after the 
polyhydroxylated dipeptide building blocks, the free caboxilic group of the terminal molecule of 
oligopeptide was coupled to 9-OH and formed lactone 28. Terminal lactone of oligopeptide was 
quantitatively cleaved using 1N KOH in MeOH after 30 min. The reaction mixture was quenched 
with 1N HCl to yield compound 29 (see Scheme 4 -15). 
Several matrices like sinapinic acid (trans-3,5-Dimethoxy-4-hydroxycinnamic acid), DHB (2,5-
dihydroxybenzoic acid), CCA (α-cyano-4-hydroxycinnamic acid), PA (picolinic acid), and Caffic 
acid were used to optimize the MALDI spectra. Amongest these only two matrices, Caffic acid 
and α-cyano-4-hydroxycinnamic acid, worked effectively for the measurement of molecular 
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masses. A MALDI spectrum for compound 28 shows different masses ranging from 538 to 2098 
Da. 
Three peaks were observed for each oligomer in MALDI, which were separated by 18 Da 
consecutively. Thus, the difference between first and last peak was 36 Da. The origin of this 
discrepancy was related to the oxidation of sulpher to sulphoxide and disulphoxide as a first 
thought. To confirm this phenomenon, reduction of compound 28 was carried out using 
TFA/TMSBr/EDT by stirring the reaction mixture for 20 min. at room temperature. MALDI 
spectra of resulting product gaves three similar peaks with consecutive difference of 18 Da. 
Additionally, with the aid of NMR spectroscopy further proofs of reduction of sulpher during 
oligomerization were gained. However, no change in chemical shift for 2-H proton signal was 
observed. The peak shift would cause upon change in the chemical/electronic environment if 
sulpher atom oxidise to sulphoxide. This led to conclude that the additional mass arising in 
MALDI spectrum is due to complexation of compound with water molecule as water has a mass 
of 18. 
After the cleavage of terminal lactone MALDI for compound 29 shows same masses with 
molecular weight of compounds in the range of 538 to 1838 Da (similar to compound 28). 
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Scheme 4 -15: Oligomerization of dipeptide building blocks. Reagents: (i) poly-DCC, HOBt, Et3N, RT, 48h, 
quant. or DCC, HOBt, Et3N, 48h, quant. (ii) 1N KOH, MeOH, 1N HCl, 30 min, quant. 
 
GPC, with polystyrene as standard, shows mixture of high molecular weight compounds masses 
ranging from 2962 Da to 36950 Da. These high molecular masses are deficient in MALDI-TOF 
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mass spectrum. HPLC also shows many signals during the retention time from 6.68 min to 14.65 
min. This clearly indicates that the product had diffent oligomeric compositions. 
4.3.3. Oligomerization of L-Tyrosine 
Tyrosine is an important nutritional ingredient and factor for biosynthesis of the brain 
neurotransmitters epinephrine, norepinephrine and dopamine. Tyr has been tested on humans for 
increasing their endurance to anxiety and stress under fatigue. It was proven in research studies 
that Tyr supplementation results in increased performance over a control group [220]. Tyr was also 
used with Trp for treatment of cocaine abuse [221]. Astbury et. al. [222] mentioned the preparation of 
poly-Tyr, but no details of the synthesis or structure were given. A recemic poly-Tyr was prepared 
by Noguchi [223, 224], using o-carbomethoxy-N-carboxy tyrosine anhydride as the starting 
monomer. The synthesis of poly-L-Tyr from o-carbobenzoxy-L-tyrosine-NCA was described by 
Katchalski and Sela [225, 226] as shown in Scheme 4 -16. 
 
 
 
Scheme 4 -16: Oligomerization of L-Tyr as performed by Katchalski and Sela [225, 226]. Reagents: (i) PCl5, 
and (ii) H2O. 
 
L-Tyr yielded N,o-dicarbobenzoxy-L-tyrosine on coupling with benzyl chloroformate between pH 
9 and 10.5. o-Carbobenzoxy-N-carboxy-L-tyrosine anhydride was obtained by treatment with 
phosphorus pentachloride. On polymerization in bulk or in benzene solution, gave poly-o-
carbobenzoxy-L-tyrosine with a number average degree of polymerization n = 20 to 80, as 
determined by amino nitrogen end group analysis. Overell and Petrow [227] repeated the synthesis 
of poly-L-Tyr from both the o-acetyl and o-carbobenzoxy-L-tyrosine-NCAs. The o-acetyl-NCA 
was obtained from o-acetyl-N-carbobenzoxy-L-Tyr by treatment with thionyl chloride, while the 
o-carbobenzoxy-NCA was prepared by the phogenation of o-carbobenzoxy-L-Tyr. Later L-Tyr 
derivative was formed on coupling benzyl chloroformate with copper salt of L-Tyr. The acetyl 
and carbobenzoxy group of poly-o-acetyl and poly-o-carbobenzoxy tyrosine respectively were 
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removed by means of anhydrous hydrogen bromide in glacial acetic acid. Poly-L-Tyr preparation 
of an average degree of polymerization n = 19 to 104. 
Oligomerization of L-Tyr was synthesized by using the coupling reagent poly-DCC or DCC with 
additive HOBt, without protection of phenolic group. The oligomerization reaction is shown in 
Scheme 4 -17. 
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Scheme 4 -17: Synthesis of tyrosine oligomers 30. Reagents used were (i) DCC, HOBt, DMF, RT, 48h, 
quant. or poly-DCC, HOBt, DMF, RT, 48h, quant. 
 
Tyrosine oligomers was prepared using 2 eq poly-DCC (N-cyclohexylcarbodiimide, N′-methyl 
polystyrene) or 2 eq DCC, 5 eq HOBt and 2 eq triethylamine corresponding to amount of Tyr 
monomer. Dimethylformamide and triethyl amine were found to be the most suitable solvent and 
base, respectively. Reaction mixture was stirred for 48 h. Yield obtained in methods using poly-
DCC or DCC are quantitative. 
MALDI (matrices: Caffic acid and Cinnamic acid) shows different molecular masses ranging 
from 344 to 4256 Da. Proton magnetic resonance spectra of compound 30 shows broad signals. 
Threfore, 2D HMQC spectrum was used to assign the region of the signal. 
4.3.4. Oligomerization of L-DOPA 
3,4-dihydroxyphenylalanine (DOPA) is a naturally occurring, unusual amino acid derived from 
post-translational modification of Tyr, as stated earlier [228]. It has been one of the principal agent 
administer to patients with Parkinson’s disease since 1967 [229]. Although rarely found in proteins, 
DOPA was detected in high yield (ca 10%) in marine mussel proteins [230], as well as eggshell 
precursor proteins of fasciola hepatica [231], and schistosoma mansoni [232]. As shown in section 
3.3, the catechol functionality of DOPA residues is mainly responsible for adhesion and cross-
linking of proteins. Michael reaction is one of the most frequently cited reactions of side-chain 
amino groups of Lys residues to a DOPA-quinone residue. The mechanism of this process is 
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unknown. Focus of several research groups is on DOPA to explore its exact role in mussel 
adhesive protein. 
Our additional goal for this study was to prepare fibrous peptides using oligomerize DOPA as 
well as copolymerization of DOPA with bicyclic dipeptide building blocks and Lys. 
Optically inactive poly(DL-β-3,4-dihydroxyphenyl-α-alanine) has been synthesized by Harwood 
and Cassidy [233] as shown in Scheme 4 -18. 
 
 
 
Scheme 4 -18: Synthesis of L-DOPA oligomers perfoemd by Harwood and Cassidy [233]. Reagents used 
were (i) SOCl2, (ii) dioxane, trace NaOH, (iii) 0.4 N NaOH, 45 min, and HCl. 
 
A solution of 4-(3,4-diacetoxybenzyl) oxazolidine-2,5-dione in dioxane was mixed with a solution 
of mixed sodium hydroxide in methanol dissolved in dioxane, the reaction was stirred for four 
days. The crud polymer was dissolved in ethyl acetate and reprecipitate by adding petroleum 
ether. In those studies, the molecular weight of polymer was found to be 7000 Da with the use of 
end group titration [234, 235]. 
Preparation of poly-DOPA has been already performed through polymerization of o,o′-
dicarbobenzoxy-DOPA-N-carboxyanhydride. Subsequent removal of the protecting group by 
alcoholic sodium hydroxide or hydrogen bromide in 1:2 dioxane/glacial acetic acid mixed solvent 
and the oligomers was characterised by using elemental analysis. The elemental analysis showed 
that the oligomerization yielded n = 2 to 3. 
The method adopted in this study to produce polyDOPA without protection of catechol moiety 
using coupling reagent poly-DCC (N-cyclohexylcarbodiimide, N′-methyl polystyrene) or DCC 
and HOBt as additive is shown in Scheme 4 -19. Characterization of oligopeptides was carried out 
using MALDI, which shows excellent fraction of alternating masses from 376 to 4672 Da. 
 
4   Adhesive Peptides and Copolymers: Synthesis 70 
OH
N
H
OH
O
n 
OH
NH2
OH
O
OH
31
i
 
 
Scheme 4 -19: Synthesis of DOPA oligomers 31. Reagents used were (i) DCC, HOBt, Et3N, 
DMF, RT, 48 h, quant. or poly-DCC, HOBt, Et3N, DMF, RT, 48 h, quant. 
 
DOPA oligomers 31 were prepared using 2 eq poly-DCC (N-cyclohexylcarbodiimide, N′-methyl 
polystyrene) or 2 eq DCC and 5 eq HOBt. The pH of the reaction mixture was maintained in 
between 8 to 9 using triethyl amine. Dimethylformamide and triethyl amine were found to be the 
most suitable solvent and base, the reaction mixture were stirred for 48 h at room temperature, 
yield obtained using both coupling reagent was quantitative. 
MALDI (matrices: Caffic acid and α-cyano-4-hydroxycinnamic acid) gives molecular weight of 
DOPA oligomers in the range of 376 to 4672 Da. Proton NMR spectrum of compound 31 show 
many broad peaks. Therefore, the spectral assignment was performed with the help of 2D HMQC 
spectrum (see chap 5). 
4.3.5. Oligomerization of L-Lysine 
Due to its polycationic property, water solubility, biodegradability and biocompatibility, poly-Lys 
shows multifarious application in the life sciences. In medical application, α-poly-L-Lys has been 
used to enhance efficacy of some interferon inducers, antiviral and antitumer agent [236, 237]. It has 
also been shown to improve drug transport by reducing drug resistance and to increase the 
efficiency of organelle fusion from hematocytes, liposomes etc. Many workers have investigated 
the use of α-poly-L-Lys in human drug delivery systems, especially for gene delivery. The 
antifolate agent methotrexate (MTX) which is one of the most widely used drugs in the treatment 
of human leukaemia, sarcomas and other forms of neoplastic diseases [238] Conjugation of poly-L-
Lys with methotrexate increased cellular uptake and offers a new way to overcome drug 
resistance related to deficient transport [239, 240]. 
Polymerization has been carried out, in the past, using the ε-amino group of Lys had to be masked 
in order to prevent its participation in the polymerization and thus to insure that all the amide 
bonds are derived from α-amino group of the monomer followed by removal of blocking group to 
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yields poly-L-Lys. The synthesis of a crude poly-L-Lys preparation was described by Frankel and 
Katchalski [241]. In 1998, Katchalski and associates [242] described the synthesis of poly-L-Lys in 
detail (see Scheme 4 -20) and gave a proof of its structure.  
 
 
 
Scheme 4 -20: Synthesis of L-Lys oligomers performed by Katschalski et. al. [242]. Reagents used were (i) 
H2O and (ii) PH4I. 
 
The method used is as: ε,N-Carbobenzoxy-α,N-carboxy-L-Lys anhydride was chosen as starting 
monomer and preparation of the desired polymer was carried out in bulk at a temperature of 
105°C with a pressure 10-4 mm of Hg. The average degree of polymerization, n = 32, of the 
product obtained being determined by amino N end group analysis. Cleavage of carbobenzoxy 
group was carried out using phosphonium iodide, which shows that decarbobenzoxylation is 
accompanied by the formation of benzyl iodide. 
Several polymerization techniques starting from monomer ε,N-carbobenzoxy-α,N-carboxy-L-Lys 
have been furnished, via ammonia initiation in dioxane [243], diethylamine initiation in 
dimethylformamide [244], and water initiation in benzene [234]. 
High molecular weight poly-L-Lys resulted through polymerization of ε,N-carbobenzyloxy-L-
lysine-N-carboxy anhydride using dry dioxane and sodium methoxide as a base and ε,N-
carbobenzyloxy group was removed HBr in acetic acid [245]. 
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Scheme 4 -21: Synthesis of L-Lys oligomers 33. Reagents used were (i) DCC, HOBt, Et3N, DMF, RT, 48h, 
quant. or poly-DCC, HOBt, Et3N, DMF, RT, 48h, quant. (ii) 60%TFA, 30% HBr, 20 min, quant. 
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In this study, the poly-L-Lys was synthesized through polymerization of ε,N-carbobenzyloxy-L-
Lys using coupling reagent DCC or poly-DCC and additive HOBt. The oligomerization reaction 
is shown in Scheme 4 -21. Cleavage of N-carbobenzyloxy group was carried out using TFA and 
HBr. 
Compound 32 were prepared using 2 eq poly-DCC (N-Cyclohexylcarbodiimide, N′-
methylpolystyrene) or 2 eq DCC and 5 eq additives HOBt. The pH of the reaction mixture was 
maintained between 8 and 9 using triethyl amine. Dimethylformamide and triethyl amine were 
found to be the most suitable solvent and base, the reaction mixture were stirred for 48 h at room 
temperature, yields obtained using the coupling reagent poly-DCC or DCC are quantitative. 
MALDI spectra with Caffic acid and cinnamic acid as matrices worked effectively leading to 
molecular weight of DOPA oligomers in the range of 547 to 4498 Da. 
Deprotection of Z-group was carried out using 60% TFA in DMF and 30% HBr in acetic acid. 
The reaction mixture was stirred for 20 min. The product was reprecipitated in cold ether to get 
33. Yield obtained was quantitative. Strong acidic nature of poly-L-Lys lead to the cleavage of 
molecular weight of oligomers on MALDI matrices, resulting into oligomers with an array of 147 
to 1050 Da. 1D Proton NMR of compound 32 and 33 contained broad peaks which led us to 
utilize 2D HMQC for assigning the spectral region. 
4.4.  Copolymerization Reaction 
The polymerization techniques available at present permit the synthesis of copolymers of α-amino 
acids with a random sequence, bulk copolymers as well as copolymers composed of a few amino 
acids with a known repeating sequence. Many of copolymers were used as a model compound in 
the study of the effect of different amino acid residues, on the crystallinity of peptides, their 
solubility properties and the backbone configuration. Some of them are used in the evaluation of 
the effect of neighboring amino acid residues and on the chemical and physical properties of 
specified functional groups present in the copolymer. 
Proteins are polyampholytes and thus particular attention was given by various authors to the 
study of copolymers composed of basic and acidic amino acids. Akabori et. al. [246] was the first to 
account a synthesis of a polyampholyte composed of DL-Lys and L-Glu, using the NCAs of ε-
carbobenzoxy-DL-Lys and γ-methyl-L-Glu as monomers. Later, several synthetic copolymers with 
a known sequence of α-amino acids have been accomplished [247]. Most of them were obtained by 
the polycondensation of peptide esters, peptide chloride hydrochlorides, or N-carbothiophenyl 
peptides. These methods usually yield polymers with low degree of polymerization. Several 
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methods of the activation of α-amino acids and peptides for the polymerizations and its isolation 
and purification methods are introduced in section 4.3.1. 
The preparation of such polymers, especially those containing trifunctional amino acids, is 
certainly a challenging problem to an organic chemist. Many of the methods adopted in the past 
few years in peptide for the suitable synthesis of the above type of copolymers. This includes, the 
carbodiimide method [45, 248] and the activation of α-carboxy groups by their transformation into 
the p-nitrophenyl, p-nitrophenyl thiol, or cynomethyl esters [249-252]. 
As stated in chapter 3, natural adhesive precursor protein (i.e., mefp-1) has been extracted from 
the blue mussel, Mytilus edilus, spread on culture plates and oxidized with mushroom tyrosinase. 
This procedure led to the formation of an adhesive that could be used for cell attachment and 
growth [76]. It has also been shown to be effective as an adhesive for the bonding of wet tissue 
samples [253]. The adhesive protein was also found to be non-toxic; however, the toxicity of 
enzymatic oxidizing agent was problematic. 
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Scheme 4 -22: Preparation of sequential polypeptide poly-Lys-DOPA. Reagents used were (i) HOBt, Et3N, 
DMF and (ii) BBr3, CHCl3. 
 
Alternatively several synthetic polypeptides containing DOPA, Lys and Tyr homo-polymers as 
well as specific sequence copolymers of L-DOPA with L-Lys and L-Glu have been 
accomplished [173, 174, 176, 186]. 
Scheme 4 -22 and Scheme 4 -23 show the preparation of sequential polymerization of poly-Lys-
DOPA and poly-Glu-DOPA. 
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Scheme 4 -23: Preparation of sequential polypeptide. Reagents used are (i) HOBt, Et3N, DMF and (ii) 
BBr3, CHCl3. 
 
Synthesis of L-Lys/L-Tyr copolymers has been performed in the laboratory of Ikeda [154, 176]. In 
addition to that, synthesis of random co-polypeptides containing as many as 18 different amino 
acids, including DOPA was also executed [177, 178]. Adhesive studies and cross linking of these 
polymers were implemented using iron and Al2O3 adherends without any oxidizing agent [175]. 
More detailed studies focused on L-Lys/L-Tyr random copolymers and complex random 
copolymers where Tyr enzyme was used as the oxidizing agent [154, 179]. This adhesive system was 
studied in water and diluted sea water and was found to form adhesive bonds, although 
conversion of Tyr residues to DOPA was inefficient. Successful oxidation was achieved only 
when the polymer chains were cleaved with chymotrypsin. 
Copolymerization of L-Tyr and L-Lys with polyhydroxylated dipeptide building blocks were 
carried out during study for this thesis. The copolymers were characterized for their size, structure 
and adhesiveness using several analytical tools. 
4.4.1. Copolymerization of Tripeptide (Bic-Tyr) 
The adhesive characteristic of mussel adhesive polymers have been attempted to mimic into 
synthetic polymers by several groups. This involves the synthetic co-polymerization of natural 
amino acids like Lys, Tyr and DOPA since these are functional amino acids in mussel adhesives. 
Polymerization of L-Tyr was already accomplished using side chain protection groups [173].Also 
the ring opening random polymerization of L-Tyr-N-carboxyanhydride was synthesized as well as 
copolymerizaion of N-carboxyanhydide (NCA) of o-acetyl-L-Tyr with NCAs of L-Val and L-Gly 
using dioxane at 25°C with N-butylamine as initiator [254]. Sequential copolymerization of Tyr-
Lys and Tyr-Glu and its conformational studies was as well accomplished [154, 184, 185, 255]. 
Synthesis of Bic-Tyr tripeptide 12 was carried out using Boc-stratergy (see Scheme 4 -5), during 
this study. Sequential copolymerization of tripeptide molecule without protection of hydroxyl and 
phenolic–OH groups was carried out using the coupling reagent HOBt, and additive HBTU. The 
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polymerization reaction was shown in Scheme 4 -24. The obtained product, poly Bic-Tyr, 
compound 34 was characterised using MALDI-TOF MS, NMR, GPC, AFM and Gel 
electrophoresis to resolve structure and size. 
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Scheme 4 -24: Synthesis of compound 34. Reagents used were (i) DCC, HOBt, Et3N, DMF, RT, 48 h, 
quant. or poly-DCC, HOBt, Et3N, DMF, RT, 48 h, quant. 
 
Tripeptide Bic-Tyr was copolymerized using both coupling reagents DCC and poly-DCC. 
Compound 34 was prepared using 2 eq poly-DCC or 2 eq DCC and 5 eq additives HOBt. The pH 
of the reaction mixture was maintained between 8 and 9 using triethyl amine. Dimethylformamide 
and triethyl amine were found to be the most suitable solvent and base. The reaction mixture was 
stirred for 48 h at room temperature, yields obtained using the coupling reagent poly-DCC or 
DCC are quantitative. 
MALDI, with caffic acid and α-cyano-4-hydroxycinnamic acid as matrices, for compound 34, 
shows that the reaction mixture contained different numbers of oligomers with their molecular 
weights ranging from 441 to 4671 Da. 
GPC of compound 34 showed that the product contained a mixture of higher molecular weight 
compounds in the range of 1628 to 9031 Da. Polystyrene was used as a standard for the 
measurement of GPC. 
The molecular size of oligopepties was measured using AFM on mica surface. According to these 
studies, compound 34 contains different molecular sizes with the average molecular particle size 
of the oligopeptides lying in the range of 2-4 nm.  
Gel electophorasis studies showed that the molecular weight of compound 34 was less then 14.4 
kDa. Marker (Amersham) ranges from 14.4 kDa to 97 kDa and compound 34 showed a single 
spot little below the 14.4 kDa band. This results shows similarity with GPC results although not 
with MALDI-TOF mass spectroscopy. 
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1D proton NMR spectrum showed only numerous unassignable peaks. COSY and HMQC were 
therefore used to assign resonances. Adhesive properties of compound 34 are tested and discussed 
in next chapter. 
4.4.2. Copolymerization of Dipeptide (Lys(2-Cl-Z)-Tyr) 
Synthetic co-polymerization of natural amino acids containing Tyr, Lys and DOPA are performed 
during this dissertation as these are functional amino acids in mussel adhesive proteins. Sequential 
polypeptides containing DOPA-Lys, Lys-Tyr, Lys-Phe were already synthesized by several other 
groups along with their conformational studies [154, 176]. 
However, these studies used side chain protected L-Lys, L-DOPA and L-Tyr for co-
polymerization. Deming and co-workers had synthesiszed water soluble copolypeptides 
containing L-DOPA and L-Lys by ring opening polymerization of α-amino acid NCA 
monomers [131]. 
Synthesis of compound 27, Lys(2-Cl-Z)-Tyr was carried using Boc-stratergy as shown in Scheme 
4 -10. Sequential copolymerization of compound 27, Lys (2-Cl-Z)-Tyr, without protection of Tyr 
phenolic group was carried out using coupling reagent HOBt and HBTU as an additive. The 
polymerization reaction is shown in Scheme 4 -25. 
 
NH
N
H
O
HCl.H2N
O
OH
OH
(  )4
NH
N
H
O
N
H
O
OH
n 
(  )4
35
Z-(2-Cl)
i
Z-(2-Cl)
 
 
Scheme 4 -25: Synthesis of compound 35. Reagents used were (i) DCC, HOBt, Et3N, DMF, RT, 48 h, 
quant. or poly-DCC, HOBt, Et3N, DMF, RT, 48 h, quant. 
 
Compound 35 were prepared using 2 eq. poly-DCC or 2 eq DCC and 5 eq additives HOBt. The 
pH of the reaction mixture was maintained in between 8 to 9 using triethylamine. 
Dimethylformamide and triethyl amine were found to be the most suitable solvent and base. The 
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reaction mixture was stirred for 48 h at room temperature and yield obtained using both coupling 
reagent poly-DCC or DCC are quantitative.  
MALDI-TOF MS of compound 35, poly-Lys(2-Cl-Z)-Tyr, in caffic acid and α-cyno-4-
hydroxycinnamic acid matrices gave moleculr mass in the range of 482 Da to 2323 Da. 
Gel permeation chromatography (standard: Polystyrene) were showed a mixture of higher 
molecular weight compounds ranging from 880 to 11450 Da. 
4.4.3. Copolymerization of (Lys(Z)-Bic-Tyr) 
Compound 15 was prepared using Boc-stratergy as shown in Scheme 4 -6. Sequential co-
polymerization of tetrapeptide Lys(Z)-Bic-Tyr without protection of secondary hydroxy group of 
Bic molecule and phenolic –OH of Tyr was carried out using coupling reagent HOBt and an 
additive HBTU. The polymerization reaction is shown in Scheme 4 -26. 
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Scheme 4 -26: Synthesis of copolymer 37. Reagents used were (i) DCC, HOBt, Et3N, DMF, RT, 48 h, 
quant. or poly-DCC, HOBt, Et3N, DMF, RT, 48 h, quant. (ii) HCl/Et2O, 8 h, quant. 
 
Compound 36 were prepared using 2 eq poly DCC (N-Cyclohexylcarbodimide, N′-methyl 
polystyrene) or 2 eq DCC and 5 eq additives HOBt. The pH of the reaction mixture was 
maintained in the range of 8 to 9 using triethylamine. Dimethylformamide and triethyl amine were 
found to be the most suitable solvent and base. The reaction mixture was stirred for 48 h at room 
temperature. Yield obtained using both coupling reagent poly-DCC or DCC was quantitative. was 
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MALDI (Caffic acid and α-cyano-4-hydroxycinnamic acid as matrices) showed a series of Lys(z)-
Bic-Tyr, Compound 36, oligomers with masses ranging from 703 Da to 2578 Da. 
Gel permeation chromatography (Polystyrene standard) results for compound 36 show a mixture 
of higher molecular weight compounds with masses ranging from 1614 Da to 32920 Da. 
Gel electrophoresis shows that the molecular weight of the compound 36 is less then 14.4 kDa, as 
the band runs little below marker at 14.4 kDa. 
1D proton NMR spectrum showed only numerous unassignable peaks. Therefore, COSY and 
HMQC were used to assign. 
AFM of compound 36 shows mixture of different molecular sized compounds with the average 
molecular size of oligomer as 3.1 nm. AFM measurement was carried out on mica surface. 
Quantitatively deportation of Z-group was carried out using HCl/Et2O. The reaction mixture was 
stirred for 8 h at room temperature, yields compound 37. Deprotection of Z-group was attempted 
under hydrogen atmosphere using 10% Pd/C in mixture of the solvent MeOH and DMF, because 
the compound 36 was not soluable in MeOH.  
After the deprotection Z-group compound 37 was characterized by MALDI using same matrices. 
It shows that molecular weight of the compounds was ranging from 569 Da to 1671 Da. 
As proton NMR of compound 37 showed numerous unassignable peaks, 2D HMQC was used to 
analyse structure. Adhesive property of this compound has been tested and discussed in next 
chapter. 
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5. Adhesive Peptides and Copolymers: 
Characterization 
This chapter describes characterization of compounds which were synthesized during the 
exploration of synthetic adhesive peptides. Analytical tools like NMR spectroscopy, MALDI-
TOF mass spectroscopy, atomic force microscopy, gel permeation chromatography and gel 
electrophoresis were used. 
1H NMR was enough for structural characterization of monomeric compounds, whereas high 
molecular weight compounds and mixtures gave broad unassignable signals. In such cases, homo- 
and heteronuclear 2D NMR spectroscopy was used to gather information on structure by means of 
chemical shifts. As evident, 2D NMR spectroscopy has superior resolution because of 
introduction of the second dimension. COSY (Correlated Spectroscopy) gives correlation of 
protons through J couplings and HMQC (Heteronuclear Multiple Quantum Correlation) 
experiment correlate protons to their directly connected hetero nucleus (e.g. 1H-13C pair). These 
features of COSY and HMQC fetched attention during this study for characterization. 
Matrix Assisted Laser Desorption Ionization-Mass Spectrometry (MALDI-MS) is an analytical 
method to determine the molecular mass of peptides and proteins in high vacuum. MALDI-TOF 
was used to measure molecular weights of oligopeptides and copolymers. Samples were prepared 
by mixing 2 µl of peptide sample with 1 µl caffic acid or 1 µl α-cyno-4-hydroxylcinnamic acid 
matrix solution. 1 µl of this solution was pipetted onto a metallic target probe and dried under air. 
The co-crystallized samples were investigated with a “Bruker FLEX III” spectrometer. Several 
matrices like sinapinic acid (trans-3,5-Dimethoxy-4-hydroxycinnamic acid), DHB (2,5-
dihydroxybenzoic acid), CCA (α-cyano-4-hydroxycinnamic acid), PA (picolinic acid), Caffic acid 
were used to optimize the MALDI spectra. Depending on the expected molecular weight of the 
synthesized compound, columns were chosen while performing MALDI-TOF measurements. 
In addition to MALDI-TOF mass spectroscopy, techniques like gel permeation chromatography 
(GPC) and gel electrophoresis on a SDS page were also used for the measurement of molecular 
weight (size based techniques). 
GPC measurements were performed using polystyrene standards with a set of three columns with 
dimethylformamide as solvent (300 × 8 mm, type SDV, 10 µm from PSS) using a differential 
refractometer as detector at 25°C. polystyrene was used as a standard for the GPC measurements 
Gel electrophoresis is a technique in which charged molecules, such as polypeptides or DNA, are 
separated according to physical properties as they are forced through a gel by an electrical 
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current [256]. Polypeptides (proteins) are commonly separated using polyacrylamide gel 
electrophoresis (PAGE) to characterize individual proteins in a complex sample or to examine 
multiple proteins within a single sample. PAGE can be used as a preparative tool to obtain a pure 
protein sample, or as an analytical tool to provide information on the mass, charge, purity or 
presence of a protein. Several forms of PAGE exist and can provide different types of information 
about the protein(s). Nondenaturing PAGE, also called native PAGE, separates proteins according 
to their mass:charge ratio. SDS-PAGE, the most widely used electrophoresis technique, separates 
proteins primarily by mass. In this study, the analysis of the mass of synthesized oligopepetides 
and copolymers samples was performed using SDS-PAGE. Samples were run on a 15% SDS-
PAGE (Sodium Dodecyl Sulphate-Polyacrylamide gel electrophoresis), on a mini Biorad system 
at a constant current of 30 mA. The molecular weight marker from Amersham (GE Healthcare) 
ranging from 97 kDa to 14 kDa was used for comparison of polypeptide bands. 
Characterization of adhesiveness of synthesizes compounds was done using NMR based 
technique, diffusion ordered spectroscopy (DOSY), and Atomic Force Microscopy (AFM). 
Details of both of these techniques as well as results obtained from these studies are discussed in 
section 5.2 and subsequent sections. 
5.1. Structural Characterization and Molecular Size of Synthesized Peptides 
5.1.1. Compound 6 (Fmoc-Bic-COOMe) 
2D correlation spectrum (COSY) was used to assign chemical shifts of compound 6 (Fmoc-Bic-
COOMe) (see Figure 5 -1). The aromatic proton signals belonging to Fmoc-groups appear at 7.89, 
7.72, 7.41 and 7.32 ppm. Proton signal appearing at 7.20 ppm belongs to Bic-NH. COSY 
spectrum shows that Bic-NH is coupled with 6-H (4.86 ppm) with a coupling constant 9.06 Hz. 
The triplet for proton 3-H at 4.69 ppm shows a correlation with 2-H (3.30 ppm) with a coupling 
constant 7.68 Hz. A singlet appearing at 5.46 ppm is for proton 9a-H. Two other protons give 
signal at 5.68 ppm (8-OH) and 5.33 ppm (7-OH) and show a correlation with a signal at 3.81 ppm 
(8-H and 7-H), with a coupling constant 3.57 Hz and 4.39 Hz. Proton signal belonging to Fmoc-α 
& β shows at 4.25 ppm. 
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Figure 5 -1: 2D COSY spectrum of compound 6 Fmoc-Bic-COOMe (500 MHz, DMSO-d6) along with 
projections. Assigned chemical shifts are shown with connecting lines. 
 
The methyl proton shows a signal at 3.63 ppm. 9-H proton appears at 3.56 ppm with a doublet of 
a doublet and a correlation with 9-OH and 8-H, with a coupling constant 3.20 Hz and 8.51 Hz. 
5.1.2. Compound 7 (NH2-Bic-COOH) 
COSY spectrum of compound 7 (NH2-Bic-COOH ) was measured in DMSO-d6 (see Figure 5 -2). 
The singlet for 9a-H appears at 5.58 ppm and shows a crosspeak with 9-H proton appearing at 
3.51 ppm. The 9-H proton shows a correlation with 8-H (3.82 ppm) proton with a coupling 
constant 3.04 Hz. Doublet of proton signal for 6-H appears at 4.53 ppm, whereas 3-H shows a 
triplet at 4.58 ppm. A correlation of the 3-H proton with 2-H with a coupling constant 7.0 Hz, 
which was appears at 3.21 ppm. 
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Figure 5 -2: COSY spectrum of compound 7, NH2-Bic-COOH (500 MHz, DMSO-d6). Assigned chemical 
shifts are shown with connecting lines. Projections of both proton axes are given. 
 
A well-resolved 2D HMQC spectrum of compound 7 is shown in Figure 5 -3. The C-9 carbon 
gives a signal at 75.78 ppm, whereas C-7 and C-8 carbon shows respective signals at 72.01 ppm 
and 71.48 ppm. The C-3 carbon appears at 66.08 ppm and C-9a carbon has shown a signal at 
61.15 ppm. The carbon atom belonging to C-6 gives a signal at 53.13 ppm and C-2 carbon shows 
at 32.73 ppm. 
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Figure 5 -3: HMQC spectrum of compound 7, NH2-Bic-COOH (500 MHz, DMSO-d6) with projections of 1H 
and 13C axis. Assigned chemical shifts are marked to corresponding spin system with connecting lines. 
5.1.3. Compound 9 (Fmoc-Bic-COOH) 
2D COSY spectrum of compound 9 (Fmoc-Bic-COOH) is given in Figure 5 -4. It shows that 
aromatic protons of the Fmoc-protection groups appear at 7.88, 7.72, 7.40 and 7.31 ppm. A signal 
at 5.47 ppm corresponds to proton 9a-H and it shows a correlation with 9-H proton (at 3.37 ppm). 
The 9-H proton shows a correlation with 8-H at 3.81 ppm. Doublet of proton signal 6-H, 
appearing at 4.81 ppm, shows a correlation with Bic-NH proton with a coupling constant 7.2 Hz. 
α and β protons belonging to Fmoc-protected group show a multiplet at 4.24 ppm, whereas a 
triplet for 3-H appears at 4.65 ppm. Additionally, a correlation of 3-H proton and 2-H proton with 
a coupling constant 7.4 Hz, appearing at 3.30 ppm is observed. 
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Figure 5 -4: 2D COSY spectrum and corresponding 1D projections of compound 9, Fmoc-Bic-COOH (500 
MHz, DMSO-d6). Assigned chemical shifts are marked to corresponding spin system with connecting lines. 
 
An HMQC spectrum of compound 9 shows a well-resolved pattern of peaks as shown in Figure 5 
-5. The carbon atoms belong to aromatic Fmoc- protected group show signals at 143.68, 143.60, 
140.54, 127.54, 127.54, 127.02, 125.20, 119.98 ppm. The C-9 carbon shows a signal at 76.37 
ppm, whereas C-7 and C-8 carbon appears at 70.66 ppm and 74.40 ppm, respectively.  
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Figure 5 -5: HMQC spectrum of compound 9 Fmoc-Bic-COOH (500 MHz, DMSO-d6). Assigned chemical 
shifts are marked to corresponding spin system with connecting lines. Projection of F2 (1H) axis is also 
give to elucidate the spectrum. 
 
α and β protons belongs to Fmoc-group shows signal at 65.76 ppm and 46.42 ppm. The C-3 
carbon appears at 61.04 ppm and C-9a carbon at 54.39 ppm. The C-6 and C-2 carbon atoms show 
signals at 64.46 ppm and 31.69 ppm, respectively. 
5.1.4. Compound 16 (Lys-Bic-Tyr) 
2D COSY spectrum of compound 16, Lys-Bic-Tyr, (Figure 5 -6) shows signals at 7.03 ppm and 
6.67 ppm with a coupling constant 8.0 Hz which corresponds to Tyr aromatic protons. A signal of 
Tyr-NH at 8.9 ppm, shows a crosspeak with Tyr-α appearing at 4.29 ppm. A coupling constant 
7.22 Hz was observed in them. Quartet signal of Tyr-α show a crosspeak with Tyr-β (2.85ppm), 
with a coupling constant 6.87 Hz.  
Proton signal for Bic-NH at 8.9 ppm and 6-H at 5.1 ppm show a correlation with a coupling 
constant 8.15 Hz. In addition to this 6-H shows a crosspeak with 8-H, 7-H and 9-H which appear 
at 3.85, 3.79 and 3.9 ppm, respectively. The triplet of 3-H at 4.76 ppm shows a correlation with 2-
H (3.24 ppm) with a coupling constant 7.22 Hz. Two broad singlets of Lys-NH one is for Lys-
NH-α at 8.90 ppm and second one for Lys-NH-ε at 8.31 ppm clearly show cross signals between 
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the Lys-NH-α and Lys-α (3.85 ppm) with a coupling constant 7.22 Hz and the cross signal 
between the Lys-NH-ε with Lys-CH2-ε (2.73 ppm). 
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Figure 5 -6: COSY spectrum of compound 16, Lys-Bic-Tyr, (500 MHz, DMSO-d6). Assigned chemical 
shifts are marked to corresponding spin system with connecting lines. 
 
The other CH2 groups belonging to Lys appears at 1.76 ppm, 1.58 ppm and 1.45 ppm 
respectively. 
5.1.5. Compound 18 (NH2-DOPA-Bic-Tyr-OMe) 
In a 2D COSY spectrum of compound 18, NH2-DOPA-Bic-Tyr-OMe, (see Figure 5 -7) aromatic 
protons of Tyr show two doublets at 6.98 ppm and 6.63 ppm with a coupling constant 8.47 Hz 
and 8.24 Hz. Aromatic protons of DOPA show two doublets and one doublet of doublet at 6.71 
ppm and 6.66 ppm, respectively, with a coupling constant 2.06 Hz and 8.01 Hz whereas doublet 
of doublet shows a signal at 6.58 ppm with a coupling constant 8.01 Hz and 2.06 Hz. The doublet 
for proton Bic-NH gives a signal at 8.99 ppm. 2D COSY shows a correlation between the Bic-NH 
and 6-H proton (8.0 Hz) with a doublet at 5.11 ppm. 
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Figure 5 -7: 2D COSY spectrum of compound 18, NH2-DOPA-Bic-Tyr-OMe (500 MHz, DMSO-d6). 
Assigned chemical shifts are marked to corresponding spin system with connecting lines and projections of 
both axes are given. 
 
The triplet for proton 3-H appears at 4.74 ppm and shows a correlation with 2-H proton (3.08 
ppm) with a coupling constant 7.33 Hz. Broad singlet for three protons of DOPA-NH3+ appears at 
7.98 ppm and shows a correlation with DOPA-α (4.03 ppm). 
A correlation of DOPA-α and multiplate DOPA-β can be also seen with its signal appearing at 
3.08 ppm. Doublet of Tyr-NH at 8.65 ppm shows a correlation with Tyr-α (8.01 Hz) appearing as 
a quartet at 8.65 ppm. Tyr-α also shows a correlation with Tyr-β (7.1 Hz) and appears as a doublet 
at 2.80 ppm. 
5.1.6. Compound 23 (Lys-DOPA-Tyr-OMe) 
2D COSY of compound 23, Lys-DOPA-Tyr-OMe is given in Figure 5 -8. 
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Figure 5 -8: 2D COSY spectrum of compound 23, Lys-DOPA-Tyr-OMe (500 MHz, DMSO-d6). Assigned 
chemical shifts are marked to corresponding spin system with connecting lines. Projections of F1 and F2 
dimensions are also shown. 
 
Two doublets of Tyr aromatic protons, appearing at 6.99 ppm and 6.67 ppm, show a correlation 
with a coupling constant 8.25 Hz and 8.43 Hz, respectively. Whereas, aromatic protons of DOPA 
show two doublets at 6.70 ppm (7.7 Hz) and 6.61 ppm (8.06 Hz) and one doublet of doublet at 
6.49 ppm (8.06 Hz and 2.20 Hz). The doublet of DOPA-NH at 8.53 ppm shows a correlation with 
DOPA-α (4.36 ppm), with a coupling constant 7.70 Hz. 2D COSY also shows a correlation 
between DOPA-α and DOPA-β with a multiplet at 2.8 ppm. Doublet of Tyr-NH at 8.68 ppm, 
showing a correlation with Tyr-α (4.45 ppm) with a coupling constant 8.25 Hz can be also seen. 
Proton of Tyr-α show a correlation with proton of Tyr-β (2.61 ppm) as a doublet of doublet with a 
coupling constant 13.75 Hz and 9.7 Hz, respectively. Two broad singlets for Lys-NH-α and Lys-
NH-ε appear at 8.23 ppm and 8.05 ppm. Lys-NH-α shows a correlation with Lys-α proton which 
appears at 3.69 ppm, and Lys-NH-ε shows a correlation with Lys-CH2-ε (2.70 ppm). Other three 
Lys-CH2 groups appear at 1.70 ppm, 1.54 ppm and 1.29 ppm. 
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5.1.7. Oligopeptides: poly-Tyr 
2D HMQC spectrum of poly-Tyr (compound 30) was taken in DMSO-d6 at 500 MHz 
spectrometer (see Figure 5 -9 (A)). Tyr aromatic proton show signals at 6.58 and 6.45 ppm, 
respectively and the aromatic carbon signal appears at 114.81 and 119.6 ppm, respectively. The α-
proton of poly-Tyr shows broad signal at 4.45 ppm corresponding to a carbon chemical shift at 
54.62 ppm. Tyr-β protons appear at 2.79 ppm with a carbon signal at 45.3 ppm. 
 
 
 
Figure 5 -9: 2D HMQC taken at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra (B) 
of poly-Tyr. Assigned chemical shifts are marked to corresponding spin system with connecting lines and 
proton plane projection is shown in A. 
 
The MALDI-TOF mass spectrum of poly-Tyr was measured using matrices Caffic acid and α-
cyano-4-hydroxy cinnamic acid. poly-Tyr shows different mixture of oligopeptides with masses 
ranging from 344 Da to 4256 Da with the highest amplitude around 1300 Da (see Figure 5 -9 B). 
5.1.8. Oligopeptides: poly-DOPA 
In 2D HMQC spectrum of poly-DOPA (see Figure 5 -10 (A)), DOPA aromatic protons show 
signals at 6.56 and 6.42 ppm with carbon chemical shifts at 115.05 and 119.84 ppm. The α-proton 
of poly-DOPA shows a signal at 4.33 ppm corresponding to its carbon chemical shift at 53.86 
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ppm. Whereas, β- carbon atom show a signal at 45.0 ppm with its proton chemical shift at 2.32 
ppm. 
 
 
 
Figure 5 -10: 2D HMQC taken at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra (B) 
of poly-DOPA. Assigned chemical shifts are marked to corresponding spin system with connecting lines in 
A. 
 
MALDI-TOF mass spectrum of poly-DOPA was carried out in caffic acid and α-cyano-4-
hydroycinnamic acid. poly-DOPA shows different mixtures of oligomers with masses ranging 
from 376 Da to 4672 Da with a maximum intensity for mass 2750 Da. 
5.1.9. Oligopeptides: poly-Lys(Z) 
In a 2D HMQC of poly-Lys(Z), aromatic proton of the Z protecting group shows signals at 7.58 
ppm and its carbon signals at 127.8 ppm. Protons belonging to CH2-Z group appear at 4.9 ppm 
with a carbon chemical shift at 65.0 ppm. The Lys-α proton shows a chemical shift at 4.2 ppm and 
a corresponding carbon chemical shift at 52.1 ppm. Two protons belonging to ε carbon atom show 
a signal at 2.92 ppm and its carbon chemical shift appears at 40.0 ppm. Other CH2 groups 
belonging to Lys show proton signals at 1.64, 1.35 and 1.2 ppm with corresponding carbon shifts 
at 29.8, 29.0 and 22.5ppm. This spectrum is shown in Figure 5 -11 (A). 
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Figure 5 -11: 2D HMQC taken at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra (B) 
of poly-Lys (Z). Assigned chemical shifts are marked to corresponding spin system with connecting lines in 
A. 
 
Caffic acid and α-cyano-4-hydroxy cinnamic acid were used as matrices measurement of 
MALDI-TOF mass spectrum of poly-Lys(Z). Poly-Lys (Z) shows different mixture of 
oligopeptides with masses ranging from 547 Da to 4498 Da with maximum intensity peak at 1750 
Da as shown in Figure 5 -11 (B). 
After the cleavage of Z-group, the α-proton of the Lys oligopeptide show a signal at 4.2 ppm and 
its carbon shift at 52.0 ppm (see Figure 5 -12 (A)).  
 
 
 
Figure 5 -12: 2D HMQC taken at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra (B) 
of poly-Lys. Assigned chemical shifts are marked to corresponding spin system with connecting lines in A. 
 
5   Adhesive Peptides and Copolymers: Characterization 92 
Two ε-proton show signals at 2.7 ppm with their carbon signal appearing at 25.99 ppm. Other 
proton signals belonging to three CH2 groups show at 1.56, 1.52 and 1.30 ppm, corresponding to 
their carbon shifts appearing at 25.99, 30.74 and 21.82 ppm, respectively. 
The MALDI-TOF mass spectrum of poly-Lys (in caffic acid and α-cyano-4-hydroxycinnamic 
acid) resulted into mixture of different oligopeptides with masses ranging from 146 Da to 1012 
Da (see Figure 5 -12 (B)). 
5.1.10. Oligopeptides: poly-Bic 
Chemical shift assignment of poly-Bic (compound 28) was performed using 2D COSY, HSQC 
and HMQC spectra. HSQC shows that the three new broad signals appearing after the 
oligomerization at 6.03, 5.89 and 4.33 ppm belong to the CH or CH3 group. 2D COSY spectrum 
shows that a signal at 6.03 ppm correlates with a signal at 4.01 ppm. Also, a signal appearing at 
4.01 ppm shows a crosspeak with a signal at 4.33 ppm. A signal appearing at 6.03 ppm in 2D 
COSY is absent in HMQC as it belongs to hydroxyl protons. 
 
 
 
Figure 5 -13: 2D HMQC recorded at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra 
(B) of compound 28 poly-Bic. Assigned chemical shifts are marked to corresponding spin system with 
connecting lines and 1D projection of proton axis is shown in A. 
 
2D COSY supplies evidences that the signal appearing at 6.03 ppm belongs to 8-OH. Peak 
appearing at 4.01 ppm belongs to 8-H and a signal appearing at 4.33 ppm belongs to 9-H. The 
peak appearing at 5.89 ppm corresponds to 9a-H (see Figure 5 -13 (A) and Figure 5 -14). 
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Based on these studies, it can be concluded that during the oligomerization of bicyclic molecules 
the terminal molecule of oligomer is converted to a lactone by utilizing 9-OH from the same 
residue. 
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Figure 5 -14: 2D COSY spectrum of compound 28 poly-Bic taken at a 500 MHz in DMSO-d6.Assigned 
chemical shifts are marked to corresponding spin system with connecting lines in A. Projections of both 
axis are also shown in figure. 
 
The assignment of peaks belonging to oligopeptides is performed using 2D COSY (see Figure 5 -
14) and can be summarized as: 5.47 ppm (9a-H), 5.01 ppm (6-H), 4.85 (3-H), 3.81 (8-H), 3.76 (7-
H), 3.71 (9-H), 3.39-3.22 (2-H). 
The MALDI-TOF mass spectrum of poly-Bic, compound 28, was measured in caffic acid and α-
cyano-4-hydroxycinnamic acid. It shows mixtures different of oligomers with masses ranging 
from 538 Da to 2358 Da and with a peak of maximum intensity at 1125 Da as shown in Figure 5 -
13 (B). 
After the hydrolysis, proton spectrum of compound 29 shows that peaks belonging to lactone (i.e., 
9a-H, 3-H, 6-H, 8-H and 9-H) disappear. 
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2D HMQC shows a signal belonging to 9a-H at 5.46 ppm with a carbon chemical shift at 60.9 
ppm. A peak at 5.01 ppm belongs to 6-H and two peaks at 4.85 and 4.6 ppm belongs to 3-H 
respectively. The carbon shift of 6-H is at 52.3 ppm and that of 3-H appears at 64.3 and 64.2 ppm. 
Three signals at 3.83, 3.75 and 3.58 ppm belong to 8-H, 7-H and 9-H protons with their carbon 
shifts corresponding to 71.04, 74.17 and 76.64 ppm. Proton signal for 2-H is seen at 3.28 ppm 
with its carbon resonance appearing at 32.1 ppm (see Figure 5 -15). 
 
 
 
Figure 5 -15: 2D HMQC recorded at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra 
(B) of compound 29 poly-Bic. Assigned chemical shifts are marked to corresponding spin system with 
connecting lines in A. 
 
MALDI-TOF mass spectrum of compound 29 (matrices: Caffic acid and α-cyano-4-hydroxy 
cinnamic acid) results into mixture of different oligopeptides with masses ranging from 538 Da to 
1838 Da as shown in Figure 5 -15 (B). 
5.1.11. Co-polymers: poly-Bic-Tyr 
2D HMQC of poly-Bic-Tyr, compound 34, gives two aromatic signals belonging to Tyr at 7.03 
and 6.61 ppm. Signal belonging to 9a appears at 5.48 ppm. Two peaks at 5.0 and 4.66 ppm are 
from 6-H and 3-H respectively. The α-proton of Tyr appears at 4.49 ppm and three signals 
appearing at 3.85, 3.69 and 3.62 ppm belongs to 8-H, 7-H and 9-H protons, respectively. Tyr-β 
proton appears at 3.36 ppm. Broad peak at 3.10 ppm belongs to 2-H as seen in Figure 5 -16 (A). 
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Figure 5 -16: 2D HMQC recorded at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra 
(B) of compound 34 poly-Bic-Tyr. Assigned chemical shifts are marked to corresponding spin system with 
connecting lines in A. A also shows 1D projection of proton axis. 
 
Caffic acid and α-cyno-4-hydroxylcinnamic acid matrices were used to get molecular weight of 
poly-Bic-Tyr using MALDI-TOF mass spectroscopy. Masses with different oligomeric 
compositions in the range of 441 to 4671 Da are seen in Figure 5 -16 (B). 
Molecular mass of poly-Bic-Tyr was also characterized using gel permission chromatography and 
has been shown in Figure 5 -17. 
 
 
 
Figure 5 -17: Gel Permeation chromatography of poly-Bic-Tyr, compound 34. Molecular weight of 9031 
Da was observed although broad peaks suggest that the oligopeptide has a distribution of masses 
between 1628 to 9031 Da. 
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Polystyrene as a standard was used for these studies. GPC confirms presence of oligomeric 
mixture of higher molecular weight compound in the ranging of 1628 to 9031 Da. The high 
intensity of peak at 9031 Da suggests its high content in the oligometic mixture. 
In addition to GPC and MALDI, molecular weight information of poly-Bic-Tyr was gained from 
running a polyacrylamide-SDS gel which is shown in Figure 5 -18.  
 
 
 
Figure 5 -18: Polyacrylamide-SDS gel of poly-Bic-Tyr (compound 34). Panel A is a marker and bands in A 
corresponds to Phosphorylase b 97 kDa, Albumin 66 kDa, Ovalbumin 45 kDa, Carbonicanhydrase 30 kDa, 
Trypsin inhibitor 20.1 kDa, α-lactalbumin 14.4 kDa. Panel B is 10 µL load of poly-Bic-Tyr which runs little 
below 14.4 kDa band of α-lactalbumin proposing that poly-Bic-Tyr has a molecular weight of ca. 9 kDa. 
 
After staining and destaining, SDS-PAGE of poly-Bic-Tyr gave a single band little below 14.4 
kDa band corresponding to α-lactalbumin. An estimation of molecular weight has been performed 
as there was no available marker. This comes to be around 9000 kDa which is in good agreement 
with results obtained from GPC. 
5.1.12. Co-polymers: poly-Lys(2-Cl-Z)-Tyr 
Two dimensional HMQC of poly-Lys(2-Cl-Z)-Tyr, compound 34, was recorded in DMSO-d6 and 
is shown in Figure 5 -19 (A). The aromatic protons of 2-Cl-Z protecting group appear at 7.40 ppm 
corresponding to carbon atom at 129.8 ppm. Protons belonging to CH2-Z group show a signal at 
5.3 ppm with a carbon chemical shift at 63 ppm. The aromatic protons of Tyr can be seen at 6.99 
ppm and 6.64 ppm, respectively whereas their carbon shifts appear at 130 ppm and 114.7 ppm. 
The Lys-α group and Tyr-α shows proton signal at 3.68 ppm and at 4.25 ppm and related to their 
carbon signals at 51.8 ppm and 54.5 ppm respectively. 
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Figure 5 -19: 2D HMQC taken at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra (B) 
of compound 35 Lys(2-Cl-Z)Tyr. Assigned chemical shifts are marked to corresponding spin system with 
connecting lines in A. 
 
Two protons belonging to ε-carbon atom and one proton belonging to Tyr-β appear at 2.94 and 
2.8 ppm with their carbon chemical shift at 39.7 ppm. CH2 groups belonging to Lys shows proton 
signals at 1.66, 1.38 and 1.19 ppm and carbon signals at 31.1, 29.0 and 22.0 ppm respectively. 
The MALDI-TOF mass spectrum of compound 35 was measured using two different matrices 
Caffic acid and α-cyano-4-hydroxy cinnamic acid (see Figure 5 -19 (B)). The result shows that the 
different mixture of oligopeptides with masses ranging from 482 Da to 2323 Da is present. 
 
 
 
Figure 5 -20: Gel permeation chromatography of poly-Lys(2-Cl-Z)-Tyr, compound 35. Molecular weight of 
11450 Da was observed although broad peaks suggest that the oligopeptide has a distribution of masses 
between 880 to 11450 Da. 
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Gel permeation chromatography study of oligopeptide compound 35 shows that the product 
containing mixture of higher molecular weight compound, which are ranging from 880 to 11450 
Da. It is shown in Figure 5 -20. 
5.1.13. Co-polymers: poly-Lys(Z)-Bic-Tyr 
In a 2D HMQC, the aromatic proton of the Z protecting group of compound 36, poly-Lys(Z)-Bic-
Tyr shows a signal at 7.34 ppm with its carbon signal at 127.5 ppm. The aromatic protons of the 
Tyr have been seen at 7.04 ppm and 6.6 ppm respectively, whereas their carbon shift appears at 
130 ppm and 114.8 ppm. Proton belonging to CH2-Z group shows a signal at 5.0 ppm and its 
carbon chemical shift appears at 64.9 ppm. Signal belonging to 9a appear at 5.5 ppm with carbon 
chemical shift at 70.1 ppm. Two peaks appearing at 5.13 ppm and 4.31 ppm belong to 6-H and 3-
H respectively and their carbon shift come out at 64.8 and 52.1 ppm. Protons of Lys-α and Tyr-α 
group shows a signal at 3.85 ppm and 4.81ppm, respectively with carbon shifts at 51.77 ppm and 
53.97 ppm. Two protons belonging to ε-carbon atom and one proton belongs to Tyr-β show a 
signal at 2.92, 2.83 ppm and 2.97 ppm and their corresponding carbon chemical shift appears at 
34.4 ppm and 39.6 ppm.  
 
 
 
Figure 5 -21: 2D HMQC taken at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra (B) 
of compound 36 Lys(2-Cl-Z)Tyr. Assigned chemical shifts are marked to corresponding spin system with 
connecting lines in A. 1D projection of proton axis is also given in A. 
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Whereas, CH2 groups belonging to Lys show proton signals at 1.73, 1.39 and 1.36 ppm and the 
carbon signals at 30.7, 28.4 and 21.4 ppm respectively. Proton signals at 3.87 ppm, 3.76 ppm and 
3.62 ppm belongs to 8-H, 7-H and 9-H of the bicyclic ring, respectively with their carbon 
chemical shifts at 71.0 ppm, 74.5 ppm and 76.0 ppm. A signal at 3.17 belongs to 2-H of bicyclic 
ring with its carbon signal appearing at 32.0 ppm as shown in Figure 5 -21 (A). 
MALDI-TOF mass spectrum of compound 36 was measured using two different matrices, Caffic 
acid and α-cyano-4-hydroxy cinnamic acid. Different mixtures of oligopeptides with masses in 
the range of 703 Da to 2758 Da were found as shown in Figure 5 -21 (B). 
 
 
 
Figure 5 -22: Gel Permeation chromatography of poly-Lys(Z)-Bic-Tyr, compound 36. Molecular weight of 
329200 Da was observed although broad peaks suggest that the oligopeptide has a distribution of masses 
between 1614 to 329200 Da with the maximum amplitude at 7052 Da. 
 
Gel permeation chromatography of oligopeptide compound 36, poly-Lys(Z)-Bic-Tyr, suggests of 
a mixture of higher molecular weight compound in the range of 1614 Da to 329200 Da. The 
highest peak is seen at 7052 Da as shown in Figure 5 -22. 
In addition to MALDI and GPC, molecular weight of compound 36, poly-Lys(Z)-Bic-Tyr, was 
also determined using SDS-PAGE. After staining and destaining, SDS-PAGE of poly-Bic-Tyr 
gave a single band that appeared slightly below 14.4 kDa which correspond to α-lactalbumin. An 
estimation of molecular weight has been performed as there was no available marker in that 
range. It suggest that the molecular weight of poly-Lys(Z)-Bic-Tyr should be ca. 9000 kDa. This 
value is in good agreement with 7052 Da as obained from GPC. 
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Figure 5 -23: Polyacrylamide-SDS gel of poly-Lys(Z)-Bic-Tyr (compound 36). Panel A is a marker and 
bands in A corresponds to Phosphorylase b 97 kDa, Albumin 66 kDa, Ovalbumin 45 kDa, 
Carbonicanhydrase 30 kDa, Trypsin inhibitor 20.1 kDa, α-lactalbumin 14.4 kDa. Panel B is 10 L load of 
poly-Bic-Tyr which runs little below 14.4 kDa band of α-lactalbumin proposing that poly-Bic-Tyr has a 
molecular weight of ca. 9 kDa. 
 
The discrepancies in the masses of compound 34 and 36 arising from MALDI and GPC (and gel 
electrophoresis) could not be understood completely. One obvious reason could be the approach 
of detecting masses as MALDI is molecular weight based and GPC (and gel electrophoresis) is 
size based technique. 
5.1.14. Co-polymers: poly-Lys-Bic-Tyr 
After the cleavage of Z group from compound 36, poly-Lys-Bic-Tyr was obtained and studied 
likewise, i.e. with the help of 2D HMQC. The chemical shifts of signals were very slightly 
affected from that of compound 36. 
The aromatic protons of the Tyr are seen at 7.00 and 6.78 ppm with their carbon shift appearing at 
129.4 and 114.6 ppm. Signal belonging to 9a appear at 5.48 ppm and it shows a signal at 61.03 
ppm in carbon dimension. Two peaks appearing at 5.03 ppm and 4.64 ppm belong to 6-H and 3-
H, respectively with their carbon shifts appearing at 51.99 ppm and 64.45 ppm. Protons of Lys-α 
and Tyr-α group show a signal at 4.30 ppm and 4.3 ppm and appear at 53.9 ppm and 51.9 ppm on 
carbon chemical shift. Two protons belonging to ε-carbon atom and one proton belonging to Tyr-
β show a signal at 2.69 and 3.15 ppm with their carbon chemical shifts appearing at 34.7 and 
48.31 ppm, respectively. Three signals of proton 8-H, 7-H and 9-H appear at 3.88, 3.78 and 3.74 
ppm and their carbon shift show at 71.1, 74.4 and 76.4 ppm. A signal for 2-H proton comes at 
3.15 ppm with its carbon shift at 31.98 ppm. Remaining three CH2 groups belonging to Lys 
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appear at 1.73, 1.39 and 1.36 ppm with their carbon shifts appearing at 30.7, 28.4 and 21.4 ppm. 
The 2D HMQC is shown in Figure 5 -24 (A). 
 
 
 
Figure 5 -24: 2D HMQC recorded at a 500 MHz in DMSO-d6 (A) and MALDI-TOF mass spectrum spectra 
(B) of compound 37 poly-Lys-Bic-Tyr. Assigned chemical shifts are marked to corresponding spin system 
with connecting lines in A. 
 
The MALDI-TOF mass spectrum of compound 37, poly-Lys-Bic-Tyr was taken in Caffic acid 
and α-cyano-4-hydroxy cinnamic acid. Using both matrices compound 37 shows a mixture 
different oligopeptides with masses ranging from 569 Da to 1671 Da as shown in Figure 5 -24 (B) 
with maximum intensity peak around 1200 Da. 
5.1.15. Comparison of Molecular Weights of Compounds 
It should be noticed that a consistent discrepancy was seen in molecular weights obtained by 
MALDI and GPC for almost each synthesized oligomer and polymer. One obvious reason could 
be the approach of detecting masses in these two methods. MALDI is molecular weight based and 
GPC is size based technique. 
One or more of the following reasons could be possible explanation for these discrepancies. 
a) MALDI mass spectra from polydisperse polymers indicate that high-mass components are 
generally underrepresented with respect to lower mass oligomer peaks. This mass discrimination 
effect is caused by a combination of several factors, including sample preparation, mass-
dependent desorption/ionization processes, and mass-dependent detection efficiency. Caution 
must be exercised when interpreting average molecular weights and molecular-weight distribution 
values from MALDI data, especially for highly polydisperse polymers. Although MALDI cannot 
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yet provide reliable molecular-weight parameters for polymers having large polydispersities, the 
combination of GPC and MALDI MS does provide a useful method for determining molecular-
weight distributions of polydisperse polymers [257, 258]. 
b) MALDI can determine molecular weight independent of polymer structure. For example, rigid 
polymers are a challenge to analyze by GPC because these polymers have a linear sticklike 
geometry [259]. Although mefp-1 has a partially helical and partially random coil structural units, 
mimicked adhesive peptide might still be linear, rigid rod like chemical moiety. While, partially 
folded bio-polymers are readily analyzed by GPC methods, which are based on correlating the 
hydrodynamic volume of the coiled biopolymer chains with molecular weight. However, the 
hydrodynamic volume of rigid-rod-like polymers does not correlate with polymer molecular 
weight; hence, molecular weights determined by GPC analysis of these structures often deviate 
strongly from the true values. 
c) Additional shortcomings of either method is proper calibration issue. 
5.2. Techniques Used for Testing Adhesive Properties 
5.2.1. Diffusion Ordered Spectroscopy 
Diffusion-ordered 2D-NMR spectroscopy (DOSY) has generated significant interest because it 
allows the NMR spectroscopic observation of mixture on the basis of the size [260, 261]. As the 
gradient strength increases, in DOSY experiments, signals decay exponentially according to the 
translational diffusion coefficients of the molecule. It can be a very important experiment because 
it permits a noninvasive chromatographic separation of components in a mixture solution without 
need to any preliminary physical separation provided spectral resolution is retained [16, 262-269]. 
DOSY NMR can also be used as a powerful tool to distinguish between the complex and non 
complex forms in a mixture of host and guest compounds due to the differences in their diffusion 
coefficients. These will be reflected in the changes in their size and mass accompanied by 
complex formation. [265, 270-272]. 
DOSY NMR has been introduced to solve such kinds of problems in polymer mixture systems 
(e.g. polymer-polymer mixtures and polymer additives mixture) [16, 267, 273, 274]. 2D-DOSY 
technique for the analysis of graft copolymer solutions has been investigated by comparing the 
diffusion behavior of the target copolymer with the mixture of constituent polymers. By 
conventional 1H NMR spectroscopy, some graft copolymers are not distinguished from the 
mixtures of their constituent polymers [275]. 
In order to check the adhesive properties of synthetic adhesive pepetides, DOSY spectrum was 
run with and without silicon nano beads. Silicon nano beads are bigger in size compared to 
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synthetic peptides. Therefore, if peptide would bind to silicon beads then it should affect 
translational diffusion of peptide. This would be expected either in the form of shift in the 
resoancnes in 1D DOSY or appearance of new signals in the 2D DOSY experiment. Nano beads 
which were used in this experiment had been synthesized by us using following protocol. 
5.2.2. Synthesis of Silicon Beads 
Mixture of water (82 mL) and ethanol (160 mL) was heated using an oil bath to 75°C. 
Simultaniously, tetraethylorthosilicate (TES) was placed in a flask in the same oil bath. At 75°C, 
ammonia was added into the mixture of solvents and stirred drastically so as to ensure very good 
mixing. After the addition of ammonia the temperature went down to 72.3°C. Once the 
temperature reached 75°C again, TES was poured into the mixture of solvents and ammonia using 
a funnel. The reaction was stirred for 15 s. Further, the reaction mixture was kept at 75°C for 2 h. 
Size of nano beads was measured using electron microscope and was found to in the range of 55 
nm to 75 nm. 
For recording DOSY spectrum of adhesive peptides in presence of nano beads, 2 mg nano beads 
were used. 
5.2.3. Atomic Force Microscopy 
The atomic force microscope (AFM) [276] is a new type of scanning probe microscope which is 
capable of mapping forces near surfaces, or by means of these forces, mapping the topography of 
the surface it self. The AFM is an offshoot of the scanning tunneling microscope (STM) [276, 277]. 
Like the STM, the AFM is capable of extremely high spatial resolution in three dimensions. The 
AFM, however, can be used to study the surfaces of both electrically conducting and 
nonconducting samples, overcoming a major limitation of the STM. 
AFM technology allowed single molecular analysis to become possible. The AFM probe has a 
sharp tip (5-50 nm radius of curvature) making the contact area of tip-substrate quite small and 
attractive forces between the AFM tip and the substrate at sub-nano Newton level can be 
monitored. Usually, for high resolution measurements, the sample is scanned instead of the tip as 
with the STM, because the AFM measures the relative displacement between the cantilever and 
few surfaces and any cantilever movement would add vibrations. For measurements of large 
samples, AFMs are available where the tip is scanned and the sample is stationary. As long as the 
AFM is operated in contact mode, little if any vibration is introduced.  
The AFM combines the principles of the STM and the stylus profiler. In the AFM the force 
between the sample and the tip is detected, rather than the tunneling current, to sense the 
5   Adhesive Peptides and Copolymers: Characterization 104 
proximity of the tip to the sample. The AFM can be used either in a static or dynamic mode. In 
the static mode, also referred to as repulsive mode or contact mode, a sharp tip at the end of a 
cantilever is brought in contact with a sample surface. During initial contact, the atoms at the end 
of the tip experience a very weak repulsive force due to the tip, electronic orbital overlap with the 
atoms in the sample surface. The force acting on the tip causes a cantilever deflection which is 
measured by tunneling, capacitive, or optical detectors. In the dynamic mode operation of the 
AFM, also referred to as attractive force imaging or non contact mode, the tip is brought in close 
proximity ( within a few nm) to, and not in contact with sample. The cantilever is deliberately 
vibrated either in amplitude modulation (AM) mode or frequency modulation (FM) mode [278]. 
Very weak van der Waals attractive forces are present at the tip-sample interface. Although in this 
technique, the normal pressure exerted at the interface is zero (desirable to avoid any surface 
deformation), it is slow and is difficult to use and is rarely used outside research environments. In 
the two modes, surface topography is measured by laterally scanning the sample under the tip 
while simultaneously measuring the separation dependent force gradient between the tip and the 
surface. In contact mode, the interaction force between the tip and sample is measured by 
measuring the cantilever deflection. In the noncontact or dynamic mode, the force gradient is 
obtained by vibrating the cantilever and measuring the shift of resonance frequency of the 
cantilever. To obtaine topographic information, the interaction force is either recorded directly, or 
used as a control parameter for a feedback circuit that maintains the force or force derivation at a 
constant value. 
The ability of the AFM to image at atomic resolution, combined with its ability to image a wide 
variety of samples under a wide variety of conditions, has created a great deal of interest in 
applying it to the study of biological structures. Images have appeared in the literature showing 
DNA, single proteins, structures such as gap junctions, and living cells [279]. 
The rupturing process of the single protein has been analyzed and the qualitative investigation 
regarding with secondary structure of both protein and peptides have been attempted by 
measuring force curves [280, 281]. AFM can also be utilized for analyzing peptide molecules. One 
can estimate hydrogen-bond energy, stiffness and α-helix content of a single α-helical peptide 
molecule from force curve analysis [282-284]. 
Molecular interactions can also be measured using AFM and unbinding forces from single 
molecular binding such as avidin and biotin, [285, 286] antigens and antibodies [287-289] and His-tag 
and nickel-nitrilo triacetic acid [290] have been accomplished. 
The study of the interaction of oligopeptides on different surfaces like mica and graphite using 
contact mode AFM was performed for synthesized adhesive peptides. Additionally, the size of 
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oligopeptides was measured. The information on the size proves to be vital if oligopeptides show 
interaction with the surface (i.e., binding). In such case its size would change.  
The briefly experimental study of the oligopeptides with different large surfaces is explained here. 
A Topometrix Explorer AFM equipped with a 2.5 µm scanner was used. Single-crystal silicon 
cantilever were used and all AFM imaging was conventional ambient non-contact mode AFM, 
with scan speeds of about 1-5 Hz and data collection at 400×400 pixels. Substrates used for 
oligopeptide adsorption were freshly cleaved mica, freshly cleaved graphite HOPG (high oriented 
pyrolytic graphite). 
All experiments were performed by mixing of 1 mg oligomer compound in 0.1 ml dry DMF, 20-
µL aliquot of the mixture was deposited on to bilayer like (mice and graphite). The sample was 
rapidly blow dried using a burst of compressed gas (Nitrogen or Argon). 
5.3. Adhesiveness of Synthesized Peptides 
5.3.1. DOSY of Lys-Bic-Tyr, Lys-DOPA-Tyr-OMe and DOPA-Bic-Tyr-OMe 
In a 1D DOSY experiment of mixtures of compounds, one expects to see different lineshapes 
depending on the rotational correlation time [291]. The rotational correlation times of all the four 
tetrapeptide are bound to be very similar because of their relatively similar size and shape. 
However, in presence of nanobeads, as proposed, one or more tetrapeptide might bind due to 
adhesive property leading to a sudden decrease in the rotational correlation time. This would 
reflect in changed diffusion coefficient. A changed diffusion coefficient would then induce 
change in the lineshape or in the form of newly appearing signals. 
Tetrapeptides like, compound 16 (Lys-Bic-Tyr), compound 23 (Lys-DOPA-Tyr-OMe) and 
compound 18 (DOPA-Bic-Tyr-OMe) were probed for adhesive properties using 1D DOSY which 
is shown in Figure 5 -25. 
No change in shape of existing signal (broadening) or appearance of new signal has been 
observed for all four tetrapepetides. However, 1D DOSY is often limited with the spectral 
resolution partly due overecrowding of spectral resoanances arising from different compound in 
the mixture. The difficulty of extracting clean diffusion parameters from overlapping signal 
decays sets strict limits on the diffusion resolution of low resolution DOSY, but in the high 
resolution case, performed as 2D DOSY, relatively small differences (of the order of 1%) in 
diffusion coefficient can be resolved.  
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Figure 5 -25: 1D DOSY spectrum of mixtures of tetrapeptide (Lys-Bic-Tyr, Lys-DOPA-Tyr-OMe and 
DOPA-Bic-Tyr-OMe) recorded at 500 Mz in D2O. Lower panel represents 1D DOSY without silicon 
nanobeads whereas upper panel is a 1D DOSY spectrum with 2 mg of silicon nanobeads. Signals 
corresponding to tetrapeptides are: (A) Lys-Bic-Tyr, (B) DOPA-Bic-Tyr-OMe, and (C) Lys-DOPA-Tyr-OMe. 
 
A 2D DOSY of compound 16 (Lys-Bic-Tyr), compound 23 (Lys-DOPA-Tyr-OMe) and 
compound 18 (DOPA-Bic-Tyr-OMe) is shown in Figure 5 -26. 
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Figure 5 -26: 2D DOSY spectrum of the mixture of tetrapeptides (compound 16 (Lys-Bic-Tyr), compound 
23 (Lys-DOPA-Tyr-OMe) and compound 18 (DOPA-Bic-Tyr-OMe)) recorded at 500 MHz with D2Oas 
solvent. Upeer panel represents spectrum with 2.2 mg of silicon nanobeads whereas lower panel 
represents blank spectrum. 
 
However, 2D DOSY spectrum of oligomers do not show binding with silicon nano beads. This is 
evident from unchanged spectral pattern and chemical shifts of oligomers with and without 
nanobeads. 
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5.3.2. DOSY of poly-Bic-Tyr 
The adhesiveness property of the oligopeptide poly-Bic-Tyr (compound 34) was measured using 
1D and 2D diffusion order spectroscopy (DOSY). 
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Figure 5 -27: 1D DOSY spectrum of poly-Bic-Tyr (compound 34) without nano beads (lower panel) and 
with 2 mg nano beads (upper panel). Solvent signal is marked. 
 
1D DOSY spectra of poly-Bic-Tyr (compound 34), with and without silicon nanobeads are shown 
in Figure 5 -27. We see relatively broad signals from the oligomer. However, no change in the 
signal pattern and no appearance of new signal suggest that poly-Bic-Tyr does not bind to 
nanobeads. To gain futher insights into the binding of nanobeads with poly-Bic-Tyr, 2D DOSY 
spectra was measured and shown in Figure 5 -28. 
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Figure 5 -28: 2D DOSY spectrum of poly-Bic-Tyr (compound 34) recorded at 500 MHz with D2O as 
solvent. Upper panel represents spectrum with 2.2 mg of silicon nanobeads whereas lower panel 
represents blank spectrum. No additionally appearing signal has been noticed in the upper panel. 
Impurities and solvent signals are marked in figure. 
 
The measurement was performed in the absence and presence of silicon nanobeads. As stated 
previously, upon binding (interaction between two species), appearance of new signals is evident. 
However, 2D DOSY also shows exactly similar spectral pattern without any new signals in 
presence of silicon nanobeads suggesting that poly-Bic-Tyr does not bind to silicon nanobeads. 
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5.3.3. DOSY of poly-Lys(Z)-Bic-Tyr and poly-Lys-Bic-Tyr 
The testing of adhesiveness was also performed in poly-Lys(Z)-Bic-Tyr (compound 36) and poly-
Lys-Bic-Tyr (copound 37) using 1D and 2D DOSY. 
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Figure 5 -29: 1D DOSY spectrum of poly-Lys(Z)-Bic-Tyr (compound 36) without nano beads (lower panel) 
and with 1.94 mg nano beads (upper panel). Solvent signal is marked. 
 
Figure 5 -29 represent 1D DOSY of poly-Lys(Z)-Bic-Tyr and Figure 5 -30 represnet 1D DOSY of 
poly-Lys-Bic-Tyr in presence and absence of silicon nanobeads. Appearance of no new signal 
suggests that there is no binding in both cases. However, both compounds give broad signals and 
therefore 2D DOSY was performed. 
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Figure 5 -30: 1D DOSY spectrum of poly-Lys-Bic-Tyr (compound 37) without nano beads (lower panel) 
and with 1.9 mg nano beads (upper panel).  
 
Figure 5 -31 and Figure 5 -32 represent 2D DOSY of poly-Lys(Z)-Bic-Tyr (compound 36) and 
poly-Lys-Bic-Tyr (compound 37). 
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Figure 5 -31: 2D DOSY spectrum of poly-Lys(Z)-Bic-Tyr (compound 36) recorded at 500 MHz with D2O as 
solvent. Upper panel represents spectrum with 2 mg of silicon nanobeads whereas lower panel represents 
blank spectrum. No additionally appearing signal has been noticed in the upper panel. Impurities and 
solvent signals are marked in figure. 
 
These spetra were recorded without silicon nanobeads in the first place and latter in the presence 
of nanobeads (2 and 1.9 mg respectively). Both spectra show no difference in the spectral pattern 
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and there was no newly appearing signal is seen. This strongly suggests that both poly-Lys(Z)-
Bic-Tyr and poly-Lys-Bic-Tyr does not bind to silicon nano beads. 
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Figure 5 -32: 2D DOSY spectrum of poly-Lys-Bic-Tyr (compound 37) recorded at 500 MHz with D2O as 
solvent. Upper panel represents spectrum with 2.2 mg of silicon nanobeads whereas lower panel 
represents blank spectrum. No additionally appearing signal has been noticed in the upper panel. 
Impurities and solvent signals are marked in figure. 
 
5.3.4. AFM Studies of poly-Bic-Tyr 
Interaction of poly-Bic-Tyr (compound 34) with large surfaces like mica and graphite was 
studded here. For all measurements 1 mg of compound 34 was dissolved in 0.1 mL dry DMF, a 
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20 µL aliquot of the mixture was deposited on to bilayer. The sample was rapidly blow dried 
using a burst of compressed gas (Nitrogen or Argon). To demonstrate the purity of the solvent 
used for sample preparation, 20 µL of the pure solvent was celebrated on the substrates blew 
dried, and AFM imaging was performed on these surfaces. No spots due to impurities of the 
solvent were found. The two AFM images of oligopeptide poly-Bic-Tyr (compound 34) on mica 
and graphite surface were shown in Figure 5 -33. 
 
A B  
 
Figure 5 -33: Image of the poly-Bic-Tyr (compound 34) on (A) mica and (B) graphite. A number of bumps 
appear in the image, each presumably corresponding to a single oligomer. Different sizes of oligomers 
suggest that the mixture of different oligomeric species is present. 
 
Using this concentration distinct oligomers of molecules were observed. Surface covered by a 
high density of dome like protrusion that emerges up to 8 nm from the substrate. Underneath these 
vesicular structures is a flat, defect-free surface. The simple interpretation of these images is that 
the oligopeptide have stably adsorbed to the substrate. 
The mixture of oligomeric poly-Bic-Tyr contains some species which are smaller in height and 
some of the oligomers are higher in height. The mean diameter of this loop is 2.0 ± 0.5 nm, on 
mica surface; similar result is obtained for the studies performed using graphite surface. The 
distribution of the diameters of the loop formed at 0.5 µM on mica surfaces was shown in Figure 
5 -34. 
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Figure 5 -34: Distribution of the diameters of the individual loops formed at 0.5 µM for the poly-Bic-Tyr 
(compound 34). 
 
This is a strong indication that the compound 34 (poly-Bic-Tyr) shows interactions (in terms of 
binding) on both mica and graphite surfaces suggesting that there is no adhesiveness. 
5.3.5. AFM Studies of poly-Lys(Z)-Bic-Tyr 
Interaction of compound 36 (poly-Lys(Z)-Bic-Tyr) with different large surfaces like mica and 
graphite is studied here and is shown in Figure 5 -35. 
 
A B  
 
Figure 5 -35: Image of poly-Lys-(Z)-Bic-Tyr (compound 36) on (A) mica and (B) graphite. A number of 
bumps appear in the image, each presumably corresponding to a single oligomer. 
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Using this concentration distinct oligomers of molecules are observed. Surface covered by a high 
density of dome like protrusion that emerges up to 8 nm from substrate. Underneath these 
vesicular structures is a flat, defect-free surface. The simple interpretation of these images is that 
the compound 36 adsorbes stably on the substrate. 
Some of oligomers seen here are smaller in height while others are higher in height. The mean 
diameter of this loop is 2.7 ± 0.8 nm, on mica surface. Similar results of the mean diameter were 
obtained using graphite surfaces. The distribution of the diameters of the loop formed at 0.5 µM 
on different surfaces was shown in Figure 5 -36. 
 
 
 
Figure 5 -36: Distribution of the diameter of the individual loops formed at 0.5 µM for poly-Lys-(Z)-Bic-Tyr 
(compound 36). 
 
This result indicates that compound 36 show interactions on both surfaces mica and graphite. It 
proves that compound 36 does not shows adhesion on mica as well as graphite surface. 
5.3.6. AFM Studies of poly-Lys-Bic-Tyr 
Similar AFM measurements were performed for compound 37 (poly-Lys-Bic-Tyr) and sample 
preparation was same like previous two compounds. Two AFM images of oligopeptide compound 
37 on mica and graphite surfaces are shown in Figure 5 -37. 
At this (1mg/0.1 mL) concentration distinct oilgomers of molecules were observed. Surface 
covered by a high density of dome like protrusion that emerges up to 7.5 nm from the surface. 
Underneath these vesicular structures is a flat, defect-free surface. A straightforward interpretation 
of these images is that the oligopeptides have stably adsorbed to the substrate surface. Distribution 
of smaller and higher heights of oligomers is seen here. 
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Figure 5 -37: Image of the poly-Lys-Bic-Tyr (compound 37) on (A) mica and (B) graphite. A number of 
bumps appear in the image, each presumably corresponding to a single oligomer. 
 
The mean diameter of this loop is 2.8 ± 0.7 nm, on mica surface, the distribution of the diameters 
of the loop formed at 0.5 µM on different surfaces was shown in Figure 5 -38. Different result 
were obtained using graphite surface, in which case the mean diameter of this loop is 1.2 ± 0.3 
nm. In the latter case, mean diameter of the loop is smaller. 
 
 
Figure 5 -38: Distributation of the diameters of the individual loops formed at 0.5 µM for poly-Lys-Bic-Tyr 
(compound 37). 
 
These results indicate that compound 37 shows interactions on the both surfaces mica and 
graphite. Results obtained from Figure 5 -38 demonstrate that poly-Lys-Bic-Tyr shows stronger 
interaction on graphite (HOPG) compared to mica surface. It proves that compound 37 shows 
intra and/or inter molecular interactions on graphite surface clearly indiacating that it has adhesive 
characteristics. 
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6. Summary and Conclusions 
Extensive studies revealed that mussel adhesion to underwater surfaces is mediated through a 
family of five proteins, named mytilus edulis foot protein (mefp-1 to 5). Presence of L-3,4-
dihydroxyphenylalanine (DOPA), an post-transationally modified amino acid, is believed to be 
responsible for both adhesive and cross linking characteristics of MAPs. Despite extensive studies 
on MAPs, there remains an incomplete understanding of their adhesive and cohesive mechanisms. 
Possible commercial applications of synthetic analogues of MAPs would be its use as glue to 
stick organs or parts of it and use as environment friendly glue. Several research groups are 
involved in exploring various physical, mechanical and biological properties of MAPs, while 
others evaluated possible synthetic analogues that would mimick adhesive characteristics. 
In this work, successful synthesis of a synthetic polypeptide has been carried out that shows 
adhesive properties. 
The synthesis of oligomers and co-polymers were performed using polyhydroxylated bicyclic 
dipeptide buiding blocks. These dipeptides feature four hydroxyl groups (similar to DOPA which 
has two hydroxyl groups). Fmoc- and Boc- protection of one of the –OH was performed so that 
the oligomerization/polymerization reaction can be carried away at amide-carbonyl backbone. 
The course of synthesis was chosen such that oligomerization of bicyclic dipeptide (Bic), Tyr, Lys 
and DOPA was achieved first. Further copolymerization of Bic-Tyr, Lys-Tyr, and Lys-Bic-Tyr 
was carried out. Polymerization was accomplished using DCC and poly-DCC. 
Structural features of these oligomers and copolymers were characterized using 1D and 2D NMR 
spectroscopy whereas molecular mass and size was determined using MALDI, GPC and gel 
electrophoretic techniques. Broad resoances in NMR and distribution of masses over a wide range 
suggested that a single species of a unique molecular weight was not present in any reaction. In 
other words, each oligomerization reaction produced a mixture of oligomer/co-polymer with wide 
mass distribution. It was found that oligomers and copolymers were mainly of the order of 1-2 
kDa based on MALDI studies. At the same time, GPC and gel electrophoresis showed about ten 
fold higher size of the oligomer and copolymers. The reason for this descipency is still unresolved 
but one suggestion could be inability of MALDI to detect exact mass of polydisperse sample. In 
such cases, MALDI spetraof high-mass components are generally underrepresented with respect 
to lower mass oligomer peaks. 
Adhesive properties of these copolymers/oligomers were accomplished using 1D and 2D 
diffusion ordered spectroscopy (DOSY) NMR experiment and AFM studies. DOSY relies on the 
translational diffusion coefficient of a molecule experiencing Brownian motions in an isotropic 
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solution. Binding of tetra, oligo and co-polymers with silicon nano beads was checked in this 
case. Upon binding with silicon nanobeads, one expects to see occurance of new peak and/or 
shifting of peak. However, none of the DOSY experiments recorded in presence of silicon 
nanobeads showed any difference from the ones which were recorded without nanobeads. 
Atomic force microscopy can map topography of a surface and gives an exteremely high 
resolution image of the surface. Co-polymers like, poly-Bic-Tyr, poly-Lys(Z)-Bic-Tyr and poly-
Lys-Bic-Tyr were probed for binding on mica and graphite surface. Results show that poly-Lys-
Bic-Tyr adheres to graphite surface. Non binding of poly-Bic-Tyr and poly-Lys(Z)-Bic-Tyr on 
mica and/or graphite surface can be easily visualized as former misses long chain, positively 
charged and polar Lys whereas presence of Z group might be influencing adhesion of latter. 
The adhesion of poly-Lys-Bic-Tyr suggests that the information gained in this study can be 
further used to probe several other synthetic peptides and polymers which mimic adhesive 
characteristics of MAPs. One approach could be to synthesize uniformely mass distributed 
polymer so that the activity can be correlated to minimum necessary length of the polymer. Also, 
Tyr and Lys could be replaced with other amino acids so that the polymer might gain further 
stability against proteolytic degredations. Mechanism to test the strength of the adhesion is also 
needed to be explored. At the same time, addition of other analogous amino acids to this polymer 
can be carried out so that the strength of the adhesion could be increased. 
Overall, results obtained in this thesis suggest that the synthetic adhesive polymers based on 
peptidomimetics can be prepared. Further studies using this approach could lead to prepare 
synthetic MAPs which will have wide applications. 
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7. Experimental Section 
This chapter presents the synthetic procedures and analytical data of the compounds those were 
synthesized during this Ph.D. work. The HPLC and GPC instruments used were as follows: 
HPLC: 
For the analytic separations the following equipment was used. 
Column: Phenomex Luna C18 (2), 150 mm, 4.6, 5 um. 
Equipment of the LC systems agilent 1100 G 1315A Bin pump, G1313A ALS, G1316A 
COLCOM, G1315B DAD, G1379 Degasser; as software “Chemstation for LC 3D Rev. A. 09.03” 
was used. 
Gel permeation chromatography (GPC): 
GPC measurements were performed versus polystyrene standards with a set of three columns with 
DMF as solvent (300 × 8 mm, type SDV, 10 µm from PSS) using a differential refractometer as 
detector at 25°C. 
7.1. Compound 1: 9a(R)H-5-oxo-(6S,7S,8S,9R)-tetrahydroxy-octahydro-thiazolo-[3,2-a] 
azepin-3R-carboxilic acid-methyl ester. 
S
N
O
HO
OHHO
OH
O
OMe
 
1 
7.1.1. Procedure 
Condensation of commercial D-glucurono-3,6-lactone (5 g, 28.4 mmol) with L-cysteine methyl 
ester (4.8 g, 28.4 mmol) using distilled water (100 mL) and pyridine (10 mL), gives bicyclic 
thiazolidinlactam 1. Yield obtained was 8.06 g. (27.4 mmol, 90%) 
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7.1.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 5.55 (s, 1H, 7-OH), 5.41 (s, 1H, 9a-H), 5.27 (s, 1H, 8-OH), 
4.73 (d, 3J3,2 = 7.4Hz, 1H, 3-H), 4.67 (s, 1H, 6-H), 4.24 (d, 3J8-OH,8 = 10.3Hz, 1H, 8-OH), 3.79 (m, 
2H, 7-H and 9-H), 3.62 (m, 1H, OMe), 3.52 (d, 3J9-H, 9 = 5.77Hz, 1H, 9-H), 3.28 (m, 2H, 2-H). 
13C NMR (300 MHz, DMSO-d6): δ = 170.55, 170.35 (CO-5, COMe), 31.39(C-2), 52.10 (OMe), 
60.97 (C-9a), 63.78 (C-3), 70.86 (C-8), 76.00 (C-7), 76.87 (C-9). 
ESI-MS (H2O/MeOH + 10 mmole NH4Ac) (m/z): 293.7 [M-H]+, 310.8 [M+NH4]+, 315.8 
[M+Na]+, 604 [2M+NH4]+, 609 [2M+Na]+. 
Melting Point: 184°C. 
7.2. Compound 2: 9a(R)H-5oxo-(6S)-trifluoromethansulfonyloxy-(7S,8S,9R)-trihydroxy-
octahydro-thiazolo [3,2-a]azepin-3R-carboxilic acid-methyl ester. 
S
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7.2.1. Procedure 
Thiazolidinlactam 1 (8.2 g, 28 mmol) was dissolved in 250 mL DCM (abs) and 50 mL pyridine. 
After cooling with an ice-bath 6mL of triflic acid anhydride (36.4 mmol, 1.3 eq) in 7 mL of DCM 
(abs) were added. The ice-bath was removed after 20 minutes and the reaction mixture was kept at 
room temperature for another 10 min. Then 100 cm3 ice were added and the product was extracted 
with DCM three times. The solvent was removed after drying with NaSO4 and triflate 2 was 
purified by column chromatography (CHCl3:MeOH in the ratio 5:1). Yield obtained was 10.9 g 
(24.6 mmol, 89%). 
7.2.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 6.60 (d, 3J7-OH,7 = 6.4 Hz, 1H, 7-OH), 5.98 (s, 1H, 6-H), 5.97 
(d, 3J8-OH,8 = 2.40 Hz, 1H, 8-OH), 5.62 (s, 1H, 9a-H), 4.79 (pt, 3J3,2 = 7.9 Hz, 1H, 3-H), 4.46 (d, 
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3J9-OH,9 = 10.6Hz, 1H, 9-OH), 4.04 (m, 1H, 7-H), 3.91 (m, 1H, 8-H), 3.64 (s, 3H, OMe), 3.61 (dd, 
3J9,9-OH =10.8 Hz and 3J9,8= 3.4Hz, 1H, 9-H), 3.33 (m, 2H). 
13C NMR (300 MHz, DMSO-d6): δ = 169.88, 162.79 (CO-5, CO-Μe), 86.01 (C-6), 76.55 
(C-9), 73.90 (C-7), 70.17 (C-8), 64.18 (C-3), 60.93 (C-9a), 52.27 (OMe), 31.27 (C-2). 
ESI-MS (CH2Cl2/MeOH + NH4AC) (m/z): 443 [M+NH4]+, 867.7 [2M+NH4]+. 
Melting Point: 55°C. 
7.3. Compound 3: 9a(R)H-(6S)-azido-5-oxo-(7R,8S,9R)-trihydroxy-octahydro-thiazolo [3, 2-
a]azepin-3R-carboxilic acid-methylester. 
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7.3.1. Procedure 
Triflate 2 (10.6 g, 24.9 mmol) was dissolved in DMF (130 mL) and NaN3 (2.5 g, 38.5 mmol) was 
added. After 40 h at room temperature and 8 h at 50°C, the solvent was removed and the residue 
extracted in EtOAc (400 mL) and H2O (100 mL). The aqueous phase was extracted three times 
with EtOAc (200 mL) and the combined organic phase was dried over NaSO4. Azide 3 was 
purified by column chromatography (EtOAc:toluene as 9:1). 6.5 g (20.4 mmol, 82%) of 3 were 
obtained as a colorless solid. 
7.3.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 5.65 (d, 3J8-OH,8 = 3.57Hz, 1H, 8-OH), 5.56 (d,  
3J7-OH,7 = 6.31 Hz, 1H, 7-OH), 5.48 (s, 1H, 9a-H), 4.78 (s, 1H, 6-H) 4.74 (pt, 3J3,2 = 3.84 Hz, 1H, 
3-H), 4.42 (d, 3J9-OH,9 = 10.43 Hz, 1H, 9-OH), 3.85 (m, 1H, 7-H), 3.80 (m, 1H, 8-H), 3.65 (s, 3H, 
OMe), 3.52 (dd, 3J9-OH,9 = 10.43Hz, 3J8,9 = 2.74Hz, 1H, 9-H), 3.29 (d, 2J2,2 = 6.04 Hz, 2H, 2-H). 
13C NMR (300 MHz, DMSO-d6): δ = 170.32 (CO2Me), 166.55(C-5), 76.53 (C-9), 74.78 
(C–7), 70.81 (C-8), 63.92 (C-3), 61.34 (C-6), 60.93 (C-9a), 52.19 (OMe), 31.39 (C-2). 
ESI-MS (CH2Cl2/MeOH + NH4AC) (m/z): 318 [M]+. 
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Melting Point: 197°C. 
7.4. Compound 4: 9a(R)H-(6S)-amino-5-oxo-(7R,8S,9R)-trihydroxy-octahydro-thiazolo[3,2-
a]azepine-3R-carboxilic acid-methylester. 
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7.4.1. Procedure 
A suspension of Pd/C (0.10 g) in MeOH (15 mL) was vigorous stirred under H2 gas until the 
uptake of H2 completed (10 min). Then Azide 3 (0.50 g, 1.57 mmol) in MeOH (5 mL) was added 
into the reaction mixture. The reaction mixture was stirred under H2 atmosphere at room 
temperature up to 6 h. Reaction was monitored by TLC; yield obtained was 0.43g. (1.47 mmol, 
94%). 
Alternatively, this compound can be also prepared as: 
Azide 3 (0.10 g, 0. 31 mmol) was dissolved in MeOH (5 mL). Pd/C (0.01 g) was added into 
reaction mixture. The reaction mixture was stirred for 6 h at room temperature under H2 
atmosphere. Reaction was monitored by TLC. Solvent was removed. Yield obtained was 0.086 g 
(29.5 mmol, 94%). 
7.4.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 8.38 (br, 3H, NH3 +), 5.95 (d, 3J8-OH,8 = 3.66 Hz, 1H, 8-OH), 
5.78 (d, 3J7-OH,7 = 5.06 Hz, 1H, 7-OH), 5.61 (s, 1H, 9a-H), 4.75 (pt, 3J3,2 = 7.6 Hz, 1H, 3-H), 4.66 
(s, 1H, 6-H), 4.43 (d, 3J9-OH,9 = 10.7 Hz, 1H, 9-OH), 3.99 (s, 1H, 7-H), 3.90 (d, 3J8,9 = 3.46Hz, 1H, 
8-H), 3.65 (s, 3H, OMe), 3.65 (d, 3J9,8 = 3.45 Hz, 1H, 9-H), 3.34 (d,2J2-H =7.676 Hz, 2H, 2-H). 
13C NMR (300 MHz, DMSO-d6): δ = 170.08 (CO-5), 165.51 (COOMe), 76.74 (C-9), 71.75 (C-7), 
69.98 (C-8), 63.88 (C-3), 61.07 (C-9a), 53.08 (C-6), 52.27 (OMe), 31.52 (C-2). 
ESI-MS (CH2Cl2/MeOH + NH4AC) (m/z):293.1 [M-H]+. 
Melting Point: 175°C. 
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7.5. Compound 5: 9a(R)H-(6S)-tert-butyooxycarbonylamino-5-oxo-(7R,8S,9R)-trihydroxy-
octahydro-thiazolo [3,2,-a]azepin-3R-carboxilic acid-methylester 
S
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Boc-HN
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5 
7.5.1. Procedure 
Preparation of 5 from Azide 3: 
Azide 3 (1g, 3.14 mmol) was dissolved in MeOH (30 mL). Boc anhydride (0.82 g, 3.77 mmol) 
and Pd/C (0.20 g) were added into reaction mixture. The reaction mixture was stirred for 6 h 
under H2 atmosphere. Reaction was monitored by TLC. Solvent was removed and reaction 
mixture was purified by column chromatography (MeOH:CH3Cl as 1:9). Yield obtained was 
1.18 g (3.01 mmol, 96%). 
Preparation of 5 from amine 4:  
Amine 4 (0.01 g, 0.03 mmol) was dissolved in MeOH (5 mL). Boc anhydride (0.009g, 
0.04 mmol) in MeOH (5 mL) was added slowly into stirring mixture. The reaction mixture was 
stirred at room temperature for 6 h. The solvent was removed and 5 was purified by column 
chromatography (MeOH:CH3Cl as 1:9). Yield obtained was 0.012 g (0.030 mmol, 90%). 
7.5.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 5.54 (d, 3JBoc-NH,6 = 9.05Hz, 1H, Boc-NH), 5.66 (d,  
3J8-OH,8 = 3.84Hz, 1H, 8-OH), 5.44(s, 1H, 9a-H), 5.33 (d, 3J7-OH,7 = 4.12Hz, 1H, 7-OH),  
4.78 (d, 3J6-H,Boc-NH = 9.06Hz, 1H, 6-H), 4.69 (t, 3J3,2 = 7.68Hz, 1H, 3-H), 4.13 (d,  
3J9-OH,9 = 11.53 Hz, 9-OH), 3.81 (m, 1H, 8-H), 3.76 (m, 1H, 7-H), 3.62 (s, 3H, OMe), 3.55 (dd, 
3J9,8 = 3.1Hz and 3J9-OH,9 = 8.5Hz, 1H, 9-H), 3.30 (m, 2H, 2-H). 
13C NMR (300 MHz, DMSO-d6): δ = 170.66, 167.97 (CO-5, COOMe), 154.97 (Boc-CO), 78.0 
(C-t-butyl), 77.23 (C-9), 74.96 (C-7), 70.31 (C-8), 63.97 (C-3), 60.90 (C-9a), 53.74 
(C-6), 52.11 (OMe), 31.40 (C-2), 28.01 (3C, t-butyl). 
ESI-MS (CH2Cl2/MeOH + NH4AC) (m/z): 393 [M-H]+, 415 [M+Na]+, 807 [2M+Na]+. 
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Melting Point: 145°C. 
7.6. Compound 6: 9a(R)H-(6S)-Fmoc-amino-5-oxo-(7R,8S,9R)-trihydroxy-octahydro-
thiazolo [3,2-a]azepin-3R-carboxilic acid-methylester. 
S
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7.6.1. Procedure 
Preparation of 6 from amine 4: 
Amine 4 (1 g, 3.4 mmol) and Fmoc-ONsu (1.38 g, 4.1 mmol) were dissolved in CH3CN (30 mL) 
and MeOH (8 mL). The reaction mixture was stirred at room temperature for 6 h. The solvent was 
removed and 6 were purified by column chromatography (MeOH:CH3Cl as 2:8). Yield obtained 
was 1.2 g (2.33 mmol, 68.18%). Same reaction was carried out using DMF as solvent where yield 
obtained was 62.5%. 
Preparation of 6 from azide 3: 
Azide 3 (1 g, 3.14 mmol) was dissolved in MeOH (30 mL). Fmoc-ONsu (1.2 eq) in CH3CN 
(30 mL) and Pd/C (0.200 g) were added into reaction mixture. The reaction mixture was stirred 
for 6 h under H2 atm. Reaction was monitored by TLC. Solvent was removed and purified by 
column chromatography (MeOH/CH3Cl 2/8). Yield obtained was 0.615 g (1.19 mmol, 38%). 
7.6.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 7.89 (d, 3JFmoc-Ar = 7.41Hz, 2H, Fmoc-Ar), 7.72(d, 
3JFmoc-Ar = 7.14Hz, 2H, Fmoc-Ar), 7.41(t, 3JFmoc-Ar = 7.14Hz, 2H, Fmoc-Ar), 7.32(t, 3JFmoc-Ar = 
7.14Hz, 2H, Fmoc-Ar), 7.20 (d, 3JBic-NH,6 = 8.78Hz, 1H, Fmoc-NH), 5.68 (d, 3J8-OH,8 = 3.57Hz, 
1H, 8-OH), 5.46 (s, 1H, 9a-H), 5.33 (d, 3J7-OH,7 = 4.39Hz, 1H, 7-OH), 4.86 (d, 3J6,Fmoc-NH = 
9.06Hz, 1H, 6-H), 4.69 (t, 3J3,2 = 7.68Hz, 1H, 3-H), 4.54 (s, 1H, 9-OH), 4.25 (m, 3H, Fmoc-α and 
β), 3.81 (m, 2H, 7-H and 8-H), 3.63 (s, 3H, OMe), 3.56 (dd, 3J9,8 = 3.20Hz and 3J9-OH,9= 8.51Hz, 
1H, 9-H), 3.30 (m, 2-H). 
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13C NMR (300 MHz, DMSO-d6): δ = 170.60 (CO-5), 167.73 (COOMe), 155.70 (Fmoc-CO), 
143.67, 140.62, 127.55, 127.01, 125.13, 120.03 (Fmoc-Ar), 77.21 (C-9), 75.01 (C-8), 70.34 (C-7), 
65.73 (Fmoc-CH2), 64.01 (C-6), 60.93 (C-3), 54.16 (C-9a), 52.13 (OMe), 46.45 (Fmoc-CH), 
31.41 (C-2). 
ESI-MS (CH2Cl2/MeOH+ NH4AC) (m/z): 515.2 [M-H]+, 537.3 [M+Na]+, 1051.4 [2M+Na]+. 
Melting Point: 118°C. 
7.7. Compound 7: 9a(R)H-(6S)-amino-5-oxo-(7R,8S,9R)-trihydroxy-octahydro-thiazolo 
[3,2,a]azepin-3R-pottasium salt of carboxylic acid. 
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7.7.1. Procedure 
Compound 4 (1.05 g, 3.6 mmol) was dissolved in (30 mL) water. 1N KOH (7.1 mL, 7.1 mmol) 
was added into reaction mixture. The reaction mixture was stirred for 30 minute at room 
temperature. Reaction was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1) and stopped after 
30 minute with 1N HCl (3.59 mL). Solvent was removed and yield obtained was quantitative. 
7.7.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 5.58 (s, 1H, 9a-H), 4.58 (Pt. 3J3,2 = 7.0 Hz, 1H, 3-H), 4.5173 
(s, 1H, 6H), 3.865 (d, 3J7,8 = 3.57 Hz, 1H, 7-H), 3.821 (d, 3J8,9 = 4.086 Hz, 1H, 8-H), 3.512 (d, 3J9,8 
= 3.043Hz, 1H, 9-H), 3.21 (m, 2H, 2-H). 
13C NMR (300 MHz, DMSO-d6): δ = 173.66, 165.55 (CO-5, COOK), 75.78 (C-9), 72.01 (C-7), 
71.48 (C-8), 66.08 (C-3), 61.15 (C-9a), 53.13 (C-6), 32.73 (C-2). 
ESI-MS (CH2Cl2/MeOH+NH4AC) (m/z): 278.8 [M-H]+, 316.9 [M-H+K]+. 
Melting Point: Decompose at 200°C. 
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7.8. Compound 8: 9a(R)H-(6S)-tetra-butyloxycarbonylamino-5-oxo-(7R,8S,9R)-trihydroxy-
octahydro-thiazolo [3,2-a]azepin-3R-carboxilicacid 
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7.8.1. Procedure 
Amine 7 (1.3 g, 4.67 mmol) was dissolved in water (20 mL), 1N Na2CO3 (9.0 mL, 9.02 mmol) 
was added into reaction mixture. Boc anhydride (1.18 g, 5.41 mmol) in 1,4-dioxane (20 mL) was 
added slowly into stirring mixture. The reaction mixture was stirred for 6 h at room temperature. 
Solvent was removed and 8 was purified by column chromatography (MeOH:CH3Cl in the ratio 
of 2:8). Yield obtained was 1.5 g (3.9 mmol, 85%). 
7.8.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 7.17(s, 1H, OH), 6.49 (d, 3JBoc-NH,6 = 8.23Hz, 1H, Boc-NH), 
5.63 (s, 1H, OH), 5.48 (s, 1H, 9a-H), 5.12(s, 1H, OH), 4.74 (d, 3J6-H,Boc-NH = 8.51Hz, 1H, 6-H), 
4.57 (t, 3J3,2 = 6.59Hz, 1H, 3-H), 3.8 (d, 3J8,9 = 3.84 Hz, 1H, 8-H), 3.68 (s, 1H, 7-H), 3.49 (s, 1H, 
9-H), 3.21 (d, 2J2-H = 6.59Hz, 1H, 2-H), 3.15(d, 2J2,3 = 4.94Hz, 1H, 2-H), 1.37 (s, 9H, t-butyl-
CH3). 
13C NMR (300 MHz, DMSO-d6): δ = 174.51 (CO-5), 167.79 (COOH), 154.77 (Boc-CO), 78.05 
(C-tbutylquart), 75.66 (C-9), 74.73 (C-7), 71.46 (C-8), 66.12 (C-3), 61.00 (C-9a), 53.52 (C-6), 
32.48 (C-2), 28.05(3C, t-butyl). 
ESI-MS (CH2Cl2/MeOH+NH4AC) (m/z): 379 [M + H+], 401 [M + Na]+, 423.0 [M-H+ + 2Na]+. 
Melting Point: Decompose at 210oC. 
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7.9. Compound 9: 9a(R)H-(6S)-Fmoc-amino-5-oxo-(7R,8S,9R)-trihydroxy-octahydro-
thiazolo [3,2-a]azepin-3R-carboxilic acid. 
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7.9.1. Procedure 
Amine 7 (0.5 g, 1.7 mmol) was dissolved in water (20 mL), 1N NaHCO3 (1.7 mL, 1.7 mmol) was 
added into reaction mixture. Fmoc-Cl (0.48 g, 1.88 mmol) in acetone (20 mL) was added slowly 
into stirring reaction mixture. Reaction mixture was stirred for 30 min. Reaction mixture was 
extracted three times with DCM. The solvent was removed and 10 were purified by column 
chromatography (MeOH:CH3Cl in the ratio 2:8 and 2 drop acetic acid). Yield obtained was 0.35 g 
(0.71 mmol, 40%). 
Alternatively, it was prepared as:  
Fmoc protected amine 6 (0.50 g, 0.95 mmol) was dissolved in acetic acid (till amine was 
dissolved). 5M HCl (2 mL) was added into reaction mixture. The reaction mixture was stirred at 
room temperature for 5 days. The solvent was removed and 10 were purified by column 
chromatography (MeOH:CH3Cl in the ratio 2:8 and 2 drop acetic acid). Yield obtained was 0.24 g 
(0.48 mmol, 50%). 
7.9.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 7.88 (d, 3JFmoc-Ar = 7.41 Hz, 2H, Fmoc-Ar), 7.72 (m, 2H, 
Fmoc-Ar), 7.40 (t, 3JFmoc-Ar = 7.41Hz, 2H, Fmoc-Ar), 7.31 (t, 3JFmoc-Ar = 7.41Hz, 2H,  
Fmoc-Ar), 5.74 (s, 1H, 8-OH), 5.47 (s, 1H, 9a-H), 4.81 (d, 3J6,Fmoc-NH = 8.78Hz, 1H, 6-H), 4.65 (t, 
3J3,2 = 7.4 Hz, 1H, 3-H), 4.24 (m, 2H, Fmoc α and β), 3.81 (s, 1H, 8-H), 3.57 (s, H, 7-H), 3.37 (s, 
1H, 9H), 3.30 (m, 2H, 2-H). 
13C NMR (300 MHz, DMSO-d6): δ = 171.87 (CO-5), 167.67 (COOH), 155.73 (Fmoc-CO), 
143.68, 143.60, 140.54, 127.54, 127.02, 125.20, 119.98 (Fmoc-Ar), 76.37 (C-9), 74.40 (C-8), 
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70.66 (C-7), 65.76 (Fmoc-CH2), 64.46 (C-6), 61.04 (C-3), 54.39 (C-9a), 46.42 (Fmoc-CH), 31.69 
(C-2). 
ESI-MS (CH2Cl2/MeOH+NH4AC) (m/z): 501.2 [M-H]+, 518.2 [M+NH4]+, 523.2 [M+Na]+. 
Melting Point: 180°C. 
7.10. Compound 10: Boc-Bic-Tyr-OMe 
OH
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7.10.1. Procedure 
Dipeptide 8 (0.20 g, 0.52 mmol) and Tyr methyl ester (0.09 g, 0.42 mmol) were dissolved in 
DMF (25 mL). Then HOBt (0.07 g, 0.52 mmol) and HBTU (0.20 g, 0.52 mmol) were added into 
reaction mixture and the pH of the reaction mixture was adjusted to 7-8 with DIPEA (0.09 mL). 
The reaction mixture was stirred for 6 h at room temperature. The solvent was removed and 9 was 
purified by flash chromatography (CHCl3:MeOH in the ratio 4:1). Yield obtained was 0.36 g 
(0.66 mmol, 92%). 
7.10.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 9.20 (br, 1H, OH), 8.55 (d, 3JTyr-NH,Tyr-α = 7.37, Tyr-NH), 
6.995 (d, 3JTyr-Ar = 8.32Hz, 2H, Tyr-Ar), 6.64 (d, 3JTyr-Ar = 8.56Hz, 2H, Tyr-Ar), 6.51 (d, 
3JBoc-NH,6 = 8.79Hz, 1H, Boc-NH), 5.55 (d, 3J8-OH,8 = 3.33Hz, 1H, 8-OH), 5.44 (s, 1H, 9a-H), 5.4 
(d, 3J9-OH,9 = 9.27Hz, 1H, 9-OH), 5.03 (d, 3J6-H = 4.52Hz, 1H, 6-H), 4.73 (d, 3J7OH,7 = 9.03Hz, 1H, 
7-OH), 4.6 (t, 3J3-H = 7.58Hz, 1H, 3-H), 4.34 (qu, 1H, Tyr-α), 3.81 (d, 3J8,9 = 3.57Hz, 1H, 8-H), 
3.74 (t, 3J7,6 and 8 = 4.28Hz, 1H, 7-H), 3.55 (s, 1H, 9-H), 3.55 (s, 3H, Tyr-OMe), 3.21 (m, 1H, 2-H), 
3.15 (m, 1H, 2H), 2.80 (d, 3JTyr-β,Tyr-α = 7.13 Hz, 2H, Tyr β), 1.38 (s, 9H, t-butyl-H). 
13C NMR (300 MHz, DMSO-d6): δ = 171 (CO-NH), 170 (CO-5C), 168 (COOMe), 156 (Boc-
CO), 155 (Try-Ar-PC), 130 (Tyr-Ar), 126.5 (Try-Ar), 115 (Tyr- Ar), 78 (Bocqut), 77 (C-9), 74.8 
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(C-8), 71 (C-7), 65 (C-3), 61 (C-9a), 54 (C-6), 53.9 (Tyr-α), 51.5 (OMe), 36.9 (Tyr-β), 32.5 (C-
2), 28 (t-butyl-CH3). 
ESI-MS (CH2Cl2/MeOH+NH4AC) (m/z): 556 [M-H]+, 573.2 [M+NH4]+, 574.2 [M+Na]+. 
Melting Point: 97oC. 
7.11. Compound 11: Bic-Tyr-OMe 
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7.11.1. Procedure  
Tetrapeptide 10 (0.10 g, 0.180 mmol) was treated with HCl (10 mL) in diethyl ether. The reaction 
mixture was stirred for 1 h at room temperature to yield the HCl salt of the free amine of 11. Yield 
obtained was quantitative. 
7.11.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 9.33 (s, NH3+), 8.66 (d, 3JTyr-NH,Tyr-α = 7.24Hz, 1H, Tyr-NH), 
6.99 (d, 3JTyr-Ar = 8.5Hz, 2H, Try-Ar), 6.66 (d, 3JTyr-Ar = 8.54Hz, 2H, Try-Ar), 5.71 (s, 1H, 8-OH), 
5.56 (d, 3J9-OH,9 = 8.99Hz, 1H, 9-OH), 5.52 (s, 1H, 9a-H), 5.26 (s, 1H, 7-OH), 4.73 (t,  
3J3,2 = 7.4Hz, 1H, 3-H), 4.33 (q, 3JTyr-α = 7.15 Hz, 1H, Tyr α), 4.30 (s, 1H, 6-H), 3.52 (s, 3H, 
OMe), 3.59 (sbr, 2H, 8-H and 7-H), 3.59 (d, 3J9,8 = 5.1 Hz, 1H, 9-H), 3.52 (s, 3H, Tyr-OMe), 3.22 
(dd, 2J2,2 = 11.0Hz and 3J2,3 = 7.3Hz, 1H, 2-H), 3.13 (dd, 2J2,2 = 11.05Hz and 3J2,3 = 7.42 Hz, 1H, 
2-H), 2.81 (dd, 3JTyr-β,Tyr-α = 6.96 Hz and 3JTyr-β,Tyr-α = 3.66 Hz, 2H, Tyr-β). 
13C NMR (300 MHz, DMSO-d6): δ = 171.31 (CO-NH), 170.14 (CO-5C), 168.37 (COOMe), 
156.09 (Tyr-Ar), 76.26 (C-9), 74.03 (C-8), 71.29 (C-7), 64.91 (C-6), 61.24 (C-9a), 54.24 (C-6), 
53.37 (Tyr-α), 51.68 (OMe), 36.28 (Tyr-β), 32.30 (C-2). 
ESI-MS (CH2Cl2/MeOH+NH4AC) (m/z): 456 [M-H]+, 911.4 [2M+H]+. 
Melting Point: Decompose at 190°C. 
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7.12. Compound 12: Bic-Tyr 
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7.12.1. Procedure 
Compound 11 (0.185 g, 0.49 mmol) was dissolved in minimum amount of H2O (10 mL), 1N 
KOH (0.98 mL, 0.98 mmol) was added into reaction mixture. The reaction mixture was stirred for 
7 h at room temperature. Reaction was monitored by TLC and stopped after 40 minute at room 
temperature with 1N HCl (0.49 mL). The solvent was removed, yield obtained was quantitative. 
7.12.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 8.62 (d, 3JTyr-NH,Tyr-α = 7.44 Hz, 1H, Tyr-NH), 7.04 (d,  
3JTyr-Ar = 8.3 Hz, 2H, Tyr-Ar), 6.67 (d, 3JTyr-Ar = 8.5 Hz, 2H, Tyr-Ar), 5.59 (s, 1H, 9a-H), 4.78 (t, 
3J3,2 = 7.53 Hz, 1H, 3-H), 4.6 (q, 3J6 = 5.3 Hz, 1H, 6-H), 4.29 (q, 3JTyr-α,Tyr-β and NH = 6.84 Hz, 1H, 
Tyr-α), 3.93 (d, 3J8,9 = 4.3 Hz, 1H, 8-H), 3.86 (t, 3J7,6 and 8 = 3.99 Hz, 1H, 7-H), 3.61 (d, 3J9,8 = 3.2 
Hz, 1H, 9-H), 3.26 (m, 1H, 2-H), 3.17 (m, 1H, 2-H), 2.87 (dd, 2JTyr-β,Tyr-β = 13.98 Hz and  
3JTyr-β, Tyr-α = 5.81 Hz, 1H, Tyr-β), 2.79 (dd, 2JTyr-β,Tyr-β = 13.8 Hz and 3JTyr-β,Tyr-α = 7.3 Hz, 1H, 
Tyr-β). 
13C NMR (300 MHz, DMSO-d6): δ = 172.00 (CO-NH), 170.00 (CO-5C), 165.32 (COOH), 159.09 
(Tyr-Ar), 130.20 (Tyr-Ar), 126.98 (Tyr-Ar), 115.02 (Tyr-Ar), 76.63 (C-9), 71.75 
(C-7), 71.01 (C-8), 64.67 (C-3), 61.34 (C-9a), 54.25 (Tyr-α), 53.25 (C-6), 36.07 (Tyr-β), 32.58 
(C-2). 
ESI-MS (CH2Cl2/MeOH+NH4AC) (m/z): 442 [M-H]+, 480 [M+Na]+. 
Melting Point: Decompose at 180°C. 
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7.13. Compound 13: Boc-Lys(Z)-Bic-Tyr-OMe 
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7.13.1. Procedure  
The HCl salt of free amine 11 (0.59 g, 1.40 mmol) and Boc Lys (Z) (0.58 g, 1.54 mmol) were 
dissolved in DMF (15 mL). Then (1.02 g, 1.96 mmol) PyBOP was added into reaction mixture 
and the pH of the reaction mixture was adjust to 7-8 with DIPEA. The reaction mixture was 
stirred for 6 h at room temperature. The solvent was removed and 13 was purified by column 
chromatography (CHCl3:MeOH in the ratio 4:1). Yield obtained was 0.859 g (1.03 mmol, 80%). 
7.13.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): δ = 8.59 (d, 3JTyr-NH,Tyr-α = 7.31 Hz, 1H, Tyr-NH), 7.84 (d,  
3JBic-NH,6 = 8.10Hz, 1H, Bic-NH), 7.33 (m, 5H, Ar-z), 7.19 (t, 3JLys-NHε,Lys-CH2 = 5.32 Hz, 1H, Lys-
NHε), 6.98 (d, 3JTyr-Ar = 8.26 Hz, 1H, Tyr-Ar), 6.94 (d, 3JLys-NHαLys-α,= 8.26 Hz, 1H, Lys-NH-α), 
6.64 (d, 3JTyr-Ar = 8.42 Hz, 1H, Tyr Ar), 5.61 (d, 3J8-OH,8 = 8.90 Hz, 1H, 8-OH), 5.56 (sbr, 1H, 9-
OH), 5.48 (s, 1H, 9a-H), 5.06 (d, 3J6,N-H= 8.4 Hz, 1H, 6-H), 5.04 (d, 3J7-OH,7 = 6.6 Hz, 1H, 7-OH), 
4.98 (s, 2H, CH2), 4.70 (t, 3J3,2 = 7.31 Hz, 1H, 3-H), 4.35 (q, 3JTyr-α,Tyr-NH = 7.15 Hz, 1H, Tyr-α), 
3.89 (m, 1H, Lys-α), 3.82 (m, 1H, 8-H), 3.70 (m, 1H, 7-H), 3.59 (dd, 3J9,9-OH = 8.3 Hz and 3J9,8 
=2.9 Hz, 1H, 9-H), 3.51 (s, 3H, OMe), 3.22 (m, 1H, 2-H), 3.12 (m, 1H, 2-H), 2.95 (m, 1H, Lys-ε), 
2.80 (d, 3JTyr-β,Tyr-α= 6.99Hz, 1H, Tyr-β), 1.70 (m, 2H, Tyr-CH2), 1.5 (m, 2H, Tyr-CH2), 1.36 (sbr, 
9H, t-butyl-CH3), 1.3 (m, 2H, Tyr-CH2). 
13C NMR (300 MHz, DMSO-d6): δ = 173.32 (CO-HN: Lys-Bic), 171.28 (CO-NH: Tyr-Bic), 
170.23 (CO-5C), 167.55 (COOMe), 156.01 (Boc-CO), 155.29 (Tyr-Ar), 142.81 (Z-Ar), 137.22 
(Z-Ar), 130.00 (Tyr-Ar), 128.26 (Z-Ar), 127.64 (Z-Ar), 126.53 (Tyr-Ar), 5.01 (Tyr-Ar), 78.01 (C-
t-butyl), 76.24 (C-9), 74.75 (C-7), 71.38 (C-8), 65.04 (CH2-Z), 64.88 (C-3), 61.23 (C-9a), 54.41 
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(Tyr-α), 54.15 (Lys-α), 52.03 (C-6), 51.61 (C-OMe), 40.00 (Lys-ε), 36.37 (Tyr-β), 32.19 (C-2), 
31.52 (Tyr-CH2), 29.06 (Tyr-CH2), 28.16 (t-butyl-CH3), 22.78 (Tyr-CH2). 
ESI-MS (m/z): 840 [M+Na]+, 856 [M+K]+. 
Melting Point: 96°C. 
7.14. Compound 14: Boc-Lys(Z)-bic-Tyr 
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7.14.1. Procedure  
Compound 13 (300 mg, 0.36 mmol) was dissolved in minimum amount of MeOH (10 mL). 1N 
KOH (0.73 mL, 0.73 mmol) was added into reaction mixture. The reaction mixture was stirred for 
7 h at room temperature. Reaction was monitored by TLC and stopped with 1N HCl (0.36 mL). 
Then the solvent was removed, yield obtained was quantitative.  
7.14.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 9.22 (s, 1H, OH), 8.51 (d, 3JTyr-NH,Tyr-α = 7.38 Hz, 1H, Tyr-
NH), 7.88 (d, 3JBic-NH,6 = 7.99 Hz, 1H, Bic-NH), 7.88 (m, 5H, Ar-Z), 7.19 (t, 
3JLys-NHε,Lys-CH2 = 4.99 Hz, 1H, Lys-NHε), 7.02 (d, 3JTyr-Ar = 8.15 Hz, 2H, Tyr-Ar), 6.93 (d,  
3JLys-NHα,Lys-α = 8.15 Hz, 1H, Lys-NHα), 6.64 (d, 3JTyr-Ar = 8.15 Hz, 2H, Tyr-Ar), 5.6 (d, 
3J8-OH,8 = 8.9 Hz, 1H, 8-OH), 5.59 (d, 3J9-OH,9 = 3.3 Hz, 1H, 9-OH), 5.48 (s, 1H, 9a-H), 5.05 (d, 
3J6,Bic-NH = 7.99Hz, 1H, 6-H), 4.98 (s, 2H, CH2), 4.73 (t, 3J3,2 = 7.22Hz, 1H, 3-H), 4.30 (q, 3JTyr-α = 
6.81Hz, 1H, Tyr-α), 3.89 (m, 1H, Lys-α), 3.81 (d, 3J8,9 = 3.2 Hz, 1H, 8-H), 3.68 (sbr, 1H, 7-H), 
3.58 (d, 3J9,8 = 5.8 Hz, 1H, 9-H), 3.22 (m, 1H, 2-H), 3.11 (m, 1H, 2-H), 2.95 ( m, 1H, Lys-ε), 2.81 
(m, 1H, Tyr-β), 1.65 (m, 2H, Lys-CH2), 1.45 (m, 2H, Lys-CH2), 1.36 (s, 11H, t-butyl-CH3 and 
Lys-CH2). 
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HMQC (500 MHz, DMSO-d6): δ = 127.5 (Ar-Z), 130 (Tyr-Ar), 114.5 (Tyr-Ar), 60.5 (C-9a), 51.5 
(C-6), 64.8 (CH2-C), 64.5 (C-3), 53.8 (Tyr-α), 54.1 (Lys-α), 70.9 (C-8), 74.5 (C-7), 75.7 (C-9), 
32.0 (C-2), 39.7 (Lys-ε), 35.8 (Tyr-β), 30.5 (Tyr-CH2), 27.5 (t-butyl-CH3 and Tyr-CH2), 18.15 
(Tyr-CH2). 
ESI-MS (m/z): 826 [M+Na]+, 842 [M+K]+. 
Melting Point: Decompose at 195°C. 
7.15. Compound 15: Lys(Z)-Bic-Tyr 
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7.15.1. Procedure 
Tetrapeptide 14 (200 mg) was treated with 10 mL HCl in diethyl ether. The reaction mixture was 
stirred for 40 min at room temperature to yield the HCl salt of the free amine of 15. Yield 
obtained was quantitative. 
7.15.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 9.25 (s, 1H, OH), 8.83 (d, 3JBic-NH,6 = 8.41Hz, 1H, Bic-NH), 
8.54 (d, 3JTyr-NH,Tyr-α = 7.71Hz, 1H, Tyr-NH), 8.21 (d, 3JNH3+,Lys-α = 4.56 Hz, 3H, Lys-NH3+), 7.32 
(m, 5H, Ar-H), 7.17 (t, 3JLys-NHε,Lys-CH2 = 5.26 Hz, 1H, Lys-NHε), 7.02 (d, 3JTyr-Ar = 8.0 Hz, 2H, 
Tyr-Ar), 6.65 (d,3JTyr–Ar = 8.06 Hz, 1H, Tyr–Ar), 5.72 (m, 2H, 8 and 9- OH), 5.49 (s, 1H, 9a-H), 
5.12 (d, 3J6-H,NH = 8.4 Hz, 1H, 6-H), 5.0 (s, 1H, 7-OH), 4.98 (s, 2H, CH2-Z), 4.76 (t, 3J3,2 = 7.19 
Hz, 1H, 3-H), 4.30 (q, 3JTyr-α,Tyr-β and NH = 6.8 Hz, 1H, Tyr-α), 3.85 (sbr, 2H, Lys-α and 8-H), 3.75 
(sbr, 1H, 7-H), 3.62 (sbr, 1H, 9-H), 3.23 (m, 1H, 2-H), 3.11 (m, 1H, 2-H), 2.96 (m, 1H, Lys-ε), 2.81 
(m, 1H, Tyr-β), 1.72 (m, 1H, Lys-CH2), 1.58 (m, 1H, Lys-CH2), 1.38 (m, 1H, Lys-CH2). 
HMQC (500 MHz, DMSO-d6):δ = 127.5 (Ar-Z), 129.8 (Tyr-Ar), 114.8 (Tyr-Ar), 61.0  
(C-9a), 52.1 (C-6), 54.82 (C-CH2), 64.5 (C-3), 53.8 (Tyr-α), 51.5 (Lys-α), 70.7 (C-8), 74.4 (C-7), 
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75.8 (C-9), 31.85 (C-2), 39.6 (Tyr-β), 36.2 (Lys-ε), 30.1 (Lys-CH2), 28.6 (Lys-CH2), 22 (Lys-
CH2). 
ESI-MS (m/z): 704 [M-H]+, 726 [M+Na]+, 742 [M+K]+. 
Melting Point: Decompose at 280°C. 
7.16. Compound 16: Lys-Bic-Tyr 
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7.16.1. Procedure 
Compound 15 (30 mg, 0.042 mmol) was dissolved in MeOH (5 mL). Pd/C (10 mg) was added 
into reaction mixture. The reaction mixture was stirred for 2 h at room temperature under H2 
atmosphere. Reaction was monitored by TLC. Solvent was removed, yield obtained was 
quantitative. 
7.16.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 9.32 (s, 1H, OH), 8.90 (d, 3JBic-NH,6 =7.22 Hz, 1H, Bic-NH) 
8.60 (d, 3JTyr-NH,Tyr-α = 7.7 Hz, 1H, Tyr-NH), 8.31 (sbr, 3H, NH3+), 8.04 (sbr, 3H, NH3+), 7.03(d, 
3JTyr-Ar = 7.99 Hz, 1H, Tyr-Ar), 6.67 (d, 3JTyr-Ar = 8.15 Hz, 1H, Tyr-Ar), 5.73 (d, 3J8-OH,8 = 8.9 Hz, 
1H, 8-OH), 5.49 (s, 1H, 9a-H), 5.10 (d, 3J6,NH = 8.15 Hz, 1H, 6-H), 4.76 (t, 3J3,2 = 7.22 Hz, 1H, 3-
H), 4.29 (q, 3JTyr-α,NH and Tyr-β = 6.87 Hz, 1H, Tyr-α), 3.85 (sbr, 2H, Lys-α and 8-H), 3.79 (sbr, 1H, 
7-H), 3.6 (d, 3J9,8 = 5.99 Hz, 1H, 9-H), 3.24 (m, 1H, 2-H), 3.12 (m, 1H, 2-H), 2.85 (dd,  
2JTyr-β,Tyr-β = 13.68 Hz and 3JTyr-βTyr-α= 6.15 Hz, 1H, Tyr-β), 2.78 (dd, 2JTyr-βTyr-β = 14.15 Hz and 
3JTyr-β,Tyr-α = 7.5 Hz, 1H, Tyr-β), 2.73 (sbr, 2H, Lys-ε), 1.76 (m, 2H, Lys-CH2), 1.58 (m, 2H, Lys-
CH2), 1.45 (m, 2H, Lys-CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 172.29 (CO-NH), 170.33 (CO-5C), 167.84 (COOH), 167.19 
(CO-NH), 155.99 (Tyr-Ar), 130.11 (Tyr-Ar), 126.98 (Tyr-Ar), 114.96 (Tyr-Ar), 76.24 (C-9), 
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74.47 (C-7), 71.08 (C-8), 64.8 (C-3), 61.18 (C-9a), 54.18 (Tyr-α), 52.56 (C-6), 51.62 (Lys-α), 
38.21 (Tyr-β), 3619 (Lys-ε), 32.22 (C-2), 30.28 (Lys-CH2), 26.13 (Lys-CH2), 20.82 (Lys-CH2). 
ESI-MS (m/z): 570 [M-H]+. 
Melting Point: Decompose at 210°C. 
7.17. Compound 17: Boc-DOPA-Bic-Tyr-OMe 
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7.17.1. Procedure 
The HCl salt of the free amine 11 (0.150 g, 0.32 mmol) and Boc-DOPA (0.117 g, 0.39 mmol) 
were dissolved in DMF (15 mL). HOBt (0.053 g, 0.39 mmol) and HBTU (0.149 g, 0.39 mmol) 
were added and the pH of the reaction mixture was adjusted to 7-8 with DIPEA. The reaction 
mixture was stirred for 6 h at room temperature. The solvent was removed and 17 was purified by 
column chromatography (CHCl3:MeOH as 4:1). Yield obtained was 0.191 g (0.26 mmol, 79%). 
7.17.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 8.62 (d, 3JTyr-NH,Tyr-α = 7.08 Hz, 1H, Tyr-NH), 8.01 (d,  
3JBic-NH,6 = 8.3 Hz, 1H, Bic-NH), 6.98 (d,3JTyr-Ar = 8.54 Hz, 1H, Tyr-Ar), 6.90 (d, 3JDOPA-Ar = 8.54 
Hz, 1H, DOPA-Ar), 6.63 (d, 3JTyr-Ar = 8.30 Hz, 1H, Tyr-Ar), 6.58 (d, 3JDOPA-Ar = 7.81 Hz, 1H, 
DOPA-Ar), 6.49 (dd, 3JDOPA-Ar = 8.05 Hz and 3JDOPA-Ar = 1.95 Hz, 1H, Dopa-Ar), 5.63 (d,  
3J8-OH,8 = 9.03 Hz, 1H, 8-OH), 5.50 (sbr, 1H, 9a-H), 5.09 (sbr, 1H, 6-H), 5.07 (d, 3J7-OH,7 = 4.15 Hz, 
7-OH), 4.70 (t, 3J3,2 = 7.44 Hz, 1H, 3-H), 4.34 (q, 3JTyr-α,NH and Tyr-β= 699 Hz, 1H, Tyr-α), 4.07 (m, 
1H, DOPA-α), 3.83 (m, 1H, 8-H), 3.73 (m, 1H, 7-H), 3.60 (dd, 1H, 3J9,9-OH = 8.78 Hz, and 3J9,8 = 
3.4 Hz, 9-H), 3.51 (s, 3H, OMe), 3.23 (dd, 2J2,2 = 11.23 and 3J2,3 = 7.31 Hz, 1H, 2-H), 3.13 (dd, 
2J2,2 = 11.10 Hz and 3J2,3 = 7.4 Hz, 1H, 2-H), 2.89 (dd, 2JDOPA-β,DOPA-β = 13.91 Hz and 3JDOPA-
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β,DOPA-α = 2.92 Hz, 2H, DOPA-β), 2.80 (d, 3JTyrβ,Tyrα = 7.08 Hz, 2H, Tyr-β), 1.29 (s, 9H, t-butyl-
CH3). 
13C NMR (500 MHz, DMSO-d6): δ = 171.32, 171.16 (CO-NH), 170.29 (CO-5C), 167.57 
(COOMe), 156.04 (Boc-CO), 155.17 (Tyr-Ar), 144.74, 143.547 (DOPA-Ar), 130.03 (Tyr-Ar), 
129.05 (DOPA-Ar), 126.53 (Tyr-Ar), 119.80 (DOPA-Ar), 116. 57 (DOPA-Ar), 115.95 (DOPA-
Ar), 115.04 (Tyr-Ar), 78.01 (t-butyl-quat), 76.30 (C-9), 74. 74 (C-7), 71. 41 (C-8), 64.91 (C-3), 
61.26 (C-9a), 56.16 (DOPA-α), 54.20 (Tyr-α), 52.17 (C-6), 51.64 (OMe), 36.81 (DOPA-β), 
36.38 (Tyr-β), 32.22 (C-2), 28.14 (t-butyl-CH3). 
ESI-MS (m/z ): 735 [M+H]+, 757 [M+Na]+, 773 [M+K]+. 
Melting Point: 185°C. 
7.18. Compound 18: DOPA-BiC-Tyr-OMe 
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7.18.1. Procedure 
Tetrapeptide 17 (275 mg) was treated with HCl (20 mL) in diethyl ether. The reaction mixture 
was stirred for 1 h at room temperature to yield the HCl salt of the free amine of 18. Yield 
obtained was quantitative. 
7.18.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 8.99 (d, 3JBic-NH,6 = 7.10 Hz, 1H, Bic-NH), 8.65 (d,  
3JTyr-NH,Tyr-α = 8.01 Hz, 1H, Tyr-NH), 7.98 (s, 3H, NH3+), 6.98 (d, 3JTyr-Ar = 8.47 Hz, 1H, Tyr-Ar), 
6.63 (d, 3JTyr-Ar = 8.24 Hz, 2H, Tyr-Ar), 6.71 (d, 3JDOPA-Ar = 2.06Hz, 1H, DOPA-Ar), 6.66 (d, 
3JDOPA-Ar = 8.01 Hz, 1H, DOPA-Ar), 6.63 (d, 3JTyr-Ar = 8.47 Hz, 2H, Tyr-Ar), 6.58 (dd,  
3JDOPA-Ar = 8.01 Hz and 3JDOPA-Ar = 2.06 Hz 1H, DOPA-Ar), 5.51 (s, 1H, 9a-H), 5.11 (d, 3J6,NH = 
8.4 Hz, 1H, 6-H), 4.74 (t, 3J3,2 = 7.33 Hz, 1H, 3-H), 4.33 (q, 3JTyr-α,NH and Tyr-β= 7.10 Hz, 1H, Tyr-
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α), 4.03 (m, 1H, DOPA-α), 3.87 (t, 3J8,9 = 4.12 Hz, 1H, 8-H), 3.78 (d, 1H, 3J7,8 = 4.35Hz, 
7-H), 3.64 (d, 3J9,8 = 3.66 Hz, 1H, 9-H), 3.51 (s, 3H, OMe), 3.25 (m, 1H, 2-H), 3.08 (m, 3H, 2-H 
and DOPA–β), 2.80 (d, 3JTyr-β,Tyr-α= 7.1 Hz, 2H, Tyr-β). 
HMQC (500 MHz, DMSO-d6): δ = 129.8 (Tyr-Ar), 116.7 (DOPA-Ar), 114.6 (Tyr-Ar), 120.1 
(DOPA-Ar), 120.2 (DOPA-Ar), 61 (C-9a), 52.2 (C-6), 64.3 (C-3), 54.1 (Tyr-α), 53.3 (DOPA-α), 
71.1 (C-8), 74.3 (C-7), 76. 1(C-9), 51.4 (OMe), 32 (C-2), 35.8 (DOPA-β), 36.2 (Tyr-β). 
ESI-MS (m/z): 635 [M+H]+, 657 [M+Na]+, 673 [M+K]+, 
Melting Point: 245°C. 
7.19. Compound 19: Boc-DOPA-Tyr-OMe 
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7.19.1. Procedure  
Boc-DOPA (1.53 g, 5.17 mmol) and Tyr methyl ester (1 g, 4.3 mmol) were dissolved in DMF 
(20 mL). Then HOBt (0.69 g, 5.17 mmol) and HBTU (1.96 g, 5.17 mmol) were added and pH of 
the reaction mixture was adjusted to 7-8 with DIPEA. The reaction mixture was stirred for 6 h at 
room temperature. The solvent was removed and 19 was purified by column chromatography 
(CHCl3:MeOH as 4:1). Yield obtained was 2.26 g (4.79 mmol, 93%). 
7.19.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 9.19 (s, 1H, OH), 8.10 (d, 3JTyr-NH,Tyr-α = 7.54Hz, 1H, Tyr-
NH), 6.977 (d, 3JTyr-Ar = 8.20 Hz, 2H, Tyr-Ar), 6.70 (d, 3JDOPA-Ar = 8.64Hz, 1H, DOPA-Ar), 6.64 
(d, 3JTyr-Ar = 8.4 Hz, 2H, Tyr-Ar), 6.57 (d, 3JDOPA-Ar = 7.98Hz, 1H, DOPA-Ar), 6.43 (dd,  
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3JDOPA-Ar = 7.9Hz and 3JDOPA-Ar = 1.99Hz, 1H, DOPA-Ar), 4.39 (q, 3JTyr-α,NH and Tyr-β = 7.17 Hz, 1H, 
Tyr-α), 4.04 (m, 1H, DOPA-α), 3.55 (s, 1H, OMe), 2.85 (m, 2H, Tyr-β), 2.69 (dd, 2JDOPA-β,DOPA-β 
= 13.5 Hz and 3JDOPA-β,DOPA-α = 3.32 Hz, 2H, DOPA-β), 1.29 (s, 3H, t-butyl-CH3). 
13C NMR (500 MHz, DMSO-d6): δ = 171.93, 171.89 (CO-NH, COMe), 156.01 (Tyr-Ar), 155.10 
(Boc-CO), 144.73,143.61 (DOPA-Ar), 130.03 (Tyr-Ar), 128.78 (DOPA-Ar), 126.89 (Tyr-Ar), 
119.89, 116.61, 115.03 (DOPA-Ar), 115.03 (Tyr-Ar), 78.00 (t-butyl-quart), 55.92 (DOPA-α), 
53.75 (Tyr-α), 51.74 (OMe), 36.79 (DOPA-β), 36.09 (Tyr-β), 28.13 (3C, t-butyl-CH3). 
ESI-MS (m/z): 473.2 [M-H+]-; 947.5 [2M-H+]-. 
Melting Point: 118°C. 
7.20. Compound 20: DOPA-Tyr-OMe 
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7.20.1. Procedure 
Dipeptide 14 (1.6 g, 3.38 mmol) was treated with HCl (20 mL) in diethyl ether. The reaction 
mixture was stirred for 1 h at room temperature to yield the HCl salt of the free amine of 15. Yield 
obtained was quantitative.  
7.20.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 9.31 (s, 1H, OH), 8.96 (d, 3JTyr-NH,Tyr-α = 7.78 Hz, 1H, Tyr-
NH), 8.07 (d, 3JNH3,DOPA-α = 8.07 Hz, 3H, NH3+), 7.00 (d, 3JTyr-Ar = 8.69 Hz, 2H, Tyr-Ar), 6.67 (d, 
3JTyr-Ar = 8.54 Hz, 2H, Tyr-Ar), 6.675 (d, 3JDOPA-Ar = 4.57Hz, 1H, DOPA-Ar), 6.65 (d,  
3JDOPA-Ar = 8.08 Hz, 1H, DOPA-Ar), 6.50 (dd, 3JDOPA-Ar = 8.01 Hz and 3JDOPA-Ar = 2.21 Hz, 1H, 
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DOPA-Ar), 4.44 (q, 3JTyr-α, NH and Tyr-β = 7.22 Hz, 1H, Tyr-α), 3.89 (m, 1H, DOPA-α), 3.58 (s, 3H, 
OMe), 3.2 (m, 1H, DOPA-β), 2.92 (m, 2H, Tyr-β), 2.82 (m, 1H, DOPA-β). 
13C NMR (500 MHz, DMSO-d6): δ = 171.21, 168.24 (CO-NH, COMe), 156.14 (Tyr-Ar), 
145.17,144.51 (DOPA-Ar), 129.98 (Tyr-Ar), 126.61 (DOPA-Ar), 125.29 (Tyr-Ar), 120.30, 
116.96, 115.14 (DOPA-Ar), 115.14 (Tyr-Ar), 54.16 (Tyr-α), 53.48 (DOPA-α), 51.91 (OMe), 
36.31 (Tyr-β), 35.95 (DOPA-β). 
ESI-MS (m/z): 375 [M +H ]+, 397 [M +Na ]+. 
Melting Point: 82°C. 
7.21. Compound 21: Boc-Bic-DOPA-Tyr-OMe 
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7.21.1. Procedure 
The HCl salt of free amine 20 (0.30 g, 0.73 mmol) and Boc-Bic (0.30 g, 0.80 mmol) was 
dissolved in DMF (30 mL). HOBt (0.10 g, 0.80 mmol) and HBTU (0.30 g, 0.80 mmol) were 
added and the pH of the reaction mixture was adjusted to 7-8 with DIPEA. The reaction mixture 
was stirred for 6 h at room temperature. Solvent was removed and 21 was purified by column 
chromatography (CHCl3:MeOH as 4:1). Yield obtained was 0.47 g (0.64 mmol, 80%). 
7.21.2. Analytical Data 
1H NMR (400 MHz, DMSO-d6): δ = 8.18 (d, 3JDOPA-NH,DOPA-α = 8.45Hz, 1H, DOPA-NH), 7.74 (d, 
3JTyr-NH,Tyr-α = 7.83Hz, 1H, Tyr-NH), 6.98 (d, 3JTyr-Ar = 8.63Hz, 2H, Tyr-Ar), 6.65 (d, 3JTyr-Ar = 
8.51Hz, 2H, Tyr-Ar), 6.58 (m, 2H, DOPA-Ar), 6.44 (m, 2H, DOPA–Ar and Bic-NH), 6.01 (d,  
3J8-OH,8 = 6.66Hz, 1H, 8-OH), 5.55 (s, 1H, 7-OH), 5.48 (s,1H, 9a-H), 4.81 (d, 3J6,Bic- NH = 8.45Hz, 
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1H, 6-H), 4.44 (t, 3J3,2 = 8.4Hz, 1H, 3-H), 4.2 (m, 2H, Tyr-α and DOPA-α), 3.85 (s, 2H, 7-H and 
8-H), 3.70 (s, 1H, 9-H), 3.45 (s, 3H, OMe), 3.14 (d, 3J2,3 = 8.86 Hz, 2H, 2-H), 2.94 (m, 2H, 
DOPA-β), 2.84 (m, 2H, Tyr-β), 1.267 (s, 9H, t-butyl-CH3). 
13C NMR (400 MHz, DMSO-d6): δ = 171.59 (CO-5C), 170.57 (Tyr-CONH), 169.51 (DOPA-
CONH), 169.07 (COOMe), 155.97 (Boc-CO), 154.91, 130.09, 126.93, 114.99 (Tyr-Ar), 144.88, 
143.63, 129.00, 119.81, 115.26, 116.14 (DOPA-Ar), 78.18 (t-butyl-quart), 77.27 (C-9), 74.69 (C-
8), 71.83 (C-7), 66.46 (C-3), 61.48 (C-9a), 54.83 (DOPA-α), 54.77 (Tyr-α), 53.78 (C-6), 51.43 
(OMe), 36.79 (DOPA-β), 36.41 (C-Tyr-β), 32.32 (C-2), 27.96 (t-butyl-3 CH3). 
ESI-MS (m/z): 735.2 [M-H]+, 752 [M+NH4]+, 757.2 [M+Na]+. 
Melting Point: 154°C. 
7.22. Compound 22: Boc-Lys(Z)-DOPA-Tyr-OMe 
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7.22.1. Procedure 
The HCl salt of free amine 20 (0.59 g, 1.57 mmol) and Boc(Z)Lys (0.50 g, 1.31 mmol) were 
dissolved in DMF (20 mL). HOBt (0.21 g, 1.57 mmol) and HBTU (0.59 g, 1.57 mmol) were 
added and the pH of the reaction mixture was adjusted to 7-8 with DIPEA. The reaction mixture 
was stirred for 7 h at room temperature. The solvent was removed and 22 was purified by column 
chromatography (CHCl3:MeOH in the ratio 4:1). Yield obtained was 0.99 g (1.26 mmol, 80%). 
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7.22.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 8.29 (d, 3JTyr-NH,Tyr-α= 7.8Hz,1H, Tyr-NH), 7.73 (d,  
3JDOPA-NH-DOPA-α= 7.57 Hz, 1H, DOPA-Ar), 6.85 (d, 3JLys-α,NH = 8.36Hz, 1H, Lys-α,NH), 6.78 (d, 
3JDOPA-Ar = 8.36Hz, 2H, DOPA-Ar), 6.64 (m, 2H, DOPA-Ar), 6.62 (d, 3JTyr-Ar= 6.62 Hz, 2H, Tyr-
Ar), 6.29(dd, 3JDOPA-Ar = 5.2 Hz and JDOPA-Ar = 1.82Hz, 1H, DOPA-Ar), 4.98 (s, 2H, CH2-Z), 4.43 
(s, 1H, DOPA-α), 4.31 (q, 3JTyr-α, NH and Tyr-β= 7.05 Hz, 1H, Tyr-α), 3.80 (s, 1H, Lys-α), 3.52 (s, 
3H, OMe), 2.96 (s, 2H, Lys-ε), 2.92 (m, 2H, DOPA-β), 2.82 (s, 2H, Tyr-β), 1.46 (s, 2H, Lys-
CH2), 1.34 (s, 3H, t-butyl-CH3), 1.22 (s, 2H, Lys-CH2), 1.12 (s, 2H, Lys-CH2). 
HMQC-NMR (500 MHz, DMSO-d6):  δ = 127.8 (C-Z), 115.19, 130.2 (C-Tyr-Ar), 118.55,  
121.04, 123.54 (DOPA-Ar), 64.7 (CH2-Z), 53.0 (DOPA-α), 53.6 (Tyr-α), 54.0 (Lys-α), 51.1 
(OMe), 35.5 (Lys-ε), 39.7 (DOPA-β), 35.8 (Tyr-β), 30.9 (Lys-CH2), 27.7 (t-butyl-3 CH3), 22.0 
(Lys-CH2), 23.4 (Lys-CH2). 
ESI-MS (m/z): 830 [M+K ]+. 
Melting Point: 88°C. 
7.23. Compound 23: Lys(Z)-DOPA-Tyr-OMe 
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7.23.1. Procedure  
Tetrapeptide 22 (0.20 g, 0.25 mmol) was treated with HCl (10 mL) in diethyl ether. The reaction 
mixture was stirred for 40 minute at room temperature to yield the HCl salt of the free amine of 
23. Yield obtained was quantitative. 
7   Experimental Section 143 
7.23.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 7.32 (m, 5H, Z), 6.96 (d, 3JTyr-Ar = 8.2 Hz, 2H, Tyr-Ar), 6.69 
(m, 1H, DOPA-Ar), 6.64 (d, 3JTyr-Ar = 8.50 Hz, 2H, Tyr-Ar), 6.60 (d, 3JDOPA-Ar = 7.99 Hz, 1H, 
DOPA-Ar), 6.49 (dd, 3JDOPA-Ar = 7.9 Hz and 3JDOPA-Ar = 2.31 Hz, 1H, DOPA-Ar), 4.98 (s, 2H, 
CH2-Ar), 4.47 (m, 1H, DOPA-α), 4.38 (m, 1H, Tyr-α), 3.67 (m, 1H, Lys-α), 3.55 (s, 3H, OMe), 
2.95 (DOPA-β), 2.86 (Tyr-β), 2.71 (Lys-ε), 1.66 (Lys-CH2), 1.36 (Lys-CH2), 1.3 (Lys-CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 128.0 (C-Z), 130.0 (Tyr-Ar), 119.9 (DOPA-Ar), 117.0 
(DOPA-Ar), 114.7 (Tyr-Ar), 114.8 (DOPA-Ar), 65.0 (CH2-Ar), 54.4 (DOPA-α), 53.9 (Tyr-α), 
51.9 (Lys-α), 51.7 (OMe), 39.9 (DOPA-β), 38.0 (Lys-ε), 35.1 (Tyr-β), 30.2 (Lys-CH2), 28.4 
(Lys-CH2), 21.0 (Lys-CH2). 
ESI-MS (m/z): 637 [M-H ]+, 659 [M+Na ]+. 
Melting Point: 128°C. 
7.24. Compound 24: Lys-DOPA-Tyr-OMe 
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7.24.1. Procedure 
Compound 23 (30 mg, 0.047 mmol) was dissolved in MeOH. Pd/C (10 mg) was added into 
reaction mixture. The reaction mixture was stirred for 3 h at room temperature under H2 
atmosphere. Reaction was monitored by TLC. Solvent was removed, yield obtained was 
quantitative. 
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7.24.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 8.68 (d, 3JDOPA-NH,DOPA-α = 8.25 Hz, 1H, DOPA-NH), 8.53 
(d, 3JTyr-NH,Tyr-α = 7.70 Hz, 1H, NH), 8.23 (sbr, 2H, NH3+, Lys-ε), 8.05 (sbr, 2H, NH3+), 6.99 ( d, 
3JTyr-Ar = 8.25 Hz, 2H, Tyr-Ar), 6.70 (d, 3JDOPA-Ar = 7.07 Hz, 1H, DOPA-Ar), 6.67 (d,  
3JTyr-Ar = 8.43 Hz, 2H, Tyr- Ar), 6.61 (d, 3JDOPA-Ar = 8.06 Hz, 1H, DOPA-Ar), 6.49 (dd, 
3JDOPA-Ar = 8.06 Hz and 3JDOPA-Ar= 2.20 Hz, 1H, DOPA-Ar), 4.45 (m, 1H, DOPA-α), 4.36 (m, 1H, 
Tyr-α), 3.69 ( m, 1H, Lys-α), 3.56 (s, 3H, OMe), 2.88 (m, 2H, DOPA-β), 2.70 (m, 2H, Lys-ε), 
2.61 (dd, 2JTyr-β,Tyr-β = 13.75 Hz and 3JTyr-β,Tyr-α = 9.7 Hz, 2H, Tyr-β), 1.70 (m, 2H, Lys- CH2), 1.54 
(qu, 2JLys-CH2,CH2 = 7.42 Hz, 2H, Lys-CH2), 1.29 (m, 2H, Lys-CH2). 
13C NMR (300 MHz, DMSO-d6): δ = 171.76, 171.06 (CO-NH), 168.30 (COOMe), 156.03 (Tyr-
Ar), 144.85, 143.79 (DOPA-Ar), 129.92 (Tyr-Ar), 128.24 (DOPA-Ar), 126.96 (Tyr-Ar), 119.95, 
116.70, 115.34 (DOPA-Ar), 115.04 (Tyr-Ar), 54.57 (DOPA-α), 53.98 (Tyr-α), 51.76 (Lys-α and 
OMe), 38.19 (DOPA-β), 36.76 (Tyr-β), 35.88 (Lys-ε), 30.25 (Lys-CH2), 26.13 (Lys-CH2), 20.83 
(Lys-CH2). 
ESI-MS (m/z): 525 [M +H ]+, [M+2Na]+. 
Melting Point: remains semi-solid. 
7.25. Compound 25: Boc-Lys(2-Cl-Z)-Tyr-OMe 
(  )4
NH-Z-(  -Cl)
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7.25.1. Procedure 
Tyrosine methyl ester (0.50 g, 2.76 mmol) and Boc(2-Cl-Z) Lys (1.26 g, 3.03 mmol) were 
dissolved in 20 mL DMF. Then HOBt (0.48 g, 3.59 mmol) and HBTU (1.36 g, 3.59 mmol) were 
added and pH of the reaction mixture was adjusted to 7-8 with DIPEA. The reaction mixture was 
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stirred for 6 h at room temperature. The solvent was removed and 25 was purified by column 
chromatography (CHCl3:MeOH as 4:1). Yield obtained was 1.39 g (2.35 mmol, 92%). 
7.25.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 7.39 (m, 2H, 2-Cl-Z), 7.24 (m, 2H, 2-Cl-Z), 6.9 (d,  
3JTyr-Ar = 8.41 Hz, 2H, Tyr-Ar), 6.74 (d, 3JTyr-Ar = 8.41 Hz, 2H, Tyr-Ar), 6.65 (d, 
3JBoc-NH, Lys-α= 8.06 Hz, 1H, Boc-NH), 5.20 (s, 2H, CH2), 4.81 (m, 1H, Tyr-α), 4.03 (sbr, 1H, Lys-
α), 3.70 (sbr, 3H, OMe), 3.11 (m, 3H, Lys-ε and Tyr-β), 2.93 (m, 1H, Tyr-β), 1.42 (sbr, 13H, t-
butyl-CH3 and Lys-CH2),1.21 (s, 2H, Lys-CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 129.5 (Ar–Z), 129.4 (Ar-Z), 130.2 (Tyr-Ar), 115.2 (Tyr-
Ar), 64.0 (CH2), 52.9 (Tyr-α), 54.0 (Lys-α), 52.4 (OMe), 40.1 (Lys-ε), 37.2 (Tyr-β), 28.1 (Lys-
CH2), 22.3 (Lys-CH2), 23.4 (Lys-CH2), 28.0 (t-butyl-3CH3). 
ESI-MS (m/z): 614 [M+Na+], 630 [M+K+]. 
Melting Point: 60°C. 
7.26. Compound 26: Boc-Lys(2-Cl-Z)-Tyr 
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7.26.1. Procedure 
Compound 25 (0.077 g, 0.15 mmol) was dissolved in minimum amount of MeOH (5 mL). 1N 
KOH (0.30 mL, 0.30 mmol) was added into reaction mixture. The reaction mixture was stirred for 
7 h at room temperature. Reaction was monitored by TLC and stopped with 1N HCl (0.15 mL). 
Then the solvent was removed, yield obtained was quantitative. 
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7.26.2. Analytical Data 
1H NMR (400 MHz, DMSO-d6): δ = 9.20 (s, 1H, OH), 7.45 (m, 2H, 2-Cl-Z), 7.34 (m, 3H, 2-Cl-
Z), 7.24 (d, 3JTyr–NH,Tyr-α = 7.0 Hz, 1H, Tyr–NH), 6.98 (d, 3JLys–NH,Lys-α = 7.71 Hz, 1H, Lys–
NH),6.90 (d, 3JTyr-Ar = 8.41 Hz, 2H, Tyr-Ar), 6.54 (d, 3JTyr-Ar = 8.4 Hz, 2H, Tyr-Ar), 5.07 (s, 2H, 
CH2), 4.02 (m, 1H, Tyr-α), 3.73 (m, 1H, Lys-α), 2.94 (m, 3H, Lys-ε and Tyr β), 2.82 (dd, 2JTyr-
β,Tyr-β = 13.3 Hz and 3JTyr-β,Tyr-α = 5.61 Hz, 1H, Tyr-β), 1.56 (m, 2H, Lys CH2), 1.3 (m, 2H, Lys-
CH2), 1.35 (s, 9H, Boc-CH3), 1.21 (m, 2H, Lys-CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 129.5 (Ar-Z), 128.2 (Ar-Z), 130.2 (Tyr-Ar), 114.2 (Tyr-Ar) 
62.2 (CH2-Z), 54.82 (Tyr-α), 54.6 (Lys-α), 38.2 (Lys-ε), 36.1 (Tyr-β), 30.2 (Lys-CH2), 28.1 (Lys-
CH2), 25.6 (t-butyl-3CH3), 22.5 (Lys-CH2). 
ESI-MS (m/z): 600 [M+Na]+, 616 [M+K]+. 
Melting Point: 196°C. 
7.27. Compound 27: Lys(2-Cl-Z)-Tyr 
(  )4
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7.27.1. Procedure 
Dipeptide 26 (280 mg, 0.48 mmol) was treated with HCl (10 mL) in diethyl ether. The reaction 
mixture was stirred for 6 h at room temperature to yield the HCl salt of the free amine of 27. Yield 
obtained was quantitative. 
7.27.2. Analytical Data 
1H NMR (500 MHz, DMSO-d6): δ = 12.84 (s, 1H, OH), 9.31 (s, 1H, OH), 8.75 (d,  
3JTyr-NH,Tyr-α = 7.62 Hz, 1H, Tyr-NH), 8.18 (s, 3H, NH3+), 7.45 (m, 2H, Ar-H), 7.35 (m, 3H, Ar-H 
and Lys-NHε), 7.04 (d, 3JTyr–Ar = 8.62 Hz, 2H, Tyr–Ar), 6.66 (d, 3JTyr-Ar = 8.62 Hz, 2H, Tyr-Ar), 
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5.06 (s, 2H, CH2), 4.37 (m, 1H, Tyr-α), 3.7 (m, 1H, Lys-α), 2.95 (m, 2H, Lys-ε), 2.82 (m, 2H, 
Tyr-β), 1.71 (m, 2H, Lys-CH2), 1.56 (m, 2H, Lys-CH2), 1.36 (m, 1H, Lys CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 129.2 (Ar-Z), 127.2 (Ar-Z), 129.9 (Tyr-Ar), 62.2 (CH2-Z), 
53.9 (Tyr-α), 51.5 (Lys-α), 39.9 (Tyr-β), 35.2 (Lys-ε), 30.2 (Lys-CH2), 28.2 (Lys-CH2), 20.8 
(Lys-CH2). 
ESI-MS (m/z): 478 [M-H]+, 500 [M+Na]+, 516 [M+K]+. 
Melting Point: 124°C. 
7.28. Compound 28: Poly-Bic 
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n = 1,2,3….7. 
7.28.1. Procedure  
Polyhydroxylated dipeptide (0.25 g, 0.89 mmol) was dissolved in DMF (10 mL). Then HOBt 
(0.60 g, 4.4 mmol) and of Poly DCC [N-Cyclohexylcarbodiimide, N´-methyl polystyrene] (1.38 g, 
1.79 mmol) were added and the pH of the reaction mixture was adjusted to 7-8 with triethylamine 
(0.25 mL, 1.79 mmol). The reaction mixture was stirred for 48 h at room temperature. The 
reaction was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1). The solvent was removed. 
Reaction mixture was washed with 10% MeOH in CHCl3 to remove excess HOBt. Yield obtained 
was quantitative. 
Alternatively, this compound was also synthesized as: 
Polyhydroxylated dipeptide (0.10 g, 0.36 mmol) was dissolved in (5 mL) DMF. Then 
HOBt(0.24 g, 1.8 mmol) and DCC (0.148 g, 0.72 mmol) were added and the pH of the reaction 
mixture was adjusted to 7-8 with triethylamine (0.10 mL, 0.72 mmol). The reaction mixture was 
stirred for 48 h at room temperature. The reaction was monitored by TLC (MeOH:EtOAC:H2O as 
2:2:1). The solvent was removed. Reaction mixture was washed with 10% MeOH in CHCl3 to 
remove the excess HOBt and DCU. Yield obtained was quantitative. 
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7.28.2. Analytical Data 
1H NMR (300 MHz, DMSO-d6): 1H NMR spectra in these solvent showed only numerous 
unassignable peaks. Therefore, experiments like 2D COSY (Correlated Spectroscopy) and HMQC 
(Heteronuclear Multiple Quantum Correlation Spectroscopy) were used to assign terminal 
lactones peaks and some peaks which belong to oligomers mixtures. 
1H NMR (600 MHz, DMSO-d6): δ = 6.03 (sbr, 8-OH), 5.89 (sbr, 9a-H), 5.47 (7-OH), 5.24 (3-H), 
4.33 (d, 3J9H,9 = 3.2 Hz, 9H), 4.01 (8-H), 3.80 (7-H), 3.28 (2-H). 
13C NMR (600 MHz, DMSO-d6): δ = 84.5 (C-9), 76.3 (C-8), 69(C-7), 60.7 (C-3), 52.9 (C-9a), 
52.2 (C-6), 33.5 (C-2). 
 
Oligomer mixtures: 
1H NMR (600 MHz, DMSO-d6): δ = 5.47 (s, 9a-H), 5.01 (s, 6-H), 4.85 (s, 3-H), 3.81 (s, 8-H), 
3.76 (s, 7-H), 3.71 (s, 9-H), 3.39 (s, 2-H), 3.22 (s, 2-H). 
13C NMR (600 MHz, DMSO-d6): δ = 74.2 (C-9), 73 (C-7), 71.2 (C-8), 64.1 (C-3), 60.8  
(C-9a), 52.1 (C-6), 32.2 (C-2). 
MALDI–TOF: A series of polyhydoxylated dipeptide oligomers were observed with masses 
ranging from 538 to 2358 Da. (n = 2; 538), (n = 3; 798), (n = 3; 1058), (n = 4; 1318), (n = 5; 
1578), (n = 6; 1838), (n = 7; 2098), (n = 8; 2358). 
GPC: GPC shows the mixture of different molecular weight compounds ranging from 2962 to 
36950 Da. 
HPLC: It shows the mixture of different peaks, while the retention time ranging from 6.58 min to 
14.65 min. 
7.29. Compound 29: Poly-Bic 
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n = 1,2…..8. 
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7.29.1. Procedure 
Compound 28 (0.02 g) was dissolve in minimum amount of DMF (3 mL). 1N KOH in MeOH 
was added into reaction mixture till pH was about 9 to 10. The reaction mixture was stirred for 
30 min at room temperature and stopped with 1N HCl in MeOH till pH was about 6 to 7. Solvent 
was removed, yield obtained was quantitative. 
7.29.2. Analytical Data 
1H NMR (600 MHz, DMSO-d6): δ = 5.46 (sbr, 9a-H), 5.01 (6-H), 4.85 and 4.6 (3-H), 3.83 (8-H), 
3.75 (7-H), 3.58 (9-H), 3.28 (2-H). 
13C NMR (600 MHz, DMSO-d6): δ = 76.64 (C-9), 74.17 (C-7), 71.04 (C-8), 60.9 (C-9a), 52.3 (C-
6), 64.3 and 64.2 (C-3), 32.1 (C-2). 
MALDI–TOF: A series of polyhydixylated dipeptide oligomers were observed with masses 
ranging from 538 to 2358 Da. (n = 2; 538), (n = 3, 798), (n = 3; 1058), (n = 4; 1318), (n = 5; 
1578), (n = 6; 1838), (n = 7, 2098), (n = 8; 2358). 
7.30. Compound 30: Poly-Tyr 
OH
N
H
O
n 
 
30 
7.30.1. Procedure  
Tyrosine methyl ester (0.10 g, 0.55 mmol) was dissolved in DMF (8 mL). Then HOBt (0.37 g, 
2.75 mmol) and DCC (0.22 g, 1.10 mmol) were added and the pH of the reaction mixture was 
adjusted to 7-8 with triethylamine (0.15 mL, 1.10 mmol). The reaction mixture was stirred for 
48 h at room temperature. Reaction was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1). The 
solvent was removed. Reaction mixture was washed with CHCl3 to remove excess HOBt and 
DCU. Yield obtained was quantitative. 
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7.30.2. Analytical Data 
(Based on 2D HMQC experiment) 
1H NMR (500 MHz, DMSO-d6): δ = 6.58 (s, Ar-H), 6.45 (s, Ar-H), 4.65-3.78 (s, Tyr-α), 2.79 (s, 
Tyr-β). 
13C NMR (500 MHz, DMSO-d6): δ = 114.81 (Tyr-Ar), 119.6 (Tyr-Ar), 55.62-53.6 (Tyr-α), 45.3 
(Tyr-β). 
MALDI–TOF: A series of Tyr oligomers were observed with masses ranging from 344 to 4256 
Da. 
7.31. Compound 31: Poly-DOPA 
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7.31.1. Procedure 
DOPA (0.10 g, 0.50 mmol) was dissolved in minimum amount of DMF (5 mL). Then HOBt 
(0.34 g, 2.52 mmol) and DCC (0.20 g, 1.01 mmol) were added and the pH of the reaction mixture 
was adjusted to 7-8 with triethylamine (0.14 mL, 1.01 mmol). The reaction mixture was stirred for 
48 h at room temperature. Reaction was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1). The 
solvent was removed. Reaction mixture was washed with CHCl3 to remove excess HOBt and 
DCU. Yield obtained was quantitative. 
7.31.2. Analytical Data 
(Based on 2D HMQC experiment) 
1H NMR (500 MHz, DMSO-d6): δ = 6.56 (DOPA-Ar), 6.42 (DOPA-Ar), 4.33 (DOPA-α), 2.85 
(DOPA-β). 
13C NMR (500 MHz, DMSO-d6): δ = 115.05 (DOPA-Ar), 119.84 (DOPA-Ar), 53.86 (DOPA-α), 
45.0 (DOPA-β). 
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MALDI–TOF: A series of DOPA oligomers were observed with masses ranging from 376 to 
4672 Da. 
7.32. Compound 32: Poly-Lys(Z) 
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7.32.1. Procedure 
Lys(Z) (0.50 g, 1.78 mmol) was dissolved in DMF (10 mL). Then of HOBt (1.2 g, 8.9 mmol) and 
DCC (0.73 g, 3.56 mmol) were added and the pH of the reaction mixture was adjusted to 7-8 with 
triethylamine (0.49 mL, 3.56 mmol). The reaction mixture was stirred for 48 h at room 
temperature. Reaction was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1). The solvent was 
removed. Reaction mixture was washed with CHCl3 to remove excess HOBt and DCU. Yield 
obtained was quantitative. 
7.32.2. Analytical Data 
(Based on 2D HMQC experiment) 
1H NMR (500 MHz, DMSO-d6): δ = 7.58 (s, Ar-H), 4.9 (s, CH2-Z), 4.2 (s, Lys-α), 2.92 (s, Lys-
ε), 1.64, 1.35, 1.2 (Lys-CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 127.8 (C-Ar), 65.0 (C-CH2), 52.1 (C-Lys-α), 40.0  
(C-Lys-ε), 29.8, 29.0, 22.5 (Lys-CH2). 
MALDI–TOF: A series of Lys (Z) oligomers were observed with masses ranging from 547 to 
4498 Da. 
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7.33. Compound 33: Poly-Lys 
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7.33.1. Procedure 
Compound 32 (15 mg) was dissolved in 60% TFA in DMF (2 mL), and then of 33% HBr 
(0.5 mL) in acetic acid were added into reaction mixture. The reaction mixture was stirred for 
20 minute. The product was precipitated by addition of ether and then dried. The crud polymer 
was dissolved in a small amount of methanol, precipitated out by addition of ether, and dried in 
vacuum. Yield obtained was 10 mg. 
7.33.2. Analytical Data 
(Based on 2D HMQC experiment) 
1H NMR (500 MHz, DMSO-d6): δ = 7.85 (sbr, NH), 4.2 (Lys-α), 2.7 (Lys-ε), 1.56 (Lys-CH2), 
1.52 (Lys-CH2), 1.30 (Lys-CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 52.0 (Lys-α), 38.23 (Lys-ε), 25.99 (Lys-CH2), 30.74 (Lys-
CH2), 21.82 (Lys-CH2). 
MALDI-TOF: A series of Lys (Z) oligomers were observed with masses ranging from 146 to 
1042 Da. 
7.34. Compound 34: Poly-Bic-Tyr 
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7.34.1. Procedure 
Compound 12 (0.05 g, 0.11 mmol) was dissolved in DMF (5 mL). Then HOBt (0.07 g, 
0.56 mmol) and Poly DCC [N-Cyclohexylcarbodiimide, N´-methyl polystyrene] (0.17 g, 
0.22 mmol) were added and the pH of the reaction mixture was adjusted to 7-8 with triethylamine 
(0.03 mL, 0.22 mmol). The reaction mixture was stirred for 48 h at room temperature. Reaction 
was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1). The solvent was removed. Reaction 
mixture was washed with 10% MeOH in CHCl3 to remove excess HOBt. Yield obtained was 
quantitative. 
Alternatively, this compound was prepared as: 
Compound 12 (0.10 g, 0.22 mmol) was dissolved in DMF (5 mL). Then HOBt (0.15 g, 
1.13 mmol) and DCC (0.09 g, 0.45 mmol) were added and the pH of the reaction mixture was 
adjusted to 7-8 with triethylamine (0.07 mL, 0.45 mmol).The reaction mixture was stirred for 48 h 
at room temperature. The solvent was removed. Reaction was monitored by TLC 
(MeOH:EtOAC:H2O as 2:2:1). Reaction mixture was washed with 10% MeOH in CHCl3 to 
remove excess HOBt and DCU. Yield obtained was quantitative. 
7.34.2. Analytical Data 
(Based on 2D HMQC experiment) 
1H NMR (500 MHz, DMSO-d6): δ = 7.03 (s, Tyr-Ar), 6.61 (s, Tyr-Ar), 5.48 (s, 9a), 5.0 (s, 6-H), 
4.66 (s, 3-H), 4.49 (Tyr-α), 3.85 (8-H), 3.69 (7-H), 3.62 (9-H), 3.36 (s, Tyr-β), 3.22-2.97 (s, 2H). 
13C NMR (500 MHz, DMSO-d6): δ = 129.3 (Tyr-Ar), 114.6 (Tyr-Ar), 75.1 (C-9H), 74.5  
(C-7), 70.7 (C-8), 60.6 (C-9a), 52.0 (C-6), 64.7 (C-3), 53.3 (Tyr-α), 32.3-32.1 (C-2H), 48.2 (Tyr-
β). 
MALDI–TOF: A series of oligomers were observed with masses ranging from 441 to 4671 Da.  
(n = 1; 441), (n = 2; 864), (n = 3; 1287), (n = 4; 1710), (n = 5; 2133), (n = 6; 2556), (n = 7; 2979), 
(n = 8; 3402), (n= 9; 3825), (n = 10; 4248). 
GPC: GPC shows the mixture of different molecular weight compounds ranging from 1628 to 
9031 Da. 
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7.35. Compound 35: Lys(2-Cl-Z)-Tyr 
(  )4
NH-Z-(  -Cl)
N
H
O
O
OH
N
H
n 
2  
35 
7.35.1. Procedure 
Compound 27 (0.05 g, 0.104 mmol) was dissolved in DMF (2 mL). Then HOBt (0.07 g, 
0.52 mmol) and Poly DCC [N-Cyclohexylcarbodiimide, N´-methyl polystyrene] (0.16 g, 
0.20 mmol) were added and the pH of the reaction mixture was adjusted to 7-8 with triethylamine 
(0.03 mL, 0.209 mmol). The reaction mixture was stirred for 48 h at room temperature. Reaction 
was monitored by TLC ((MeOH:EtOAC:H2O as 2:2:1). The solvent was removed. Reaction 
mixture was washed with 10% MeOH in CHCl3 to remove excess HOBt. Yield obtained was 
quantitative. 
Alternative, compound 35 was synthesized as: 
Compound 27 (0.05 g, 0.104 mmol) was dissolved in DMF (5 mL). Then HOBt (0.07 g, 
0.52 mmol) and DCC (0.04 g, 0.20 mmol) were added and the pH of the reaction mixture was 
adjusted to 7-8 with triethylamine (0.03 mL, 0.209 mmol). The reaction mixture was stirred for 
48 h at room temperature. Reaction was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1). The 
solvent was removed. Reaction mixture was washed with 10% MeOH in CHCl3 to removed 
excess HOBt and DCU. Yield obtained was quantitative. 
7.35.2. Analytical Data 
(Based on 2D HMQC experiment) 
1H NMR (500 MHz, DMSO-d6): δ = 7.45, 7.34 (br, Ar-Z), 6.99 (Tyr-Ar), 6.64 (Tyr-Ar), 5.3 
(CH2-Ar), 4.8-4.25 (Tyr-α), 3.68 (Lys-α), 2.94-2.8 (Tyr-β and Lys-ε), 1.66 (Lys-CH2), 1.38 (Lys-
CH2), 1.19 (Lys-CH2). 
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13C NMR (500 MHz, DMSO-d6): δ = 130.0 (Tyr-Ar), 129.8 (Ar-Z), 114.7 (Tyr-Ar), 63.0 (CH2-
Ar), 54.5 (Tyr-α), 51.8 (Lys-α), 39.9-39.6 (Tyr-β and Lys-ε), 31.1 (Lys-CH2), 29.0 (Lys-CH2), 
22.0 (Lys-CH2). 
MALDI–TOF: A series of Lys (2-Cl-Z) oligomers were observed with masses ranging from 482 
to 2323 Da. (n = 1; 482), (n = 2; 941.6), (n = 3; 1403), (n = 4; 1862.5), (n = 5; 2323.9). 
GPC: GPC shows the mixture of different molecular weight compounds ranging from 880 to 
11450 Da. 
7.36. Compound 36: Poly-Lys(Z)-Bic-Tyr 
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7.36.1. Procedure 
Compound 15 (0.050 g, 0.071 mmol) was dissolved in DMF (5 mL). Then HOBt (0.048 g, 
0.35 mmol) and Poly DCC [N-Cyclohexylcarbodiimide, N´-methyl polystyrene] (0.109 g, 
0.142 mmol) were added and the pH of the reaction mixture was adjusted to 7-8 with 
triethylamine (0.02 mL, 0.142 mmol). The reaction mixture was stirred for 48 h at room 
temperature. Reaction was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1). The solvent was 
removed. Reaction mixture was washed with 10% MeOH in CHCl3 to remove excess HOBt. 
Yield obtained was quantitative. 
Alternatively, this product was synthesized as: 
Compound 15 (0.050 g, 0.071 mmol) was dissolved in DMF (5 mL). Then HOBt (0.048 g, 
0.35 mmol) and DCC (0.029 g, 0.142 mmol) were added and the pH of the reaction mixture was 
adjusted to 7-8 with triethylamine (0.02 mL, 0.142 mmol). The reaction mixture was stirred for 
48 h at room temperature. Reaction was monitored by TLC (MeOH:EtOAC:H2O as 2:2:1). The 
solvent was removed. Reaction mixture was washed with 10% MeOH in CHCl3 to remove excess 
HOBt and DCU. Yield obtained was quantitative. 
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7.36.2. Analytical Data 
(Based on 2D HMQC experiment) 
1H NMR (500 MHz, DMSO-d6): δ = 7.34 (Ar-Z), 7.04 (Tyr-Ar), 6.66 (Tyr-Ar), 5.5 (9a-H), 5.13 
(6-H), 5.0 (CH2-Ar), 4.31 (Tyr-α), 4.77 (3-H), 3.87 (8-H), 3.85 (Lys-α), 3.76 (7-H), 3.62 (9-H), 
3.11-3.25 (2-H), 2.97 (Tyr-β), 2.92-2.83 (Lys-ε), 1.73 (Lys-CH2), 1.39 (Lys-CH2), 1.36 (Lys-
CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 130.0 (Tyr-Ar), 127.5 (Ar-Z), 114.8 (Tyr-Ar), 76.0 (C-9), 
74.5 (C-7), 71.0 (C-8), 70.1 (C-9a), 64.9 (CH2-Ar), 64.8 (C-3), 53.97 (Tyr-α), 51.77 (Lys-α), 52.1 
(C-6), 32.0 (C-2), 39.6 (Tyr-β), 34.4 (Lys-ε), 30.7 (Lys-CH2), 28.4 (Lys-CH2), 21.4 (Lys-CH2). 
MALDI–TOF: A series of oligomers were observed with masses ranging from 742 to 2783 Da.  
(n = 2; 1410), (n = 3; 2096.8), (n = 4; 2783.2). 
GPC: GPC shows the mixture of different molecular weight compounds ranging from 1614 to 
32920 Da. 
7.37. Compound 37: Poly-Lys-Bic-Tyr 
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7.37.1. Procedure 
Compound 36 (25 mg) was treated with HCl (10 mL) in diethyl ether. The reaction mixture was 
stirred for 8 h at room temperature to yield the HCl salt of the free amine of 37. Yield obtained 
was quantitative. 
7.37.2. Analytical Data 
(Based on 2D HMQC experiment) 
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1H NMR (500 MHz, DMSO-d6): δ = 7.30-7.0 (Tyr-Ar), 6.88-6.28 (Tyr-Ar), 5.48 (9a-H), 5.03 (6-
H), 4.64-4.59 (3-H), 4.30 (Tyr-α), 4.30 (Lys-α), 3.98-3.77 (8-H), 3.78 (7-H), 3.74 (9-H), 3.15 
(Tyr-β),2.69 (Lys-ε), 3.22-3.07 (2-H), 1.55 (Lys-CH2), 1.32 (Lys-CH2), 0.83 (Lys-CH2). 
13C NMR (500 MHz, DMSO-d6): δ = 129.4 (Tyr-Ar), 114.76-114.58 (Tyr-Ar), 61.03 (C-9a), 
51.99 (C-6), 64.59-64.3 (C-3), 53.9 (Lys-α), 51.9 (Tyr-α), 71.1 (C-8), 75.4 (C-7), 76.4 (C-9), 
48.31 (Tyr-β), 34.7 (Lys-ε), 31.98 (C-2), 26.08 (Lys-CH2), 21.41 (Lys-CH2), 13.49 (Lys-CH2). 
MALDI-TOF: A series of oligomers were observed with masses ranging from 569 to 1671 Da. 
7.38. Compound 38: Saponification Reaction 
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38 
X1 = OH, N3, NH2, Boc-NH. 
XOH = KOH, NaOH, LiOH. 
7.38.1. Procedure  
Methyl ester of X1 (where X1 could be either acid or azide or amine or Boc-NH) (1 g, 1 eq) was 
dissolved in H2O till ester was soluble. XOH (2 eq, 1N) was added into reaction mixture. Reaction 
was monitored by TLC and stopped after 30 min with (1 eq, 1N) HCl. Solvent was removed, yield 
obtained was quantitative. Saponification reaction did not work for azide as the 6-H atom is more 
acidic. 
7.38.2. Analytical Data 
(a) For X1 = acid, 
1H NMR (300 MHz, DMSO-d6): δ = 7.94 (s, 1H, COOH), 5.45 (s, 1H, 9a-H), 4.59 (pt, 
3J3,2 = 7.96 Hz, 1H, 3-H), 4.32 (sbr, 1H, 6-H), 3.39 (sbr, 1H, 7-H), 3.62 (d, 3J8,9 = 5.49 Hz, 1H, 
8-H), 3.44 (dd, 3J9,9-OH = 8.78Hz and 3J9,8 = 3.29 Hz, 1H, 9-H), 3.16 (m, 2H, 2-H). 
13C NMR (300 MHz, DMSO-d6): δ = 170.55, 170.35 (CO-5, COMe), 31.39(C-2), 52.10 (OMe), 
60.97 (C-9a), 63.78 (C-3), 70.86 (C-8), 76.00 (C-7), 76.87 (C-9). 
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ESI-MS (H2O/MeOH + 10 mmole/NH4Ac) (m/z): 293.7 [MH]+, 310.8 [M+NH4]+, 315.8 
[M+Na]+, 604 [2M+NH4]+, 609 [2M+Na]+. 
Melting Point: Decompose at 208°C. 
(b) For X1 = amine, 
1H NMR (300 MHz, DMSO-d6): δ = 5.58 (s, 1H, 9a-H), 4.58 (pt. 3J3,2 = 7.0 Hz, 1H, 3-H), 4.51 (s, 
1H, 6H), 3.86 (d, 3J7,8 = 3.57 Hz, 1H, 7-H), 3.82 (d, 3J8,9 = 4.086 Hz, 1H, 8-H), 3.51 (d,  
3J9,8 = 3.043Hz, 1H, 9-H), 3.21 (m, 2H, 2-H). 
13C NMR (300 MHz, DMSO-d6): δ = 173.66, 165.55 (CO-5, CO-OH), 75.78 (C-9), 72.01  
(C-7), 71.48 (C-8), 66.08 (C-3), 61.15 (C-9a), 53.13 (C-6), 32.73 (C-2). 
ESI-MS (CH2Cl2/MeOH+NH4AC) (m/z): 278.8 [M-H]+. 
Melting Point: Decompose at 200°C. 
(c) for X1 = Boc-NH, 
1H NMR (500 MHz, DMSO-d6): δ = 7.17 (s, 1H, OH), 6.49 (d, 3JBoc-NH,6 = 8.23Hz, 1H, Boc-NH), 
5.63 (s, 1H, OH), 5.48 (s, 1H, 9a-H), 5.12 (s, 1H, OH), 4.74 (d, 3J6-H,Boc-NH = 8.51Hz, 1H, 6-H), 
4.57 (t, 3J3,2 = 6.59Hz, 1H, 3-H), 3.8 (d, 3J8,9 = 3.84 Hz, 1H, 8-H), 3.68 (s, 1H, 7-H), 3.49 (s, 1H, 
9-H), 3.21 (d, 3J2,3 = 6.59Hz, 1H, 2-H), 3.15 (d, 3J2,3 = 4.94Hz, 1H, 2-H), 1.37 (s, 9H, t-butyl-
CH3). 
13C NMR (300 MHz, DMSO-d6): δ = 174.51 (CO-5), 167.79 (COOH), 154.77 (Boc-CO), 78.05 
(C-t-butylquart), 75.66 (C-9), 74.73 (C-7), 71.46 (C-8), 66.12 (C-3), 61.00 (C-9a), 53.52 (C-6), 
32.48 (C-2), 28.05(3C, t-butyl CH3). 
ESI-MS (CH2Cl2/MeOH+NH4AC) (m/z): 379 [M + H+], 401 [M + Na]+, 423.0  
[M-H+ + 2Na]+. 
Melting Point: Decompose at 210°C. 
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